{"source": "HomoSapiens", "value": 1, "ngenes": 32713, "description": "Homo Sapiens", "id": "6c30e01a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-168256", "value": 0.16179881236774174, "ngenes": 3372, "description": "Immune System", "id": "6c30e01b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1280215", "value": 0.019381408980311116, "ngenes": 1238, "description": "Cytokine Signaling in Immune system", "id": "6c30e01c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-449147", "value": 0.08273255430211818, "ngenes": 820, "description": "Signaling by Interleukins", "id": "6c30e01d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-6783589", "value": 0.000878008396942418, "ngenes": 37, "description": "Interleukin-6 family signaling", "id": "6c30e01e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1059683", "value": 7.391887120768272e-08, "ngenes": 20, "description": "Interleukin-6 signaling", "id": "6c30e01f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6788467", "value": 1.977247329093225e-10, "ngenes": 23, "description": "IL-6-type cytokine receptor ligand interactions", "id": "6c30e020-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1266695", "value": 5.874233971696563e-06, "ngenes": 55, "description": "Interleukin-7 signaling", "id": "6c30e021-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-448424", "value": 0.9983392746661979, "ngenes": 149, "description": "Interleukin-17 signaling", "id": "6c30e022-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-450294", "value": 0.952003734737143, "ngenes": 131, "description": "MAP kinase activation", "id": "6c30e023-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-450282", "value": 0.3039793880704522, "ngenes": 70, "description": "MAPK targets/ Nuclear events mediated by MAP kinases", "id": "6c30e024-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-199920", "value": 0.41522455244533674, "ngenes": 17, "description": "CREB phosphorylation", "id": "6c30e025-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-198753", "value": 0.37761079458939656, "ngenes": 48, "description": "ERK/MAPK targets", "id": "6c30e026-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-202670", "value": 0.05382852466722305, "ngenes": 29, "description": "ERKs are inactivated", "id": "6c30e027-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-450341", "value": 0.30407382717235315, "ngenes": 25, "description": "Activation of the AP-1 family of transcription factors", "id": "6c30e028-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-450302", "value": 0.5872342674363719, "ngenes": 48, "description": "activated TAK1 mediates p38 MAPK activation", "id": "6c30e029-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-450321", "value": 0.08467202887201626, "ngenes": 48, "description": "JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1", "id": "6c30e02a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5684264", "value": 0.20494411367087506, "ngenes": 29, "description": "MAP3K8 (TPL2)-dependent MAPK1/3 activation", "id": "6c30e02b-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-446652", "value": 0.347333768619178, "ngenes": 258, "description": "Interleukin-1 family signaling", "id": "6c30e02c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9020702", "value": 0.25749615433632317, "ngenes": 180, "description": "Interleukin-1 signaling", "id": "6c30e02d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-445989", "value": 0.7461737503777922, "ngenes": 62, "description": "TAK1 activates NFkB by phosphorylation and activation of IKKs complex", "id": "6c30e02e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5684264", "value": 0.20494411367087506, "ngenes": 29, "description": "MAP3K8 (TPL2)-dependent MAPK1/3 activation", "id": "6c30e02f-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-448706", "value": 0.1742798089341715, "ngenes": 12, "description": "Interleukin-1 processing", "id": "6c30e030-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9007892", "value": 0.00018260766141667314, "ngenes": 7, "description": "Interleukin-38 signaling", "id": "6c30e031-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9008059", "value": 0.01644052010881652, "ngenes": 49, "description": "Interleukin-37 signaling", "id": "6c30e032-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9012546", "value": 0.7545689250795384, "ngenes": 17, "description": "Interleukin-18 signaling", "id": "6c30e033-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9014826", "value": 0.05910865159139596, "ngenes": 13, "description": "Interleukin-36 pathway", "id": "6c30e034-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9014843", "value": 0.5234684174892665, "ngenes": 9, "description": "Interleukin-33 signaling", "id": "6c30e035-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-449836", "value": 0.2813230162724913, "ngenes": 37, "description": "Other interleukin signaling", "id": "6c30e036-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6783783", "value": 0.47326733180748626, "ngenes": 71, "description": "Interleukin-10 signaling", "id": "6c30e037-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6785807", "value": 0.4679326534333106, "ngenes": 195, "description": "Interleukin-4 and Interleukin-13 signaling", "id": "6c30e038-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8854691", "value": 0.0006290643780517479, "ngenes": 40, "description": "Interleukin-20 family signaling", "id": "6c30e039-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-447115", "value": 7.425759051428888e-05, "ngenes": 91, "description": "Interleukin-12 family signaling", "id": "6c30e03a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9020591", "value": 0.06306926833487561, "ngenes": 75, "description": "Interleukin-12 signaling", "id": "6c30e03b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8950505", "value": 0.005551593929785786, "ngenes": 64, "description": "Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation", "id": "6c30e03c-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8984722", "value": 6.169007758500197e-05, "ngenes": 17, "description": "Interleukin-35 Signalling", "id": "6c30e03d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9020933", "value": 0.08758512881758648, "ngenes": 14, "description": "Interleukin-23 signaling", "id": "6c30e03e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9020956", "value": 4.744156019031792e-07, "ngenes": 16, "description": "Interleukin-27 signaling", "id": "6c30e03f-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-451927", "value": 0.10204685416276443, "ngenes": 85, "description": "Interleukin-2 family signaling", "id": "6c30e040-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8983432", "value": 0.9142497083471408, "ngenes": 26, "description": "Interleukin-15 signaling", "id": "6c30e041-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8985947", "value": 4.833253483512908e-05, "ngenes": 16, "description": "Interleukin-9 signaling", "id": "6c30e042-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9020558", "value": 0.980932284280478, "ngenes": 19, "description": "Interleukin-2 signaling", "id": "6c30e043-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9020958", "value": 0.003995495432952322, "ngenes": 17, "description": "Interleukin-21 signaling", "id": "6c30e044-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-912526", "value": 0.9439099697859671, "ngenes": 46, "description": "Interleukin receptor SHC signaling", "id": "6c30e045-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-512988", "value": 0.37408492199398546, "ngenes": 80, "description": "Interleukin-3, Interleukin-5 and GM-CSF signaling", "id": "6c30e046-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-912526", "value": 0.9439099697859671, "ngenes": 46, "description": "Interleukin receptor SHC signaling", "id": "6c30e047-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-912631", "value": 0.03358907183212736, "ngenes": 39, "description": "Regulation of signaling by CBL", "id": "6c30e048-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-913531", "value": 0.0014947109816141372, "ngenes": 339, "description": "Interferon Signaling", "id": "6c30e049-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1169410", "value": 2.223679263699002e-06, "ngenes": 139, "description": "Antiviral mechanism by IFN-stimulated genes", "id": "6c30e04a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1169408", "value": 0.2878768830891785, "ngenes": 121, "description": "ISG15 antiviral mechanism", "id": "6c30e04b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8983711", "value": 0.0005601830888343021, "ngenes": 19, "description": "OAS antiviral response", "id": "6c30e04c-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-877300", "value": 0.040556413506663204, "ngenes": 167, "description": "Interferon gamma signaling", "id": "6c30e04d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-877312", "value": 0.02955597704355524, "ngenes": 21, "description": "Regulation of IFNG signaling", "id": "6c30e04e-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-909733", "value": 0.0010238479704531309, "ngenes": 111, "description": "Interferon alpha/beta signaling", "id": "6c30e04f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-912694", "value": 0.00020034761943121384, "ngenes": 36, "description": "Regulation of IFNA signaling", "id": "6c30e050-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-1170546", "value": 0.0005748723680122831, "ngenes": 26, "description": "Prolactin receptor signaling", "id": "6c30e051-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9607240", "value": 0.1582304151822842, "ngenes": 77, "description": "FLT3 Signaling", "id": "6c30e052-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-109704", "value": 1.152032535262405e-06, "ngenes": 80, "description": "PI3K Cascade", "id": "6c30e053-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-165158", "value": 0.8528146719641481, "ngenes": 10, "description": "Activation of AKT2", "id": "6c30e054-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5673001", "value": 0.773184284378466, "ngenes": 499, "description": "RAF/MAP kinase cascade", "id": "6c30e055-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5658442", "value": 0.3059896160410839, "ngenes": 119, "description": "Regulation of RAS by GAPs", "id": "6c30e056-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5673000", "value": 0.17764948199395705, "ngenes": 57, "description": "RAF activation", "id": "6c30e057-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5674135", "value": 0.38820335494891073, "ngenes": 68, "description": "MAP2K and MAPK activation", "id": "6c30e058-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5675221", "value": 0.4883227273231137, "ngenes": 70, "description": "Negative regulation of MAPK pathway", "id": "6c30e059-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5674499", "value": 0.09314686211408571, "ngenes": 10, "description": "Negative feedback regulation of MAPK pathway", "id": "6c30e05a-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9648002", "value": 0.6651875951883908, "ngenes": 49, "description": "RAS processing", "id": "6c30e05b-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9645135", "value": 2.482692656523164e-08, "ngenes": 10, "description": "STAT5 Activation", "id": "6c30e05c-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5668541", "value": 0.8775715761333365, "ngenes": 176, "description": "TNFR2 non-canonical NF-kB pathway", "id": "6c30e05d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5669034", "value": 0.09916536199769871, "ngenes": 51, "description": "TNFs bind their physiological receptors", "id": "6c30e05e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5676590", "value": 0.438641842350912, "ngenes": 105, "description": "NIK-->noncanonical NF-kB signaling", "id": "6c30e05f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5676594", "value": 0.11777630059142877, "ngenes": 29, "description": "TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway", "id": "6c30e060-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-982772", "value": 6.271609238185378e-05, "ngenes": 44, "description": "Growth hormone receptor signaling", "id": "6c30e061-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1280218", "value": 0.14518948415085434, "ngenes": 1297, "description": "Adaptive Immune System", "id": "6c30e062-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-983705", "value": 0.016420715281249436, "ngenes": 201, "description": "Signaling by the B Cell Receptor (BCR)", "id": "6c30e063-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1168372", "value": 0.37924176668899345, "ngenes": 146, "description": "Downstream signaling events of B Cell Receptor (BCR)", "id": "6c30e064-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1169091", "value": 0.40358438321135004, "ngenes": 118, "description": "Activation of NF-kappaB in B cells", "id": "6c30e065-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1169092", "value": 0.33306107336922713, "ngenes": 7, "description": "Activation of RAS in B cells", "id": "6c30e066-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2025928", "value": 0.0421821021089173, "ngenes": 21, "description": "Calcineurin activates NFAT", "id": "6c30e067-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5690714", "value": 0.5287457145205242, "ngenes": 21, "description": "CD22 mediated BCR regulation", "id": "6c30e068-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-983695", "value": 0.2439807815582183, "ngenes": 56, "description": "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers", "id": "6c30e069-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-983169", "value": 0.6504738560394484, "ngenes": 661, "description": "Class I MHC mediated antigen processing & presentation", "id": "6c30e06a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1236975", "value": 0.08489618425859641, "ngenes": 167, "description": "Antigen processing-Cross presentation", "id": "6c30e06b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1236973", "value": 0.3126086995958799, "ngenes": 17, "description": "Cross-presentation of particulate exogenous antigens (phagosomes)", "id": "6c30e06c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1236974", "value": 0.14984797572041342, "ngenes": 137, "description": "ER-Phagosome pathway", "id": "6c30e06d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1236977", "value": 0.042355281174816135, "ngenes": 21, "description": "Endosomal/Vacuolar pathway", "id": "6c30e06e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1236978", "value": 0.082471670657363, "ngenes": 84, "description": "Cross-presentation of soluble exogenous antigens (endosomes)", "id": "6c30e06f-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-983168", "value": 0.3879787020358802, "ngenes": 561, "description": "Antigen processing: Ubiquitination & Proteasome degradation", "id": "6c30e070-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-983170", "value": 0.1383119592095422, "ngenes": 44, "description": "Antigen Presentation: Folding, assembly and peptide loading of class I MHC", "id": "6c30e071-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-198933", "value": 0.25775443310056195, "ngenes": 220, "description": "Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell", "id": "6c30e072-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-202403", "value": 0.17538871250314741, "ngenes": 214, "description": "TCR signaling", "id": "6c30e073-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-202424", "value": 0.3443827103012087, "ngenes": 171, "description": "Downstream TCR signaling", "id": "6c30e074-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-202427", "value": 0.892117185936382, "ngenes": 35, "description": "Phosphorylation of CD3 and TCR zeta chains", "id": "6c30e075-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-202430", "value": 0.9769646472509208, "ngenes": 29, "description": "Translocation of ZAP-70 to Immunological synapse", "id": "6c30e076-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-202433", "value": 0.6281127492810145, "ngenes": 52, "description": "Generation of second messenger molecules", "id": "6c30e077-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-2132295", "value": 0.7105862632774661, "ngenes": 181, "description": "MHC class II antigen presentation", "id": "6c30e078-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-388841", "value": 0.4335743497863355, "ngenes": 125, "description": "Costimulation by the CD28 family", "id": "6c30e079-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-389356", "value": 0.4270541421617548, "ngenes": 72, "description": "CD28 co-stimulation", "id": "6c30e07a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-389357", "value": 0.766085574148801, "ngenes": 51, "description": "CD28 dependent PI3K/Akt signaling", "id": "6c30e07b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-389359", "value": 0.11863213781216937, "ngenes": 27, "description": "CD28 dependent Vav1 pathway", "id": "6c30e07c-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-389513", "value": 0.0682703740597573, "ngenes": 47, "description": "CTLA4 inhibitory signaling", "id": "6c30e07d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-389948", "value": 0.9336322000525845, "ngenes": 29, "description": "PD-1 signaling", "id": "6c30e07e-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-392517", "value": 0.488511260239706, "ngenes": 30, "description": "Rap1 signalling", "id": "6c30e07f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8851680", "value": 0.6483581712829315, "ngenes": 17, "description": "Butyrophilin (BTN) family interactions", "id": "6c30e080-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-168249", "value": 0.49590622125641004, "ngenes": 1745, "description": "Innate Immune System", "id": "6c30e081-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1222556", "value": 0.25320644153618055, "ngenes": 59, "description": "ROS and RNS production in phagocytes", "id": "6c30e082-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6803157", "value": 0.05436886729829192, "ngenes": 117, "description": "Antimicrobial peptides", "id": "6c30e083-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1461973", "value": 0.6323881002309694, "ngenes": 60, "description": "Defensins", "id": "6c30e084-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1461957", "value": 0.3561826694897887, "ngenes": 48, "description": "Beta defensins", "id": "6c30e085-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1462054", "value": 0.8762122038040836, "ngenes": 12, "description": "Alpha-defensins", "id": "6c30e086-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-6799990", "value": 4.2677770894650205e-06, "ngenes": 7, "description": "Metal sequestration by antimicrobial proteins", "id": "6c30e087-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6803544", "value": 0.0038629075862268427, "ngenes": 4, "description": "Ion influx/efflux at host-pathogen interface", "id": "6c30e088-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1834949", "value": 0.0782228105791333, "ngenes": 98, "description": "Cytosolic sensors of pathogen-associated DNA ", "id": "6c30e089-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1606322", "value": 0.0002175109356923296, "ngenes": 30, "description": "ZBP1(DAI) mediated induction of type I IFNs", "id": "6c30e08a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1606341", "value": 0.9889635739310592, "ngenes": 5, "description": "IRF3 mediated activation of type 1 IFN", "id": "6c30e08b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1810476", "value": 0.0003615197562040352, "ngenes": 26, "description": "RIP-mediated NFkB activation via ZBP1", "id": "6c30e08c-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-3134963", "value": 0.08605247725321616, "ngenes": 13, "description": "DEx/H-box helicases activate type I IFN and inflammatory cytokines production ", "id": "6c30e08d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3134973", "value": 0.1865797600490249, "ngenes": 12, "description": "LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production", "id": "6c30e08e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3134975", "value": 0.4270541421617548, "ngenes": 19, "description": "Regulation of innate immune responses to cytosolic DNA", "id": "6c30e08f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1834941", "value": 0.6748593457762166, "ngenes": 21, "description": "STING mediated induction of host immune responses", "id": "6c30e090-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3249367", "value": 0.09049131798267977, "ngenes": 3, "description": "STAT6-mediated induction of chemokines", "id": "6c30e091-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3270619", "value": 0.39450092076989585, "ngenes": 18, "description": "IRF3-mediated induction of type I IFN", "id": "6c30e092-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-168898", "value": 0.7880847486523629, "ngenes": 287, "description": "Toll-like Receptor Cascades", "id": "6c30e093-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-166016", "value": 0.441944419315339, "ngenes": 242, "description": "Toll Like Receptor 4 (TLR4) Cascade", "id": "6c30e094-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-166020", "value": 0.8129942065725239, "ngenes": 3, "description": "Transfer of LPS from LBP carrier to CD14", "id": "6c30e095-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-166058", "value": 0.9439099697859671, "ngenes": 187, "description": "MyD88:MAL(TIRAP) cascade initiated on plasma membrane", "id": "6c30e096-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-450294", "value": 0.952003734737143, "ngenes": 131, "description": "MAP kinase activation", "id": "6c30e097-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-450282", "value": 0.3039793880704522, "ngenes": 70, "description": "MAPK targets/ Nuclear events mediated by MAP kinases", "id": "6c30e098-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-199920", "value": 0.41522455244533674, "ngenes": 17, "description": "CREB phosphorylation", "id": "6c30e099-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-198753", "value": 0.37761079458939656, "ngenes": 48, "description": "ERK/MAPK targets", "id": "6c30e09a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-202670", "value": 0.05382852466722305, "ngenes": 29, "description": "ERKs are inactivated", "id": "6c30e09b-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-450341", "value": 0.30407382717235315, "ngenes": 25, "description": "Activation of the AP-1 family of transcription factors", "id": "6c30e09c-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-450302", "value": 0.5872342674363719, "ngenes": 48, "description": "activated TAK1 mediates p38 MAPK activation", "id": "6c30e09d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-450321", "value": 0.08467202887201626, "ngenes": 48, "description": "JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1", "id": "6c30e09e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5684264", "value": 0.20494411367087506, "ngenes": 29, "description": "MAP3K8 (TPL2)-dependent MAPK1/3 activation", "id": "6c30e09f-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-445989", "value": 0.7461737503777922, "ngenes": 62, "description": "TAK1 activates NFkB by phosphorylation and activation of IKKs complex", "id": "6c30e0a0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-937039", "value": 0.26897492804448975, "ngenes": 26, "description": "IRAK1 recruits IKK complex", "id": "6c30e0a1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-937042", "value": 0.7303569146834761, "ngenes": 22, "description": "IRAK2 mediated activation of TAK1 complex", "id": "6c30e0a2-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-166166", "value": 0.3149293538271384, "ngenes": 198, "description": "MyD88-independent TLR4 cascade ", "id": "6c30e0a3-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-937061", "value": 0.3149293538271384, "ngenes": 198, "description": "TRIF(TICAM1)-mediated TLR4 signaling ", "id": "6c30e0a4-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-450294", "value": 0.952003734737143, "ngenes": 131, "description": "MAP kinase activation", "id": "6c30e0a5-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-450282", "value": 0.3039793880704522, "ngenes": 70, "description": "MAPK targets/ Nuclear events mediated by MAP kinases", "id": "6c30e0a6-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-199920", "value": 0.41522455244533674, "ngenes": 17, "description": "CREB phosphorylation", "id": "6c30e0a7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-198753", "value": 0.37761079458939656, "ngenes": 48, "description": "ERK/MAPK targets", "id": "6c30e0a8-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-202670", "value": 0.05382852466722305, "ngenes": 29, "description": "ERKs are inactivated", "id": "6c30e0a9-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-450341", "value": 0.30407382717235315, "ngenes": 25, "description": "Activation of the AP-1 family of transcription factors", "id": "6c30e0aa-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-450302", "value": 0.5872342674363719, "ngenes": 48, "description": "activated TAK1 mediates p38 MAPK activation", "id": "6c30e0ab-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-450321", "value": 0.08467202887201626, "ngenes": 48, "description": "JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1", "id": "6c30e0ac-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5684264", "value": 0.20494411367087506, "ngenes": 29, "description": "MAP3K8 (TPL2)-dependent MAPK1/3 activation", "id": "6c30e0ad-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-2562578", "value": 0.5587714499057822, "ngenes": 15, "description": "TRIF-mediated programmed cell death", "id": "6c30e0ae-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-445989", "value": 0.7461737503777922, "ngenes": 62, "description": "TAK1 activates NFkB by phosphorylation and activation of IKKs complex", "id": "6c30e0af-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-936964", "value": 0.02466306326642021, "ngenes": 30, "description": "Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon", "id": "6c30e0b0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-937041", "value": 0.7425883379587369, "ngenes": 45, "description": "IKK complex recruitment mediated by RIP1", "id": "6c30e0b1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-937072", "value": 0.7425883379587369, "ngenes": 30, "description": "TRAF6-mediated induction of TAK1 complex within TLR4 complex", "id": "6c30e0b2-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-1679131", "value": 0.03557238532077688, "ngenes": 23, "description": "Trafficking and processing of endosomal TLR", "id": "6c30e0b3-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-168164", "value": 0.24103954491873092, "ngenes": 194, "description": "Toll Like Receptor 3 (TLR3) Cascade", "id": "6c30e0b4-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-168927", "value": 0.29372426562890075, "ngenes": 41, "description": "TICAM1, RIP1-mediated IKK complex recruitment", "id": "6c30e0b5-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-450294", "value": 0.952003734737143, "ngenes": 131, "description": "MAP kinase activation", "id": "6c30e0b6-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-450282", "value": 0.3039793880704522, "ngenes": 70, "description": "MAPK targets/ Nuclear events mediated by MAP kinases", "id": "6c30e0b7-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-199920", "value": 0.41522455244533674, "ngenes": 17, "description": "CREB phosphorylation", "id": "6c30e0b8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-198753", "value": 0.37761079458939656, "ngenes": 48, "description": "ERK/MAPK targets", "id": "6c30e0b9-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-202670", "value": 0.05382852466722305, "ngenes": 29, "description": "ERKs are inactivated", "id": "6c30e0ba-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-450341", "value": 0.30407382717235315, "ngenes": 25, "description": "Activation of the AP-1 family of transcription factors", "id": "6c30e0bb-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-450302", "value": 0.5872342674363719, "ngenes": 48, "description": "activated TAK1 mediates p38 MAPK activation", "id": "6c30e0bc-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-450321", "value": 0.08467202887201626, "ngenes": 48, "description": "JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1", "id": "6c30e0bd-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5684264", "value": 0.20494411367087506, "ngenes": 29, "description": "MAP3K8 (TPL2)-dependent MAPK1/3 activation", "id": "6c30e0be-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-445989", "value": 0.7461737503777922, "ngenes": 62, "description": "TAK1 activates NFkB by phosphorylation and activation of IKKs complex", "id": "6c30e0bf-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9013957", "value": 2.831555926221463e-05, "ngenes": 12, "description": "TLR3-mediated TICAM1-dependent programmed cell death", "id": "6c30e0c0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9013973", "value": 0.0007763277061395761, "ngenes": 25, "description": "TICAM1-dependent activation of IRF3/IRF7", "id": "6c30e0c1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9014325", "value": 0.5217316925393626, "ngenes": 25, "description": "TICAM1,TRAF6-dependent induction of TAK1 complex", "id": "6c30e0c2-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-168138", "value": 0.83323885084569, "ngenes": 180, "description": "Toll Like Receptor 9 (TLR9) Cascade", "id": "6c30e0c3-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-975155", "value": 0.8123457972362099, "ngenes": 176, "description": "MyD88 dependent cascade initiated on endosome", "id": "6c30e0c4-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-975138", "value": 0.896449074379589, "ngenes": 172, "description": "TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation", "id": "6c30e0c5-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-450294", "value": 0.952003734737143, "ngenes": 131, "description": "MAP kinase activation", "id": "6c30e0c6-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-450282", "value": 0.3039793880704522, "ngenes": 70, "description": "MAPK targets/ Nuclear events mediated by MAP kinases", "id": "6c30e0c7-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-199920", "value": 0.41522455244533674, "ngenes": 17, "description": "CREB phosphorylation", "id": "6c30e0c8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-198753", "value": 0.37761079458939656, "ngenes": 48, "description": "ERK/MAPK targets", "id": "6c30e0c9-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-202670", "value": 0.05382852466722305, "ngenes": 29, "description": "ERKs are inactivated", "id": "6c30e0ca-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-450341", "value": 0.30407382717235315, "ngenes": 25, "description": "Activation of the AP-1 family of transcription factors", "id": "6c30e0cb-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-450302", "value": 0.5872342674363719, "ngenes": 48, "description": "activated TAK1 mediates p38 MAPK activation", "id": "6c30e0cc-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-450321", "value": 0.08467202887201626, "ngenes": 48, "description": "JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1", "id": "6c30e0cd-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5684264", "value": 0.20494411367087506, "ngenes": 29, "description": "MAP3K8 (TPL2)-dependent MAPK1/3 activation", "id": "6c30e0ce-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-445989", "value": 0.7461737503777922, "ngenes": 62, "description": "TAK1 activates NFkB by phosphorylation and activation of IKKs complex", "id": "6c30e0cf-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-975144", "value": 0.26897492804448975, "ngenes": 26, "description": "IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation", "id": "6c30e0d0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-975163", "value": 0.6903353742376312, "ngenes": 29, "description": "IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation", "id": "6c30e0d1-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-975110", "value": 0.6029470467883523, "ngenes": 27, "description": "TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling", "id": "6c30e0d2-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-168142", "value": 0.8421637022685342, "ngenes": 167, "description": "Toll Like Receptor 10 (TLR10) Cascade", "id": "6c30e0d3-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-975871", "value": 0.8421637022685342, "ngenes": 167, "description": "MyD88 cascade initiated on plasma membrane", "id": "6c30e0d4-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-450294", "value": 0.952003734737143, "ngenes": 131, "description": "MAP kinase activation", "id": "6c30e0d5-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-450282", "value": 0.3039793880704522, "ngenes": 70, "description": "MAPK targets/ Nuclear events mediated by MAP kinases", "id": "6c30e0d6-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-199920", "value": 0.41522455244533674, "ngenes": 17, "description": "CREB phosphorylation", "id": "6c30e0d7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-198753", "value": 0.37761079458939656, "ngenes": 48, "description": "ERK/MAPK targets", "id": "6c30e0d8-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-202670", "value": 0.05382852466722305, "ngenes": 29, "description": "ERKs are inactivated", "id": "6c30e0d9-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-450341", "value": 0.30407382717235315, "ngenes": 25, "description": "Activation of the AP-1 family of transcription factors", "id": "6c30e0da-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-450302", "value": 0.5872342674363719, "ngenes": 48, "description": "activated TAK1 mediates p38 MAPK activation", "id": "6c30e0db-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-450321", "value": 0.08467202887201626, "ngenes": 48, "description": "JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1", "id": "6c30e0dc-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5684264", "value": 0.20494411367087506, "ngenes": 29, "description": "MAP3K8 (TPL2)-dependent MAPK1/3 activation", "id": "6c30e0dd-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-445989", "value": 0.7461737503777922, "ngenes": 62, "description": "TAK1 activates NFkB by phosphorylation and activation of IKKs complex", "id": "6c30e0de-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-937039", "value": 0.26897492804448975, "ngenes": 26, "description": "IRAK1 recruits IKK complex", "id": "6c30e0df-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-937042", "value": 0.7303569146834761, "ngenes": 22, "description": "IRAK2 mediated activation of TAK1 complex", "id": "6c30e0e0-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-168176", "value": 0.8421637022685342, "ngenes": 167, "description": "Toll Like Receptor 5 (TLR5) Cascade", "id": "6c30e0e1-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-975871", "value": 0.8421637022685342, "ngenes": 167, "description": "MyD88 cascade initiated on plasma membrane", "id": "6c30e0e2-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-450294", "value": 0.952003734737143, "ngenes": 131, "description": "MAP kinase activation", "id": "6c30e0e3-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-450282", "value": 0.3039793880704522, "ngenes": 70, "description": "MAPK targets/ Nuclear events mediated by MAP kinases", "id": "6c30e0e4-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-199920", "value": 0.41522455244533674, "ngenes": 17, "description": "CREB phosphorylation", "id": "6c30e0e5-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-198753", "value": 0.37761079458939656, "ngenes": 48, "description": "ERK/MAPK targets", "id": "6c30e0e6-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-202670", "value": 0.05382852466722305, "ngenes": 29, "description": "ERKs are inactivated", "id": "6c30e0e7-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-450341", "value": 0.30407382717235315, "ngenes": 25, "description": "Activation of the AP-1 family of transcription factors", "id": "6c30e0e8-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-450302", "value": 0.5872342674363719, "ngenes": 48, "description": "activated TAK1 mediates p38 MAPK activation", "id": "6c30e0e9-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-450321", "value": 0.08467202887201626, "ngenes": 48, "description": "JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1", "id": "6c30e0ea-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5684264", "value": 0.20494411367087506, "ngenes": 29, "description": "MAP3K8 (TPL2)-dependent MAPK1/3 activation", "id": "6c30e0eb-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-445989", "value": 0.7461737503777922, "ngenes": 62, "description": "TAK1 activates NFkB by phosphorylation and activation of IKKs complex", "id": "6c30e0ec-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-937039", "value": 0.26897492804448975, "ngenes": 26, "description": "IRAK1 recruits IKK complex", "id": "6c30e0ed-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-937042", "value": 0.7303569146834761, "ngenes": 22, "description": "IRAK2 mediated activation of TAK1 complex", "id": "6c30e0ee-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-168181", "value": 0.9336226860594022, "ngenes": 179, "description": "Toll Like Receptor 7/8 (TLR7/8) Cascade", "id": "6c30e0ef-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-975155", "value": 0.8123457972362099, "ngenes": 176, "description": "MyD88 dependent cascade initiated on endosome", "id": "6c30e0f0-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-975138", "value": 0.896449074379589, "ngenes": 172, "description": "TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation", "id": "6c30e0f1-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-450294", "value": 0.952003734737143, "ngenes": 131, "description": "MAP kinase activation", "id": "6c30e0f2-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-450282", "value": 0.3039793880704522, "ngenes": 70, "description": "MAPK targets/ Nuclear events mediated by MAP kinases", "id": "6c30e0f3-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-199920", "value": 0.41522455244533674, "ngenes": 17, "description": "CREB phosphorylation", "id": "6c30e0f4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-198753", "value": 0.37761079458939656, "ngenes": 48, "description": "ERK/MAPK targets", "id": "6c30e0f5-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-202670", "value": 0.05382852466722305, "ngenes": 29, "description": "ERKs are inactivated", "id": "6c30e0f6-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-450341", "value": 0.30407382717235315, "ngenes": 25, "description": "Activation of the AP-1 family of transcription factors", "id": "6c30e0f7-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-450302", "value": 0.5872342674363719, "ngenes": 48, "description": "activated TAK1 mediates p38 MAPK activation", "id": "6c30e0f8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-450321", "value": 0.08467202887201626, "ngenes": 48, "description": "JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1", "id": "6c30e0f9-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5684264", "value": 0.20494411367087506, "ngenes": 29, "description": "MAP3K8 (TPL2)-dependent MAPK1/3 activation", "id": "6c30e0fa-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-445989", "value": 0.7461737503777922, "ngenes": 62, "description": "TAK1 activates NFkB by phosphorylation and activation of IKKs complex", "id": "6c30e0fb-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-975144", "value": 0.26897492804448975, "ngenes": 26, "description": "IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation", "id": "6c30e0fc-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-975163", "value": 0.6903353742376312, "ngenes": 29, "description": "IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation", "id": "6c30e0fd-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-975110", "value": 0.6029470467883523, "ngenes": 27, "description": "TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling", "id": "6c30e0fe-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-181438", "value": 0.9414065335544575, "ngenes": 192, "description": "Toll Like Receptor 2 (TLR2) Cascade", "id": "6c30e0ff-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-168179", "value": 0.9414065335544575, "ngenes": 192, "description": "Toll Like Receptor TLR1:TLR2 Cascade", "id": "6c30e100-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-166058", "value": 0.9439099697859671, "ngenes": 187, "description": "MyD88:MAL(TIRAP) cascade initiated on plasma membrane", "id": "6c30e101-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-450294", "value": 0.952003734737143, "ngenes": 131, "description": "MAP kinase activation", "id": "6c30e102-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-450282", "value": 0.3039793880704522, "ngenes": 70, "description": "MAPK targets/ Nuclear events mediated by MAP kinases", "id": "6c30e103-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-199920", "value": 0.41522455244533674, "ngenes": 17, "description": "CREB phosphorylation", "id": "6c30e104-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-198753", "value": 0.37761079458939656, "ngenes": 48, "description": "ERK/MAPK targets", "id": "6c30e105-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-202670", "value": 0.05382852466722305, "ngenes": 29, "description": "ERKs are inactivated", "id": "6c30e106-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-450341", "value": 0.30407382717235315, "ngenes": 25, "description": "Activation of the AP-1 family of transcription factors", "id": "6c30e107-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-450302", "value": 0.5872342674363719, "ngenes": 48, "description": "activated TAK1 mediates p38 MAPK activation", "id": "6c30e108-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-450321", "value": 0.08467202887201626, "ngenes": 48, "description": "JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1", "id": "6c30e109-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5684264", "value": 0.20494411367087506, "ngenes": 29, "description": "MAP3K8 (TPL2)-dependent MAPK1/3 activation", "id": "6c30e10a-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-445989", "value": 0.7461737503777922, "ngenes": 62, "description": "TAK1 activates NFkB by phosphorylation and activation of IKKs complex", "id": "6c30e10b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-937039", "value": 0.26897492804448975, "ngenes": 26, "description": "IRAK1 recruits IKK complex", "id": "6c30e10c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-937042", "value": 0.7303569146834761, "ngenes": 22, "description": "IRAK2 mediated activation of TAK1 complex", "id": "6c30e10d-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-168188", "value": 0.9439099697859671, "ngenes": 187, "description": "Toll Like Receptor TLR6:TLR2 Cascade", "id": "6c30e10e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-166058", "value": 0.9439099697859671, "ngenes": 187, "description": "MyD88:MAL(TIRAP) cascade initiated on plasma membrane", "id": "6c30e10f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-450294", "value": 0.952003734737143, "ngenes": 131, "description": "MAP kinase activation", "id": "6c30e110-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-450282", "value": 0.3039793880704522, "ngenes": 70, "description": "MAPK targets/ Nuclear events mediated by MAP kinases", "id": "6c30e111-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-199920", "value": 0.41522455244533674, "ngenes": 17, "description": "CREB phosphorylation", "id": "6c30e112-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-198753", "value": 0.37761079458939656, "ngenes": 48, "description": "ERK/MAPK targets", "id": "6c30e113-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-202670", "value": 0.05382852466722305, "ngenes": 29, "description": "ERKs are inactivated", "id": "6c30e114-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-450341", "value": 0.30407382717235315, "ngenes": 25, "description": "Activation of the AP-1 family of transcription factors", "id": "6c30e115-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-450302", "value": 0.5872342674363719, "ngenes": 48, "description": "activated TAK1 mediates p38 MAPK activation", "id": "6c30e116-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-450321", "value": 0.08467202887201626, "ngenes": 48, "description": "JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1", "id": "6c30e117-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5684264", "value": 0.20494411367087506, "ngenes": 29, "description": "MAP3K8 (TPL2)-dependent MAPK1/3 activation", "id": "6c30e118-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-445989", "value": 0.7461737503777922, "ngenes": 62, "description": "TAK1 activates NFkB by phosphorylation and activation of IKKs complex", "id": "6c30e119-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-937039", "value": 0.26897492804448975, "ngenes": 26, "description": "IRAK1 recruits IKK complex", "id": "6c30e11a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-937042", "value": 0.7303569146834761, "ngenes": 22, "description": "IRAK2 mediated activation of TAK1 complex", "id": "6c30e11b-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-5686938", "value": 4.651958297659607e-05, "ngenes": 34, "description": "Regulation of TLR by endogenous ligand", "id": "6c30e11c-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-166658", "value": 0.773184284378466, "ngenes": 105, "description": "Complement cascade", "id": "6c30e11d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-166665", "value": 0.006051251035021077, "ngenes": 10, "description": "Terminal pathway of complement", "id": "6c30e11e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-166663", "value": 0.6061642085440843, "ngenes": 51, "description": "Initial triggering of complement", "id": "6c30e11f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-166786", "value": 0.3516344422591895, "ngenes": 40, "description": "Creation of C4 and C2 activators", "id": "6c30e120-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-173623", "value": 0.37801353668737425, "ngenes": 23, "description": "Classical antibody-mediated complement activation", "id": "6c30e121-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-166662", "value": 0.11718463292876465, "ngenes": 17, "description": "Lectin pathway of complement activation", "id": "6c30e122-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2855086", "value": 0.1564558274957353, "ngenes": 13, "description": "Ficolins bind to repetitive carbohydrate structures on the target cell surface", "id": "6c30e123-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-173736", "value": 0.13013248793148463, "ngenes": 8, "description": "Alternative complement activation", "id": "6c30e124-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-174577", "value": 0.5731260007449505, "ngenes": 10, "description": "Activation of C3 and C5", "id": "6c30e125-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-977606", "value": 0.7590317409527214, "ngenes": 85, "description": "Regulation of Complement cascade", "id": "6c30e126-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-168643", "value": 0.2181196202333426, "ngenes": 110, "description": "Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways", "id": "6c30e127-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-168638", "value": 0.44983472976479355, "ngenes": 75, "description": "NOD1/2 Signaling Pathway", "id": "6c30e128-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-622312", "value": 0.911195249508345, "ngenes": 38, "description": "Inflammasomes", "id": "6c30e129-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-844455", "value": 2.143333994131961e-11, "ngenes": 9, "description": "The NLRP1 inflammasome", "id": "6c30e12a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-844456", "value": 0.07626097175864055, "ngenes": 26, "description": "The NLRP3 inflammasome", "id": "6c30e12b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-844615", "value": 0.8483799675055577, "ngenes": 7, "description": "The AIM2 inflammasome", "id": "6c30e12c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-844623", "value": 0.5599165269735425, "ngenes": 4, "description": "The IPAF inflammasome", "id": "6c30e12d-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-2029480", "value": 0.03565365558003148, "ngenes": 179, "description": "Fcgamma receptor (FCGR) dependent phagocytosis", "id": "6c30e12e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2029481", "value": 0.13278428461478467, "ngenes": 39, "description": "FCGR activation", "id": "6c30e12f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2029482", "value": 0.11488241298221397, "ngenes": 135, "description": "Regulation of actin dynamics for phagocytic cup formation", "id": "6c30e130-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2029485", "value": 0.12866893093871307, "ngenes": 57, "description": "Role of phospholipids in phagocytosis", "id": "6c30e131-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-2172127", "value": 0.22194052090094885, "ngenes": 76, "description": "DAP12 interactions", "id": "6c30e132-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2424491", "value": 0.19903555036842982, "ngenes": 57, "description": "DAP12 signaling", "id": "6c30e133-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-2454202", "value": 0.18220809876328026, "ngenes": 259, "description": "Fc epsilon receptor (FCERI) signaling", "id": "6c30e134-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2730905", "value": 0.3104251810423078, "ngenes": 47, "description": "Role of LAT2/NTAL/LAB on calcium mobilization", "id": "6c30e135-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2871796", "value": 0.04141028470738186, "ngenes": 70, "description": "FCERI mediated MAPK activation", "id": "6c30e136-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2871809", "value": 0.056611024136825845, "ngenes": 60, "description": "FCERI mediated Ca+2 mobilization", "id": "6c30e137-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2871837", "value": 0.40358438321135004, "ngenes": 160, "description": "FCERI mediated NF-kB activation", "id": "6c30e138-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5621481", "value": 0.9663554336950456, "ngenes": 261, "description": "C-type lectin receptors (CLRs)", "id": "6c30e139-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5607764", "value": 0.8915673409858498, "ngenes": 187, "description": "CLEC7A (Dectin-1) signaling", "id": "6c30e13a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5607761", "value": 0.4725038559346471, "ngenes": 108, "description": "Dectin-1 mediated noncanonical NF-kB signaling", "id": "6c30e13b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5607763", "value": 0.00012227641244890396, "ngenes": 20, "description": "CLEC7A (Dectin-1) induces NFAT activation", "id": "6c30e13c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5660668", "value": 1.2971572369837297e-05, "ngenes": 12, "description": "CLEC7A/inflammasome pathway", "id": "6c30e13d-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5621480", "value": 0.6244236821919106, "ngenes": 49, "description": "Dectin-2 family", "id": "6c30e13e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5621575", "value": 0.2419419966469857, "ngenes": 35, "description": "CD209 (DC-SIGN) signaling", "id": "6c30e13f-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-6798695", "value": 0.36589927731620464, "ngenes": 762, "description": "Neutrophil degranulation", "id": "6c30e140-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-879415", "value": 0.42163277677639927, "ngenes": 24, "description": "Advanced glycosylation endproduct receptor signaling", "id": "6c30e141-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-168928", "value": 0.03427636482595004, "ngenes": 132, "description": "DDX58/IFIH1-mediated induction of interferon-alpha/beta", "id": "6c30e142-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-918233", "value": 1.195720275272739e-05, "ngenes": 22, "description": "TRAF3-dependent IRF activation pathway", "id": "6c30e143-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-933541", "value": 2.76337631542031e-05, "ngenes": 44, "description": "TRAF6 mediated IRF7 activation", "id": "6c30e144-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-933542", "value": 0.04221144179473597, "ngenes": 44, "description": "TRAF6 mediated NF-kB activation", "id": "6c30e145-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-933543", "value": 6.475915440737017e-05, "ngenes": 22, "description": "NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10", "id": "6c30e146-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-936440", "value": 0.028780947208731034, "ngenes": 57, "description": "Negative regulators of DDX58/IFIH1 signaling", "id": "6c30e147-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9645460", "value": 0.9918138628754422, "ngenes": 23, "description": "Alpha-protein kinase 1 signaling pathway", "id": "6c30e148-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-162582", "value": 0.892117185936382, "ngenes": 4377, "description": "Signal Transduction", "id": "6c30e149-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5683057", "value": 0.5816969265324365, "ngenes": 588, "description": "MAPK family signaling cascades", "id": "6c30e14a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5684996", "value": 0.8040452606597581, "ngenes": 509, "description": "MAPK1/MAPK3 signaling", "id": "6c30e14b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-112409", "value": 0.2242552143512601, "ngenes": 35, "description": "RAF-independent MAPK1/3 activation", "id": "6c30e14c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-110056", "value": 2.967170959466438e-08, "ngenes": 15, "description": "MAPK3 (ERK1) activation", "id": "6c30e14d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-112411", "value": 7.84377383374616e-08, "ngenes": 14, "description": "MAPK1 (ERK2) activation", "id": "6c30e14e-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5673001", "value": 0.773184284378466, "ngenes": 499, "description": "RAF/MAP kinase cascade", "id": "6c30e14f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5658442", "value": 0.3059896160410839, "ngenes": 119, "description": "Regulation of RAS by GAPs", "id": "6c30e150-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5673000", "value": 0.17764948199395705, "ngenes": 57, "description": "RAF activation", "id": "6c30e151-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5674135", "value": 0.38820335494891073, "ngenes": 68, "description": "MAP2K and MAPK activation", "id": "6c30e152-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5675221", "value": 0.4883227273231137, "ngenes": 70, "description": "Negative regulation of MAPK pathway", "id": "6c30e153-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5674499", "value": 0.09314686211408571, "ngenes": 10, "description": "Negative feedback regulation of MAPK pathway", "id": "6c30e154-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9648002", "value": 0.6651875951883908, "ngenes": 49, "description": "RAS processing", "id": "6c30e155-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-5687128", "value": 0.45095164818038547, "ngenes": 167, "description": "MAPK6/MAPK4 signaling", "id": "6c30e156-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-372790", "value": 0.47980972658207865, "ngenes": 1638, "description": "Signaling by GPCR", "id": "6c30e157-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-388396", "value": 0.6182093910401724, "ngenes": 1536, "description": "GPCR downstream signalling", "id": "6c30e158-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-418594", "value": 0.2664201064530495, "ngenes": 589, "description": "G alpha (i) signalling events", "id": "6c30e159-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-111885", "value": 0.2144051601635095, "ngenes": 158, "description": "Opioid Signalling", "id": "6c30e15a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-112040", "value": 1.6565008776664282e-05, "ngenes": 95, "description": "G-protein mediated events", "id": "6c30e15b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-112043", "value": 2.0165384176479855e-05, "ngenes": 94, "description": "PLC beta mediated events", "id": "6c30e15c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-111996", "value": 0.00017738385282217102, "ngenes": 73, "description": "Ca-dependent events", "id": "6c30e15d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-111997", "value": 0.0001887851715897561, "ngenes": 69, "description": "CaM pathway", "id": "6c30e15e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-111933", "value": 0.0001887851715897561, "ngenes": 69, "description": "Calmodulin induced events", "id": "6c30e15f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-111932", "value": 0.0005827936679312777, "ngenes": 28, "description": "CaMK IV-mediated phosphorylation of CREB", "id": "6c30e160-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-111957", "value": 0.0071048880363027865, "ngenes": 9, "description": "Cam-PDE 1 activation", "id": "6c30e161-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-111931", "value": 0.0008642956342357437, "ngenes": 33, "description": "PKA-mediated phosphorylation of CREB", "id": "6c30e162-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-163615", "value": 1.420104100157167e-05, "ngenes": 28, "description": "PKA activation", "id": "6c30e163-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-111995", "value": 0.05054192137281901, "ngenes": 4, "description": "phospho-PLA2 pathway", "id": "6c30e164-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-170660", "value": 0.00024940882952630676, "ngenes": 12, "description": "Adenylate cyclase activating pathway", "id": "6c30e165-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-170670", "value": 0.00014288284850742032, "ngenes": 17, "description": "Adenylate cyclase inhibitory pathway", "id": "6c30e166-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-180024", "value": 0.0005712146879189095, "ngenes": 47, "description": "DARPP-32 events", "id": "6c30e167-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-202040", "value": 0.01643308690134094, "ngenes": 42, "description": "G-protein activation", "id": "6c30e168-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-2187338", "value": 0.23765650749627418, "ngenes": 123, "description": "Visual phototransduction", "id": "6c30e169-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2187335", "value": 0.03811676372790524, "ngenes": 7, "description": "The retinoid cycle in cones (daylight vision)", "id": "6c30e16a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2453902", "value": 0.08405210225046043, "ngenes": 27, "description": "The canonical retinoid cycle in rods (twilight vision)", "id": "6c30e16b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2514856", "value": 0.012393955086495045, "ngenes": 40, "description": "The phototransduction cascade", "id": "6c30e16c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2485179", "value": 1.4459583012747076e-10, "ngenes": 10, "description": "Activation of the phototransduction cascade", "id": "6c30e16d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2514859", "value": 0.025076692400157037, "ngenes": 39, "description": "Inactivation, recovery and regulation of the phototransduction cascade", "id": "6c30e16e-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-975634", "value": 1.6615644682680222e-06, "ngenes": 57, "description": "Retinoid metabolism and transport", "id": "6c30e16f-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-416476", "value": 0.36492591020578596, "ngenes": 340, "description": "G alpha (q) signalling events", "id": "6c30e170-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-881907", "value": 0.0914115733302693, "ngenes": 37, "description": "Gastrin-CREB signalling pathway via PKC and MAPK", "id": "6c30e171-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2179392", "value": 0.01106170271979886, "ngenes": 15, "description": "EGFR Transactivation by Gastrin", "id": "6c30e172-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-114508", "value": 0.7076076934348605, "ngenes": 49, "description": "Effects of PIP2 hydrolysis", "id": "6c30e173-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-426048", "value": 0.7186022398507529, "ngenes": 10, "description": "Arachidonate production from DAG", "id": "6c30e174-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-418555", "value": 0.157444001676096, "ngenes": 647, "description": "G alpha (s) signalling events", "id": "6c30e175-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-381753", "value": 0.1429421912937814, "ngenes": 449, "description": "Olfactory Signaling Pathway", "id": "6c30e176-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-397795", "value": 0.00335638504595083, "ngenes": 52, "description": "G-protein beta:gamma signalling", "id": "6c30e177-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-392451", "value": 0.002553432668966539, "ngenes": 41, "description": "G beta:gamma signalling through PI3Kgamma", "id": "6c30e178-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-418217", "value": 0.0024261542529064183, "ngenes": 26, "description": "G beta:gamma signalling through PLC beta", "id": "6c30e179-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8964315", "value": 0.00387262051380261, "ngenes": 23, "description": "G beta:gamma signalling through BTK", "id": "6c30e17a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8964616", "value": 0.004643981822308239, "ngenes": 28, "description": "G beta:gamma signalling through CDC42", "id": "6c30e17b-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-416482", "value": 0.03113661977489383, "ngenes": 135, "description": "G alpha (12/13) signalling events", "id": "6c30e17c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-418597", "value": 0.3316323015156968, "ngenes": 65, "description": "G alpha (z) signalling events", "id": "6c30e17d-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-500792", "value": 0.4657903614548386, "ngenes": 647, "description": "GPCR ligand binding", "id": "6c30e17e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-373076", "value": 0.5316236551928429, "ngenes": 478, "description": "Class A/1 (Rhodopsin-like receptors)", "id": "6c30e17f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3296197", "value": 0.0006295670362956322, "ngenes": 4, "description": "Hydroxycarboxylic acid-binding receptors", "id": "6c30e180-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-375281", "value": 0.6813163780359266, "ngenes": 15, "description": "Hormone ligand-binding receptors", "id": "6c30e181-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-375276", "value": 0.18585545889626537, "ngenes": 281, "description": "Peptide ligand-binding receptors", "id": "6c30e182-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-380095", "value": 0.07099961162414926, "ngenes": 11, "description": "Tachykinin receptors bind tachykinins", "id": "6c30e183-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-380108", "value": 0.4977666857430223, "ngenes": 87, "description": "Chemokine receptors bind chemokines", "id": "6c30e184-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-388479", "value": 0.6310285067216549, "ngenes": 7, "description": "Vasopressin-like receptors", "id": "6c30e185-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-389397", "value": 0.16530764299132653, "ngenes": 10, "description": "Orexin and neuropeptides FF and QRFP bind to their respective receptors", "id": "6c30e186-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-444473", "value": 0.5629005751269436, "ngenes": 14, "description": "Formyl peptide receptors bind formyl peptides and many other ligands", "id": "6c30e187-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-444821", "value": 2.432938228655966e-07, "ngenes": 9, "description": "Relaxin receptors", "id": "6c30e188-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-375280", "value": 0.6720859971758778, "ngenes": 60, "description": "Amine ligand-binding receptors", "id": "6c30e189-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-390648", "value": 0.03571588620361942, "ngenes": 10, "description": "Muscarinic acetylcholine receptors", "id": "6c30e18a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-390650", "value": 0.6806363127271342, "ngenes": 4, "description": "Histamine receptors", "id": "6c30e18b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-390651", "value": 0.8419288698522914, "ngenes": 9, "description": "Dopamine receptors", "id": "6c30e18c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-390666", "value": 0.32553052874001387, "ngenes": 17, "description": "Serotonin receptors", "id": "6c30e18d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-390696", "value": 0.04739247910512178, "ngenes": 12, "description": "Adrenoceptors", "id": "6c30e18e-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-391903", "value": 0.013907253730877518, "ngenes": 25, "description": "Eicosanoid ligand-binding receptors", "id": "6c30e18f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-391906", "value": 0.009772795147492562, "ngenes": 5, "description": "Leukotriene receptors", "id": "6c30e190-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-391908", "value": 0.005289702619621665, "ngenes": 19, "description": "Prostanoid ligand receptors", "id": "6c30e191-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-418038", "value": 0.03485474818342154, "ngenes": 30, "description": "Nucleotide-like (purinergic) receptors", "id": "6c30e192-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-417957", "value": 0.00823742229822088, "ngenes": 22, "description": "P2Y receptors", "id": "6c30e193-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-417973", "value": 0.47910293314870767, "ngenes": 8, "description": "Adenosine P1 receptors", "id": "6c30e194-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-419408", "value": 0.039622414202229034, "ngenes": 22, "description": "Lysosphingolipid and LPA receptors", "id": "6c30e195-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-419771", "value": 0.2588779113488508, "ngenes": 13, "description": "Opsins", "id": "6c30e196-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-444209", "value": 0.28894032713180756, "ngenes": 5, "description": "Free fatty acid receptors", "id": "6c30e197-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-373080", "value": 0.7790381966040238, "ngenes": 123, "description": "Class B/2 (Secretin family receptors)", "id": "6c30e198-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-419812", "value": 0.0001858417837488147, "ngenes": 12, "description": "Calcitonin-like ligand receptors", "id": "6c30e199-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-420092", "value": 0.0034275894733210087, "ngenes": 44, "description": "Glucagon-type ligand receptors", "id": "6c30e19a-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-420499", "value": 0.8162032367401373, "ngenes": 47, "description": "Class C/3 (Metabotropic glutamate/pheromone receptors)", "id": "6c30e19b-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-9006925", "value": 0.4612376757616533, "ngenes": 559, "description": "Intracellular signaling by second messengers", "id": "6c30e19c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1489509", "value": 3.4205712671113806e-06, "ngenes": 77, "description": "DAG and IP3 signaling", "id": "6c30e19d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-111997", "value": 0.0001887851715897561, "ngenes": 69, "description": "CaM pathway", "id": "6c30e19e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-111933", "value": 0.0001887851715897561, "ngenes": 69, "description": "Calmodulin induced events", "id": "6c30e19f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-111932", "value": 0.0005827936679312777, "ngenes": 28, "description": "CaMK IV-mediated phosphorylation of CREB", "id": "6c30e1a0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-111957", "value": 0.0071048880363027865, "ngenes": 9, "description": "Cam-PDE 1 activation", "id": "6c30e1a1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-111931", "value": 0.0008642956342357437, "ngenes": 33, "description": "PKA-mediated phosphorylation of CREB", "id": "6c30e1a2-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-163615", "value": 1.420104100157167e-05, "ngenes": 28, "description": "PKA activation", "id": "6c30e1a3-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}]}, {"source": "R-HSA-1257604", "value": 0.2970203647185184, "ngenes": 486, "description": "PIP3 activates AKT signaling", "id": "6c30e1a4-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-198323", "value": 4.580263388414675e-05, "ngenes": 27, "description": "AKT phosphorylates targets in the cytosol", "id": "6c30e1a5-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-198693", "value": 0.002540379179010643, "ngenes": 23, "description": "AKT phosphorylates targets in the nucleus", "id": "6c30e1a6-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-199418", "value": 0.17234876275127914, "ngenes": 209, "description": "Negative regulation of the PI3K/AKT network", "id": "6c30e1a7-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-6811558", "value": 0.13132890693760677, "ngenes": 198, "description": "PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling", "id": "6c30e1a8-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-6807070", "value": 0.8280981462000525, "ngenes": 243, "description": "PTEN Regulation", "id": "6c30e1a9-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8943724", "value": 0.01328490013888854, "ngenes": 96, "description": "Regulation of PTEN gene transcription", "id": "6c30e1aa-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8943723", "value": 0.03493303598831189, "ngenes": 19, "description": "Regulation of PTEN mRNA translation", "id": "6c30e1ab-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8948700", "value": 0.08877452788763002, "ngenes": 17, "description": "Competing endogenous RNAs (ceRNAs) regulate PTEN translation", "id": "6c30e1ac-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8948747", "value": 0.628813502783174, "ngenes": 24, "description": "Regulation of PTEN localization", "id": "6c30e1ad-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8948751", "value": 0.2223842410301124, "ngenes": 124, "description": "Regulation of PTEN stability and activity", "id": "6c30e1ae-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-9006934", "value": 0.16935052266888523, "ngenes": 906, "description": "Signaling by Receptor Tyrosine Kinases", "id": "6c30e1af-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2404192", "value": 3.127241122112941e-06, "ngenes": 99, "description": "Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)", "id": "6c30e1b0-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2428924", "value": 3.769744872004506e-06, "ngenes": 98, "description": "IGF1R signaling cascade", "id": "6c30e1b1-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2428928", "value": 3.420049661379434e-06, "ngenes": 95, "description": "IRS-related events triggered by IGF1R", "id": "6c30e1b2-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-112399", "value": 1.995868316687976e-05, "ngenes": 86, "description": "IRS-mediated signalling", "id": "6c30e1b3-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-112412", "value": 0.009404956330056426, "ngenes": 10, "description": "SOS-mediated signalling", "id": "6c30e1b4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-109704", "value": 1.152032535262405e-06, "ngenes": 80, "description": "PI3K Cascade", "id": "6c30e1b5-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-165158", "value": 0.8528146719641481, "ngenes": 10, "description": "Activation of AKT2", "id": "6c30e1b6-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-2428933", "value": 0.003259070816410955, "ngenes": 19, "description": "SHC-related events triggered by IGF1R", "id": "6c30e1b7-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-74752", "value": 0.11718463292876465, "ngenes": 140, "description": "Signaling by Insulin receptor", "id": "6c30e1b8-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-74751", "value": 0.2845866963495071, "ngenes": 100, "description": "Insulin receptor signalling cascade", "id": "6c30e1b9-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-112399", "value": 1.995868316687976e-05, "ngenes": 86, "description": "IRS-mediated signalling", "id": "6c30e1ba-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-112412", "value": 0.009404956330056426, "ngenes": 10, "description": "SOS-mediated signalling", "id": "6c30e1bb-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-109704", "value": 1.152032535262405e-06, "ngenes": 80, "description": "PI3K Cascade", "id": "6c30e1bc-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-165158", "value": 0.8528146719641481, "ngenes": 10, "description": "Activation of AKT2", "id": "6c30e1bd-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-74713", "value": 0.1666585392542835, "ngenes": 8, "description": "IRS activation", "id": "6c30e1be-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-74749", "value": 0.0035400001481955138, "ngenes": 19, "description": "Signal attenuation", "id": "6c30e1bf-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-77387", "value": 0.2878768830891785, "ngenes": 42, "description": "Insulin receptor recycling", "id": "6c30e1c0-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1227986", "value": 0.2800856559284229, "ngenes": 105, "description": "Signaling by ERBB2", "id": "6c30e1c1-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1250196", "value": 0.06732578837410506, "ngenes": 42, "description": "SHC1 events in ERBB2 signaling", "id": "6c30e1c2-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1251932", "value": 2.839965339633245e-07, "ngenes": 10, "description": "PLCG1 events in ERBB2 signaling", "id": "6c30e1c3-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1306955", "value": 1.611685708244368e-08, "ngenes": 16, "description": "GRB7 events in ERBB2 signaling", "id": "6c30e1c4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8863795", "value": 0.9663554336950456, "ngenes": 59, "description": "Downregulation of ERBB2 signaling", "id": "6c30e1c5-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1358803", "value": 0.2878768830891785, "ngenes": 34, "description": "Downregulation of ERBB2:ERBB3 signaling", "id": "6c30e1c6-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1963640", "value": 0.04602606735657477, "ngenes": 29, "description": "GRB2 events in ERBB2 signaling", "id": "6c30e1c7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1963642", "value": 0.03179713164334258, "ngenes": 36, "description": "PI3K events in ERBB2 signaling", "id": "6c30e1c8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6785631", "value": 8.305789602061557e-07, "ngenes": 29, "description": "ERBB2 Regulates Cell Motility", "id": "6c30e1c9-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8847993", "value": 0.2886746697384467, "ngenes": 26, "description": "ERBB2 Activates PTK6 Signaling", "id": "6c30e1ca-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9652282", "value": 0.0006761301884331578, "ngenes": 8, "description": "Drug-mediated inhibition of ERBB2 signaling", "id": "6c30e1cb-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1236394", "value": 0.008788552532989817, "ngenes": 110, "description": "Signaling by ERBB4", "id": "6c30e1cc-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1250342", "value": 0.16522327467338443, "ngenes": 20, "description": "PI3K events in ERBB4 signaling", "id": "6c30e1cd-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1250347", "value": 0.7192973977226396, "ngenes": 24, "description": "SHC1 events in ERBB4 signaling", "id": "6c30e1ce-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1251985", "value": 0.0010686353272628657, "ngenes": 55, "description": "Nuclear signaling by ERBB4", "id": "6c30e1cf-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1253288", "value": 0.9959390140289811, "ngenes": 19, "description": "Downregulation of ERBB4 signaling", "id": "6c30e1d0-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-190236", "value": 0.05183499212401642, "ngenes": 154, "description": "Signaling by FGFR", "id": "6c30e1d1-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5654736", "value": 0.0024879213492771126, "ngenes": 98, "description": "Signaling by FGFR1", "id": "6c30e1d2-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5654726", "value": 0.00014992506067097722, "ngenes": 65, "description": "Negative regulation of FGFR1 signaling", "id": "6c30e1d3-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1295596", "value": 0.005707039903081132, "ngenes": 34, "description": "Spry regulation of FGF signaling", "id": "6c30e1d4-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-190242", "value": 0.0010138903086550478, "ngenes": 27, "description": "FGFR1 ligand binding and activation", "id": "6c30e1d5-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-190370", "value": 0.9336226860594022, "ngenes": 11, "description": "FGFR1b ligand binding and activation", "id": "6c30e1d6-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-190373", "value": 0.04101500546212591, "ngenes": 23, "description": "FGFR1c ligand binding and activation", "id": "6c30e1d7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-190374", "value": 0.40358438321135004, "ngenes": 6, "description": "FGFR1c and Klotho ligand binding and activation", "id": "6c30e1d8-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5654687", "value": 2.0027413470342196e-05, "ngenes": 60, "description": "Downstream signaling of activated FGFR1", "id": "6c30e1d9-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5654219", "value": 0.00039339106040743935, "ngenes": 28, "description": "Phospholipase C-mediated cascade: FGFR1", "id": "6c30e1da-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5654688", "value": 0.0005575926325393357, "ngenes": 37, "description": "SHC-mediated cascade:FGFR1", "id": "6c30e1db-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5654689", "value": 0.02031833766869572, "ngenes": 43, "description": "PI-3K cascade:FGFR1", "id": "6c30e1dc-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5654693", "value": 0.0012730883262428415, "ngenes": 40, "description": "FRS-mediated FGFR1 signaling", "id": "6c30e1dd-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5658623", "value": 0.06481943294621698, "ngenes": 19, "description": "FGFRL1 modulation of FGFR1 signaling", "id": "6c30e1de-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5654738", "value": 0.13544610530037454, "ngenes": 133, "description": "Signaling by FGFR2", "id": "6c30e1df-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5654727", "value": 0.00028602695769214904, "ngenes": 67, "description": "Negative regulation of FGFR2 signaling", "id": "6c30e1e0-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1295596", "value": 0.005707039903081132, "ngenes": 34, "description": "Spry regulation of FGF signaling", "id": "6c30e1e1-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-190241", "value": 0.00014106664083792536, "ngenes": 32, "description": "FGFR2 ligand binding and activation", "id": "6c30e1e2-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-190375", "value": 0.024413573485453484, "ngenes": 23, "description": "FGFR2c ligand binding and activation", "id": "6c30e1e3-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-190377", "value": 0.00835966888969455, "ngenes": 15, "description": "FGFR2b ligand binding and activation", "id": "6c30e1e4-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5654696", "value": 4.426691360197892e-05, "ngenes": 58, "description": "Downstream signaling of activated FGFR2", "id": "6c30e1e5-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5654221", "value": 2.1621189009765425e-05, "ngenes": 31, "description": "Phospholipase C-mediated cascade; FGFR2", "id": "6c30e1e6-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5654695", "value": 3.3185354539761605e-05, "ngenes": 46, "description": "PI-3K cascade:FGFR2", "id": "6c30e1e7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5654699", "value": 7.0557585043323695e-06, "ngenes": 40, "description": "SHC-mediated cascade:FGFR2", "id": "6c30e1e8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5654700", "value": 4.1780840290246384e-05, "ngenes": 43, "description": "FRS-mediated FGFR2 signaling", "id": "6c30e1e9-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-6803529", "value": 1.0, "ngenes": 42, "description": "FGFR2 alternative splicing", "id": "6c30e1ea-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5654741", "value": 0.018023700675703067, "ngenes": 82, "description": "Signaling by FGFR3", "id": "6c30e1eb-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5654732", "value": 0.0024348302445445272, "ngenes": 60, "description": "Negative regulation of FGFR3 signaling", "id": "6c30e1ec-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1295596", "value": 0.005707039903081132, "ngenes": 34, "description": "Spry regulation of FGF signaling", "id": "6c30e1ed-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-190239", "value": 7.670282285333512e-05, "ngenes": 22, "description": "FGFR3 ligand binding and activation", "id": "6c30e1ee-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-190371", "value": 0.011492239871251973, "ngenes": 14, "description": "FGFR3b ligand binding and activation", "id": "6c30e1ef-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-190372", "value": 7.670282285333512e-05, "ngenes": 22, "description": "FGFR3c ligand binding and activation", "id": "6c30e1f0-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5654708", "value": 0.03910643637382603, "ngenes": 51, "description": "Downstream signaling of activated FGFR3", "id": "6c30e1f1-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5654227", "value": 7.791773884074965e-06, "ngenes": 24, "description": "Phospholipase C-mediated cascade; FGFR3", "id": "6c30e1f2-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5654704", "value": 0.003900138141989245, "ngenes": 33, "description": "SHC-mediated cascade:FGFR3", "id": "6c30e1f3-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5654706", "value": 0.19448101222577807, "ngenes": 36, "description": "FRS-mediated FGFR3 signaling", "id": "6c30e1f4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5654710", "value": 0.0037352313881067623, "ngenes": 39, "description": "PI-3K cascade:FGFR3", "id": "6c30e1f5-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-5654743", "value": 0.0014995580455194769, "ngenes": 85, "description": "Signaling by FGFR4", "id": "6c30e1f6-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5654733", "value": 8.35254360151713e-05, "ngenes": 63, "description": "Negative regulation of FGFR4 signaling", "id": "6c30e1f7-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1295596", "value": 0.005707039903081132, "ngenes": 34, "description": "Spry regulation of FGF signaling", "id": "6c30e1f8-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-190322", "value": 0.00020183287145104014, "ngenes": 25, "description": "FGFR4 ligand binding and activation", "id": "6c30e1f9-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1307965", "value": 2.1462056760691976e-08, "ngenes": 5, "description": "betaKlotho-mediated ligand binding", "id": "6c30e1fa-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5654716", "value": 1.5712680820364634e-06, "ngenes": 54, "description": "Downstream signaling of activated FGFR4", "id": "6c30e1fb-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5654228", "value": 4.383497095217588e-08, "ngenes": 27, "description": "Phospholipase C-mediated cascade; FGFR4", "id": "6c30e1fc-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5654712", "value": 7.155850422545485e-09, "ngenes": 39, "description": "FRS-mediated FGFR4 signaling", "id": "6c30e1fd-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5654719", "value": 4.7127678026307884e-08, "ngenes": 36, "description": "SHC-mediated cascade:FGFR4", "id": "6c30e1fe-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5654720", "value": 0.11434224145791108, "ngenes": 42, "description": "PI-3K cascade:FGFR4", "id": "6c30e1ff-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-1433557", "value": 0.0348424688820253, "ngenes": 82, "description": "Signaling by SCF-KIT", "id": "6c30e200-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1433559", "value": 0.048581704410858004, "ngenes": 28, "description": "Regulation of KIT signaling", "id": "6c30e201-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-166520", "value": 0.0910095200991322, "ngenes": 242, "description": "Signaling by NTRKs", "id": "6c30e202-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-187037", "value": 0.094402319339291, "ngenes": 194, "description": "Signaling by NTRK1 (TRKA)", "id": "6c30e203-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-167021", "value": 0.03532779869508126, "ngenes": 6, "description": "PLC-gamma1 signalling", "id": "6c30e204-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-187687", "value": 0.6797349259540392, "ngenes": 63, "description": "Signalling to ERKs", "id": "6c30e205-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-169893", "value": 0.7473399204644617, "ngenes": 28, "description": "Prolonged ERK activation events", "id": "6c30e206-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-170968", "value": 0.050310682818448686, "ngenes": 23, "description": "Frs2-mediated activation", "id": "6c30e207-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-170984", "value": 0.04708620276120134, "ngenes": 15, "description": "ARMS-mediated activation", "id": "6c30e208-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-167044", "value": 0.4025892610337889, "ngenes": 37, "description": "Signalling to RAS", "id": "6c30e209-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-171007", "value": 0.6358440082541856, "ngenes": 23, "description": "p38MAPK events", "id": "6c30e20a-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-187706", "value": 0.7332760974416715, "ngenes": 8, "description": "Signalling to p38 via RIT and RIN", "id": "6c30e20b-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-177504", "value": 0.08948858883702099, "ngenes": 24, "description": "Retrograde neurotrophin signalling", "id": "6c30e20c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-187015", "value": 2.4126874297190546e-05, "ngenes": 11, "description": "Activation of TRKA receptors", "id": "6c30e20d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-187024", "value": 8.682333373019592e-06, "ngenes": 10, "description": "NGF-independant TRKA activation", "id": "6c30e20e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-187042", "value": 0.8607422770166848, "ngenes": 4, "description": "TRKA activation by NGF", "id": "6c30e20f-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-198203", "value": 0.027424415704063284, "ngenes": 16, "description": "PI3K/AKT activation", "id": "6c30e210-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-198745", "value": 0.0020390428560717174, "ngenes": 7, "description": "Signalling to STAT3", "id": "6c30e211-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-198765", "value": 0.005927840964887873, "ngenes": 6, "description": "Signalling to ERK5", "id": "6c30e212-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-198725", "value": 0.02721745736594524, "ngenes": 98, "description": "Nuclear Events (kinase and transcription factor activation)", "id": "6c30e213-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-199920", "value": 0.41522455244533674, "ngenes": 17, "description": "CREB phosphorylation", "id": "6c30e214-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-198753", "value": 0.37761079458939656, "ngenes": 48, "description": "ERK/MAPK targets", "id": "6c30e215-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-202670", "value": 0.05382852466722305, "ngenes": 29, "description": "ERKs are inactivated", "id": "6c30e216-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9031628", "value": 0.005115793101241494, "ngenes": 50, "description": "NGF-stimulated transcription", "id": "6c30e217-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-9036866", "value": 0.3297641666272556, "ngenes": 10, "description": "Expression and Processing of Neurotrophins", "id": "6c30e218-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-167060", "value": 0.3297641666272556, "ngenes": 10, "description": "NGF processing", "id": "6c30e219-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9006115", "value": 0.0006191850973483202, "ngenes": 58, "description": "Signaling by NTRK2 (TRKB)", "id": "6c30e21a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9024909", "value": 1.4392459700143932e-05, "ngenes": 10, "description": "BDNF activates NTRK2 (TRKB) signaling", "id": "6c30e21b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9025046", "value": 1.6317760016151596e-05, "ngenes": 4, "description": "NTF3 activates NTRK2 (TRKB) signaling", "id": "6c30e21c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9026357", "value": 7.977077563276931e-06, "ngenes": 4, "description": "NTF4 activates NTRK2 (TRKB) signaling", "id": "6c30e21d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9026519", "value": 1.9033478526034442e-07, "ngenes": 22, "description": "Activated NTRK2 signals through RAS", "id": "6c30e21e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9026527", "value": 1.6307240466831002e-06, "ngenes": 13, "description": "Activated NTRK2 signals through PLCG1", "id": "6c30e21f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9028335", "value": 1.5712680820364634e-06, "ngenes": 23, "description": "Activated NTRK2 signals through PI3K", "id": "6c30e220-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9028731", "value": 2.461222086965114e-07, "ngenes": 25, "description": "Activated NTRK2 signals through FRS2 and FRS3", "id": "6c30e221-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9032500", "value": 0.01787353628397429, "ngenes": 23, "description": "Activated NTRK2 signals through FYN", "id": "6c30e222-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9032759", "value": 0.02396259087052327, "ngenes": 18, "description": "NTRK2 activates RAC1", "id": "6c30e223-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9032845", "value": 2.8311426663101815e-05, "ngenes": 17, "description": "Activated NTRK2 signals through CDK5", "id": "6c30e224-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9034015", "value": 2.1621189009765425e-05, "ngenes": 39, "description": "Signaling by NTRK3 (TRKC)", "id": "6c30e225-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9034013", "value": 0.13849393937894053, "ngenes": 5, "description": "NTF3 activates NTRK3 signaling", "id": "6c30e226-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9034793", "value": 0.12158064656201929, "ngenes": 7, "description": "Activated NTRK3 signals through PLCG1", "id": "6c30e227-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9034864", "value": 0.08273255430211818, "ngenes": 16, "description": "Activated NTRK3 signals through RAS", "id": "6c30e228-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9603381", "value": 0.027424415704063284, "ngenes": 16, "description": "Activated NTRK3 signals through PI3K", "id": "6c30e229-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9603505", "value": 0.1564558274957353, "ngenes": 10, "description": "NTRK3 as a dependence receptor", "id": "6c30e22a-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-177929", "value": 0.0910095200991322, "ngenes": 92, "description": "Signaling by EGFR", "id": "6c30e22b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-179812", "value": 1.8724171558569187e-07, "ngenes": 19, "description": "GRB2 events in EGFR signaling", "id": "6c30e22c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-180292", "value": 1.257012163546275e-09, "ngenes": 31, "description": "GAB1 signalosome", "id": "6c30e22d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-180336", "value": 3.5493466952511793e-07, "ngenes": 22, "description": "SHC1 events in EGFR signaling", "id": "6c30e22e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-182971", "value": 0.4913022893462179, "ngenes": 53, "description": "EGFR downregulation", "id": "6c30e22f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-212718", "value": 2.4587934648425797e-08, "ngenes": 13, "description": "EGFR interacts with phospholipase C-gamma", "id": "6c30e230-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-186797", "value": 0.37193571216149546, "ngenes": 102, "description": "Signaling by PDGF", "id": "6c30e231-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-186763", "value": 2.7266144030044515e-11, "ngenes": 56, "description": "Downstream signal transduction", "id": "6c30e232-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-194138", "value": 0.311142600654939, "ngenes": 223, "description": "Signaling by VEGF", "id": "6c30e233-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-194306", "value": 0.010152105094168851, "ngenes": 7, "description": "Neurophilin interactions with VEGF and VEGFR", "id": "6c30e234-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-194313", "value": 2.1126681472025933e-08, "ngenes": 14, "description": "VEGF ligand-receptor interactions", "id": "6c30e235-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-195399", "value": 2.1126681472025933e-08, "ngenes": 14, "description": "VEGF binds to VEGFR leading to receptor dimerization", "id": "6c30e236-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-4420097", "value": 0.1801058541582589, "ngenes": 206, "description": "VEGFA-VEGFR2 Pathway", "id": "6c30e237-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5218920", "value": 0.04176388566311142, "ngenes": 64, "description": "VEGFR2 mediated vascular permeability", "id": "6c30e238-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5218921", "value": 0.1408443680339908, "ngenes": 42, "description": "VEGFR2 mediated cell proliferation", "id": "6c30e239-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-6806834", "value": 0.9439099697859671, "ngenes": 146, "description": "Signaling by MET", "id": "6c30e23a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-6806942", "value": 0.8281572468510247, "ngenes": 12, "description": "MET Receptor Activation", "id": "6c30e23b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6807004", "value": 0.2515606404425243, "ngenes": 37, "description": "Negative regulation of MET activity", "id": "6c30e23c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8851805", "value": 0.14563131492669845, "ngenes": 19, "description": "MET activates RAS signaling", "id": "6c30e23d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8851907", "value": 0.04141163230994763, "ngenes": 17, "description": "MET activates PI3K/AKT signaling", "id": "6c30e23e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8865999", "value": 0.013517055726045238, "ngenes": 11, "description": "MET activates PTPN11", "id": "6c30e23f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8875878", "value": 0.741089605098735, "ngenes": 79, "description": "MET promotes cell motility", "id": "6c30e240-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8874081", "value": 0.5847352058012586, "ngenes": 58, "description": "MET activates PTK2 signaling", "id": "6c30e241-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8875513", "value": 0.892117185936382, "ngenes": 12, "description": "MET interacts with TNS proteins", "id": "6c30e242-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8875555", "value": 0.04617468651161317, "ngenes": 24, "description": "MET activates RAP1 and RAC1", "id": "6c30e243-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8875656", "value": 0.0012239796513365436, "ngenes": 21, "description": "MET receptor recycling", "id": "6c30e244-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8875791", "value": 0.009931149699526574, "ngenes": 8, "description": "MET activates STAT3", "id": "6c30e245-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8852405", "value": 0.0235855531539651, "ngenes": 8, "description": "Signaling by MST1", "id": "6c30e246-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-165159", "value": 0.05622577070435696, "ngenes": 74, "description": "MTOR signalling", "id": "6c30e247-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-165181", "value": 0.32861229515854307, "ngenes": 7, "description": "Inhibition of TSC complex formation by PKB", "id": "6c30e248-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-166208", "value": 0.05102426357355853, "ngenes": 38, "description": "mTORC1-mediated signalling", "id": "6c30e249-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-380972", "value": 0.0051465732192984845, "ngenes": 50, "description": "Energy dependent regulation of mTOR by LKB1-AMPK", "id": "6c30e24a-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-157118", "value": 0.6524451780002364, "ngenes": 377, "description": "Signaling by NOTCH", "id": "6c30e24b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1912422", "value": 0.3762931529042661, "ngenes": 154, "description": "Pre-NOTCH Expression and Processing", "id": "6c30e24c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1912399", "value": 0.00012044421577835566, "ngenes": 15, "description": "Pre-NOTCH Processing in the Endoplasmic Reticulum", "id": "6c30e24d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1912408", "value": 0.3873472564068461, "ngenes": 122, "description": "Pre-NOTCH Transcription and Translation", "id": "6c30e24e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1912420", "value": 0.3005710001296286, "ngenes": 35, "description": "Pre-NOTCH Processing in Golgi", "id": "6c30e24f-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1980143", "value": 0.6243505240971601, "ngenes": 121, "description": "Signaling by NOTCH1", "id": "6c30e250-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2122947", "value": 0.6704463751907526, "ngenes": 78, "description": "NOTCH1 Intracellular Domain Regulates Transcription", "id": "6c30e251-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2122948", "value": 0.006482188376467031, "ngenes": 53, "description": "Activated NOTCH1 Transmits Signal to the Nucleus", "id": "6c30e252-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1980145", "value": 0.08452296166723249, "ngenes": 63, "description": "Signaling by NOTCH2", "id": "6c30e253-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2197563", "value": 0.21025976397122137, "ngenes": 23, "description": "NOTCH2 intracellular domain regulates transcription", "id": "6c30e254-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2979096", "value": 0.05711874686208369, "ngenes": 46, "description": "NOTCH2 Activation and Transmission of Signal to the Nucleus", "id": "6c30e255-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9012852", "value": 0.5858985909958582, "ngenes": 75, "description": "Signaling by NOTCH3", "id": "6c30e256-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9013508", "value": 0.00120181504378378, "ngenes": 32, "description": "NOTCH3 Intracellular Domain Regulates Transcription", "id": "6c30e257-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9013507", "value": 0.14279509914816474, "ngenes": 44, "description": "NOTCH3 Activation and Transmission of Signal to the Nucleus", "id": "6c30e258-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9017802", "value": 1.2928883455556802e-05, "ngenes": 15, "description": "Noncanonical activation of NOTCH3", "id": "6c30e259-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-9013694", "value": 0.6404568972959231, "ngenes": 146, "description": "Signaling by NOTCH4", "id": "6c30e25a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9013695", "value": 0.003115025809423024, "ngenes": 32, "description": "NOTCH4 Intracellular Domain Regulates Transcription", "id": "6c30e25b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9013700", "value": 0.285319014387246, "ngenes": 19, "description": "NOTCH4 Activation and Transmission of Signal to the Nucleus", "id": "6c30e25c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9604323", "value": 0.34309723571021866, "ngenes": 99, "description": "Negative regulation of NOTCH4 signaling", "id": "6c30e25d-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-73887", "value": 0.08355761512175974, "ngenes": 249, "description": "Death Receptor Signalling", "id": "6c30e25e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-193704", "value": 0.13966130319430406, "ngenes": 171, "description": "p75 NTR receptor-mediated signalling", "id": "6c30e25f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-193697", "value": 1.6974740703596646e-06, "ngenes": 15, "description": "p75NTR regulates axonogenesis", "id": "6c30e260-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-193634", "value": 3.75694388522179e-06, "ngenes": 14, "description": "Axonal growth inhibition (RHOA activation)", "id": "6c30e261-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-209563", "value": 0.37505951722622016, "ngenes": 4, "description": "Axonal growth stimulation", "id": "6c30e262-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-204998", "value": 0.08395455688468902, "ngenes": 143, "description": "Cell death signalling via NRAGE, NRIF and NADE", "id": "6c30e263-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-193648", "value": 0.07491799843814244, "ngenes": 108, "description": "NRAGE signals death through JNK", "id": "6c30e264-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-205025", "value": 0.8685801207373276, "ngenes": 11, "description": "NADE modulates death signalling", "id": "6c30e265-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-205043", "value": 0.4070409819551181, "ngenes": 31, "description": "NRIF signals cell death from the nucleus", "id": "6c30e266-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-193670", "value": 0.6927427333893111, "ngenes": 6, "description": "p75NTR negatively regulates cell cycle via SC1", "id": "6c30e267-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-193681", "value": 0.1386816034494381, "ngenes": 3, "description": "Ceramide signalling", "id": "6c30e268-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-193692", "value": 0.011728668507539407, "ngenes": 20, "description": "Regulated proteolysis of p75NTR", "id": "6c30e269-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-193639", "value": 0.1412341395017127, "ngenes": 24, "description": "p75NTR signals via NF-kB", "id": "6c30e26a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-209543", "value": 0.029724465075552424, "ngenes": 21, "description": "p75NTR recruits signalling complexes", "id": "6c30e26b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-209560", "value": 0.7167729431434001, "ngenes": 21, "description": "NF-kB is activated and signals survival", "id": "6c30e26c-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-75893", "value": 0.03992416523412151, "ngenes": 81, "description": "TNF signaling", "id": "6c30e26d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5357786", "value": 0.0017871398837396783, "ngenes": 24, "description": "TNFR1-induced proapoptotic signaling", "id": "6c30e26e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5357905", "value": 0.023613763242224358, "ngenes": 63, "description": "Regulation of TNFR1 signaling", "id": "6c30e26f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5357956", "value": 0.020199926327732962, "ngenes": 54, "description": "TNFR1-induced NFkappaB signaling pathway", "id": "6c30e270-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5626978", "value": 0.08948858883702099, "ngenes": 8, "description": "TNFR1-mediated ceramide production", "id": "6c30e271-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-75157", "value": 0.09314686211408571, "ngenes": 11, "description": "FasL/ CD95L signaling", "id": "6c30e272-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-75158", "value": 0.015755523564464403, "ngenes": 15, "description": "TRAIL  signaling", "id": "6c30e273-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-194315", "value": 3.944383065460088e-12, "ngenes": 790, "description": "Signaling by Rho GTPases", "id": "6c30e274-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-194840", "value": 0.11777630059142877, "ngenes": 281, "description": "Rho GTPase cycle", "id": "6c30e275-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-195258", "value": 1.810207507923121e-15, "ngenes": 539, "description": "RHO GTPase Effectors", "id": "6c30e276-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5625740", "value": 0.18654593622304647, "ngenes": 131, "description": "RHO GTPases activate PKNs", "id": "6c30e277-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5625886", "value": 0.25660140713950697, "ngenes": 82, "description": "Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3", "id": "6c30e278-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5625900", "value": 5.442599144409427e-08, "ngenes": 30, "description": "RHO GTPases activate CIT", "id": "6c30e279-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5625970", "value": 0.03633607763122008, "ngenes": 26, "description": "RHO GTPases activate KTN1", "id": "6c30e27a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5626467", "value": 0.1645659867202405, "ngenes": 55, "description": "RHO GTPases activate IQGAPs", "id": "6c30e27b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5627083", "value": 0.9727778104212363, "ngenes": 3, "description": "RHO GTPases regulate CFTR trafficking", "id": "6c30e27c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5627117", "value": 4.869812208484977e-05, "ngenes": 34, "description": "RHO GTPases Activate ROCKs", "id": "6c30e27d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5627123", "value": 0.4160269568822072, "ngenes": 42, "description": "RHO GTPases activate PAKs", "id": "6c30e27e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5663213", "value": 0.36637729884820325, "ngenes": 73, "description": "RHO GTPases Activate WASPs and WAVEs", "id": "6c30e27f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5663220", "value": 2.733592647901166e-19, "ngenes": 235, "description": "RHO GTPases Activate Formins", "id": "6c30e280-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5666185", "value": 0.00021412419612234736, "ngenes": 14, "description": "RHO GTPases Activate Rhotekin and Rhophilins", "id": "6c30e281-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5668599", "value": 0.18409007721134127, "ngenes": 46, "description": "RHO GTPases Activate NADPH Oxidases", "id": "6c30e282-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-195721", "value": 0.3039725421196323, "ngenes": 522, "description": "Signaling by WNT", "id": "6c30e283-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-195253", "value": 1.0, "ngenes": 155, "description": "Degradation of beta-catenin by the destruction complex", "id": "6c30e284-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-196299", "value": 0.0001920482334355008, "ngenes": 37, "description": "Beta-catenin phosphorylation cascade", "id": "6c30e285-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-4641265", "value": 0.4997500712929101, "ngenes": 24, "description": "Repression of WNT target genes", "id": "6c30e286-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-201681", "value": 0.9337922739076233, "ngenes": 368, "description": "TCF dependent signaling in response to WNT", "id": "6c30e287-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-201688", "value": 0.030969459276942064, "ngenes": 19, "description": "WNT mediated activation of DVL", "id": "6c30e288-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3769402", "value": 0.03865997145679512, "ngenes": 79, "description": "Deactivation of the beta-catenin transactivating complex", "id": "6c30e289-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3772470", "value": 0.00387262051380261, "ngenes": 24, "description": "Negative regulation of TCF-dependent signaling by WNT ligand antagonists", "id": "6c30e28a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-201722", "value": 0.27850576007925537, "ngenes": 125, "description": "Formation of the beta-catenin:TCF transactivating complex", "id": "6c30e28b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-4411364", "value": 0.6182093910401724, "ngenes": 21, "description": "Binding of TCF/LEF:CTNNB1 to target gene promoters", "id": "6c30e28c-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-4641257", "value": 0.206098983484953, "ngenes": 93, "description": "Degradation of AXIN", "id": "6c30e28d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-4641258", "value": 0.18434687639744474, "ngenes": 101, "description": "Degradation of DVL", "id": "6c30e28e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-4641262", "value": 0.0005275499722332369, "ngenes": 59, "description": "Disassembly of the destruction complex and recruitment of AXIN to the membrane", "id": "6c30e28f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-4641263", "value": 0.9460747628576336, "ngenes": 33, "description": "Regulation of FZD by ubiquitination", "id": "6c30e290-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5368598", "value": 0.1963468323101704, "ngenes": 8, "description": "Negative regulation of TCF-dependent signaling by DVL-interacting proteins", "id": "6c30e291-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-3238698", "value": 0.04670468591871563, "ngenes": 39, "description": "WNT ligand biogenesis and trafficking", "id": "6c30e292-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3858494", "value": 0.6697973918363818, "ngenes": 246, "description": "Beta-catenin independent WNT signaling", "id": "6c30e293-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-4086398", "value": 0.0017272563701686604, "ngenes": 96, "description": "Ca2+ pathway", "id": "6c30e294-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-4086400", "value": 0.45171707912759174, "ngenes": 158, "description": "PCP/CE pathway", "id": "6c30e295-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-4608870", "value": 0.27970304757240905, "ngenes": 108, "description": "Asymmetric localization of PCP proteins", "id": "6c30e296-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5099900", "value": 0.2865605231109962, "ngenes": 27, "description": "WNT5A-dependent internalization of FZD4", "id": "6c30e297-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5140745", "value": 0.3564846829683502, "ngenes": 22, "description": "WNT5A-dependent internalization of FZD2, FZD5 and ROR2", "id": "6c30e298-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-9006936", "value": 0.5544466027451358, "ngenes": 180, "description": "Signaling by TGFB family members", "id": "6c30e299-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-201451", "value": 0.019316565753224404, "ngenes": 45, "description": "Signaling by BMP", "id": "6c30e29a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-170834", "value": 0.7790381966040238, "ngenes": 134, "description": "Signaling by TGF-beta Receptor Complex", "id": "6c30e29b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2173789", "value": 0.9294905350882442, "ngenes": 56, "description": "TGF-beta receptor signaling activates SMADs", "id": "6c30e29c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2173788", "value": 0.6726781823364537, "ngenes": 46, "description": "Downregulation of TGF-beta receptor signaling", "id": "6c30e29d-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-2173791", "value": 0.8646430582683339, "ngenes": 33, "description": "TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)", "id": "6c30e29e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2173793", "value": 0.6594729876998179, "ngenes": 83, "description": "Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer", "id": "6c30e29f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2173795", "value": 0.18220809876328026, "ngenes": 48, "description": "Downregulation of SMAD2/3:SMAD4 transcriptional activity", "id": "6c30e2a0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2173796", "value": 0.7779813594787727, "ngenes": 59, "description": "SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription", "id": "6c30e2a1-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-1502540", "value": 3.862488674605148e-05, "ngenes": 23, "description": "Signaling by Activin", "id": "6c30e2a2-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2473224", "value": 3.766960290325469e-05, "ngenes": 5, "description": "Antagonism of Activin by Follistatin", "id": "6c30e2a3-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-2028269", "value": 0.17333361669232408, "ngenes": 28, "description": "Signaling by Hippo", "id": "6c30e2a4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2586552", "value": 9.072873963458432e-08, "ngenes": 19, "description": "Signaling by Leptin", "id": "6c30e2a5-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-354192", "value": 3.883605354354573e-07, "ngenes": 55, "description": "Integrin signaling", "id": "6c30e2a6-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-354194", "value": 7.852385342734759e-06, "ngenes": 29, "description": "GRB2:SOS provides linkage to MAPK signaling for Integrins ", "id": "6c30e2a7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-372708", "value": 2.5404816941260024e-06, "ngenes": 30, "description": "p130Cas linkage to MAPK signaling for integrins", "id": "6c30e2a8-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5358351", "value": 0.1476028121201309, "ngenes": 234, "description": "Signaling by Hedgehog", "id": "6c30e2a9-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5358346", "value": 0.22244939914919934, "ngenes": 106, "description": "Hedgehog ligand biogenesis", "id": "6c30e2aa-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5362798", "value": 2.6892531473764623e-06, "ngenes": 10, "description": "Release of Hh-Np from the secreting cell", "id": "6c30e2ab-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5610787", "value": 0.06639095317036248, "ngenes": 180, "description": "Hedgehog 'off' state", "id": "6c30e2ac-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5610780", "value": 0.18809402957346233, "ngenes": 106, "description": "Degradation of GLI1 by the proteasome", "id": "6c30e2ad-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5610783", "value": 0.37801353668737425, "ngenes": 107, "description": "Degradation of GLI2 by the proteasome", "id": "6c30e2ae-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5610785", "value": 0.35335709825244555, "ngenes": 107, "description": "GLI3 is processed to GLI3R by the proteasome", "id": "6c30e2af-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5632684", "value": 0.4130606009998631, "ngenes": 141, "description": "Hedgehog 'on' state", "id": "6c30e2b0-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5632681", "value": 1.0, "ngenes": 13, "description": "Ligand-receptor interactions", "id": "6c30e2b1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5635838", "value": 0.335525319755066, "ngenes": 27, "description": "Activation of SMO", "id": "6c30e2b2-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5635851", "value": 0.8727450972808245, "ngenes": 9, "description": "GLI proteins bind promoters of Hh responsive genes to promote transcription", "id": "6c30e2b3-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-9006931", "value": 0.911195249508345, "ngenes": 459, "description": "Signaling by Nuclear Receptors", "id": "6c30e2b4-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5362517", "value": 0.034471212691761025, "ngenes": 68, "description": "Signaling by Retinoic Acid", "id": "6c30e2b5-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5365859", "value": 0.02182778031023468, "ngenes": 36, "description": "RA biosynthesis pathway", "id": "6c30e2b6-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8939211", "value": 0.6806363127271342, "ngenes": 341, "description": "ESR-mediated signaling", "id": "6c30e2b7-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9018519", "value": 0.20877577970458766, "ngenes": 214, "description": "Estrogen-dependent gene expression", "id": "6c30e2b8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9009391", "value": 0.7741994561499094, "ngenes": 137, "description": "Extra-nuclear estrogen signaling", "id": "6c30e2b9-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9634635", "value": 0.7473399204644617, "ngenes": 20, "description": "Estrogen-stimulated signaling through PRKCZ", "id": "6c30e2ba-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9634638", "value": 2.410192033629928e-06, "ngenes": 48, "description": "Estrogen-dependent nuclear events downstream of ESR-membrane signaling", "id": "6c30e2bb-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-9024446", "value": 0.004284324668402769, "ngenes": 75, "description": "NR1H2 and NR1H3-mediated signaling", "id": "6c30e2bc-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9029558", "value": 0.011105557399037657, "ngenes": 13, "description": "NR1H2 & NR1H3 regulate gene expression linked to lipogenesis", "id": "6c30e2bd-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9029569", "value": 0.09624969271644013, "ngenes": 60, "description": "NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux", "id": "6c30e2be-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9031525", "value": 0.004643981822308239, "ngenes": 6, "description": "NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake ", "id": "6c30e2bf-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9031528", "value": 0.7224609124803231, "ngenes": 6, "description": "NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose", "id": "6c30e2c0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9623433", "value": 0.10835711704809321, "ngenes": 15, "description": "NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis", "id": "6c30e2c1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9632974", "value": 0.005872747901628582, "ngenes": 7, "description": "NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis ", "id": "6c30e2c2-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-9006927", "value": 0.9835282197825542, "ngenes": 108, "description": "Signaling by Non-Receptor Tyrosine Kinases", "id": "6c30e2c3-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8848021", "value": 0.9835282197825542, "ngenes": 108, "description": "Signaling by PTK6", "id": "6c30e2c4-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8847993", "value": 0.2886746697384467, "ngenes": 26, "description": "ERBB2 Activates PTK6 Signaling", "id": "6c30e2c5-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8849468", "value": 0.3105000347204391, "ngenes": 7, "description": "PTK6 Regulates Proteins Involved in RNA Processing", "id": "6c30e2c6-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8849469", "value": 0.12606057065819284, "ngenes": 19, "description": "PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1", "id": "6c30e2c7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8849470", "value": 5.531027031359787e-12, "ngenes": 12, "description": "PTK6 Regulates Cell Cycle", "id": "6c30e2c8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8849471", "value": 0.12658850526430682, "ngenes": 29, "description": "PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases", "id": "6c30e2c9-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8849472", "value": 0.4679326534333106, "ngenes": 4, "description": "PTK6 Down-Regulation", "id": "6c30e2ca-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8849473", "value": 0.9885069429216391, "ngenes": 10, "description": "PTK6 Expression", "id": "6c30e2cb-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8849474", "value": 0.08071596492002911, "ngenes": 11, "description": "PTK6 Activates STAT3", "id": "6c30e2cc-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8857538", "value": 0.13544610530037454, "ngenes": 14, "description": "PTK6 promotes HIF1A stabilization", "id": "6c30e2cd-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-9006335", "value": 0.381884965945311, "ngenes": 38, "description": "Signaling by Erythropoietin", "id": "6c30e2ce-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9027276", "value": 0.488511260239706, "ngenes": 19, "description": "Erythropoietin activates Phosphoinositide-3-kinase (PI3K)", "id": "6c30e2cf-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9027277", "value": 0.4076559686789506, "ngenes": 8, "description": "Erythropoietin activates Phospholipase C gamma (PLCG)", "id": "6c30e2d0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9027283", "value": 7.670282285333512e-05, "ngenes": 7, "description": "Erythropoietin activates STAT5", "id": "6c30e2d1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9027284", "value": 0.034178961817951, "ngenes": 19, "description": "Erythropoietin activates RAS", "id": "6c30e2d2-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-73894", "value": 0.8421637022685342, "ngenes": 569, "description": "DNA Repair", "id": "6c30e2d3-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-73893", "value": 0.22525895843574129, "ngenes": 84, "description": "DNA Damage Bypass", "id": "6c30e2d4-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-110313", "value": 0.027290452487671677, "ngenes": 67, "description": "Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template", "id": "6c30e2d5-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-110312", "value": 0.23101931330920364, "ngenes": 31, "description": "Translesion synthesis by REV1", "id": "6c30e2d6-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-110320", "value": 0.07216718884547364, "ngenes": 38, "description": "Translesion Synthesis by POLH", "id": "6c30e2d7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5655862", "value": 0.2242552143512601, "ngenes": 32, "description": "Translesion synthesis by POLK", "id": "6c30e2d8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5656121", "value": 0.23670600436336778, "ngenes": 32, "description": "Translesion synthesis by POLI", "id": "6c30e2d9-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5656169", "value": 0.01454611151750584, "ngenes": 56, "description": "Termination of translesion DNA synthesis", "id": "6c30e2da-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-110314", "value": 0.19107353249696638, "ngenes": 54, "description": "Recognition of DNA damage by PCNA-containing replication complex", "id": "6c30e2db-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-73884", "value": 0.06646056888960032, "ngenes": 124, "description": "Base Excision Repair", "id": "6c30e2dc-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-73929", "value": 0.5143080464812152, "ngenes": 78, "description": "Base-Excision Repair, AP Site Formation", "id": "6c30e2dd-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-73928", "value": 0.47651336544962763, "ngenes": 72, "description": "Depyrimidination", "id": "6c30e2de-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-110328", "value": 0.47651336544962763, "ngenes": 72, "description": "Recognition and association of DNA glycosylase with site containing an affected pyrimidine", "id": "6c30e2df-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-110329", "value": 0.47651336544962763, "ngenes": 72, "description": "Cleavage of the damaged pyrimidine ", "id": "6c30e2e0-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-73927", "value": 0.502298916871708, "ngenes": 68, "description": "Depurination", "id": "6c30e2e1-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-110330", "value": 0.502298916871708, "ngenes": 68, "description": "Recognition and association of DNA glycosylase with site containing an affected purine", "id": "6c30e2e2-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-110331", "value": 0.502298916871708, "ngenes": 68, "description": "Cleavage of the damaged purine", "id": "6c30e2e3-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-73933", "value": 0.00021412419612234736, "ngenes": 64, "description": "Resolution of Abasic Sites (AP sites)", "id": "6c30e2e4-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-110357", "value": 0.016256147075884766, "ngenes": 18, "description": "Displacement of DNA glycosylase by APEX1", "id": "6c30e2e5-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-110373", "value": 2.943254424725633e-06, "ngenes": 41, "description": "Resolution of AP sites via the multiple-nucleotide patch replacement pathway", "id": "6c30e2e6-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-110362", "value": 9.764523224732009e-09, "ngenes": 13, "description": "POLB-Dependent Long Patch Base Excision Repair", "id": "6c30e2e7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5651801", "value": 6.720936033398776e-06, "ngenes": 34, "description": "PCNA-Dependent Long Patch Base Excision Repair", "id": "6c30e2e8-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5649702", "value": 0.6410363842981289, "ngenes": 10, "description": "APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway", "id": "6c30e2e9-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-110381", "value": 0.7293707254845762, "ngenes": 7, "description": "Resolution of AP sites via the single-nucleotide replacement pathway", "id": "6c30e2ea-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-73930", "value": 0.8111422677179204, "ngenes": 3, "description": "Abasic sugar-phosphate removal via the single-nucleotide replacement pathway", "id": "6c30e2eb-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-73942", "value": 0.4986834201013867, "ngenes": 12, "description": "DNA Damage Reversal", "id": "6c30e2ec-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-73943", "value": 0.5373409330966188, "ngenes": 11, "description": "Reversal of alkylation damage by DNA dioxygenases", "id": "6c30e2ed-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-112126", "value": 0.3141368580252026, "ngenes": 7, "description": "ALKBH3 mediated reversal of alkylation damage", "id": "6c30e2ee-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-5358508", "value": 7.895294760389891e-05, "ngenes": 27, "description": "Mismatch Repair", "id": "6c30e2ef-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5358565", "value": 0.00016217300672399882, "ngenes": 26, "description": "Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)", "id": "6c30e2f0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5358606", "value": 0.36589358267990646, "ngenes": 25, "description": "Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)", "id": "6c30e2f1-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5693532", "value": 0.0012102438643614311, "ngenes": 306, "description": "DNA Double-Strand Break Repair", "id": "6c30e2f2-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5693538", "value": 9.61955553794708e-05, "ngenes": 245, "description": "Homology Directed Repair", "id": "6c30e2f3-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5693567", "value": 0.013092250383894118, "ngenes": 236, "description": "HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)", "id": "6c30e2f4-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5685938", "value": 1.315685124888794e-11, "ngenes": 84, "description": "HDR through Single Strand Annealing (SSA)", "id": "6c30e2f5-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5685942", "value": 3.768517343118013e-07, "ngenes": 137, "description": "HDR through Homologous Recombination (HRR)", "id": "6c30e2f6-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5693537", "value": 4.396084513987445e-09, "ngenes": 76, "description": "Resolution of D-Loop Structures", "id": "6c30e2f7-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5693554", "value": 1.7880487808961204e-11, "ngenes": 61, "description": "Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)", "id": "6c30e2f8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5693568", "value": 5.522396628120763e-09, "ngenes": 71, "description": "Resolution of D-loop Structures through Holliday Junction Intermediates", "id": "6c30e2f9-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5693579", "value": 4.73362671157399e-09, "ngenes": 90, "description": "Homologous DNA Pairing and Strand Exchange", "id": "6c30e2fa-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5693616", "value": 3.037543557092693e-08, "ngenes": 87, "description": "Presynaptic phase of homologous DNA pairing and strand exchange", "id": "6c30e2fb-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-5693607", "value": 0.001676468697031404, "ngenes": 168, "description": "Processing of DNA double-strand break ends", "id": "6c30e2fc-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5685939", "value": 3.515912596544605e-15, "ngenes": 20, "description": "HDR through MMEJ (alt-NHEJ)", "id": "6c30e2fd-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5693606", "value": 0.07473743625090015, "ngenes": 140, "description": "DNA Double Strand Break Response", "id": "6c30e2fe-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5693548", "value": 5.8670203945385345e-05, "ngenes": 20, "description": "Sensing of DNA Double Strand Breaks", "id": "6c30e2ff-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5693565", "value": 0.29995571371997276, "ngenes": 135, "description": "Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks", "id": "6c30e300-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5693571", "value": 0.5208636539308686, "ngenes": 111, "description": "Nonhomologous End-Joining (NHEJ)", "id": "6c30e301-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5696398", "value": 0.40193505916893224, "ngenes": 188, "description": "Nucleotide Excision Repair", "id": "6c30e302-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5696399", "value": 0.09715419664695664, "ngenes": 141, "description": "Global Genome Nucleotide Excision Repair (GG-NER)", "id": "6c30e303-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5696394", "value": 0.016510506564976796, "ngenes": 63, "description": "DNA Damage Recognition in GG-NER", "id": "6c30e304-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5696395", "value": 0.014411332318169094, "ngenes": 73, "description": "Formation of Incision Complex in GG-NER", "id": "6c30e305-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5696397", "value": 0.01811044690864369, "ngenes": 43, "description": "Gap-filling DNA repair synthesis and ligation in GG-NER", "id": "6c30e306-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5696400", "value": 0.5941676500612814, "ngenes": 75, "description": "Dual Incision in GG-NER", "id": "6c30e307-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-6781827", "value": 0.36764469877191447, "ngenes": 140, "description": "Transcription-Coupled Nucleotide Excision Repair (TC-NER)", "id": "6c30e308-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-6781823", "value": 0.18097352972225192, "ngenes": 98, "description": "Formation of TC-NER Pre-Incision Complex", "id": "6c30e309-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6782135", "value": 0.7354394954439764, "ngenes": 121, "description": "Dual incision in TC-NER", "id": "6c30e30a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6782210", "value": 0.7779813594787727, "ngenes": 118, "description": "Gap-filling DNA repair synthesis and ligation in TC-NER", "id": "6c30e30b-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-6783310", "value": 0.0380066539758174, "ngenes": 70, "description": "Fanconi Anemia Pathway", "id": "6c30e30c-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8953854", "value": 0.2903524067665774, "ngenes": 1106, "description": "Metabolism of RNA", "id": "6c30e30d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-75067", "value": 0.4247338650518724, "ngenes": 51, "description": "Processing of Capped Intronless Pre-mRNA", "id": "6c30e30e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-111367", "value": 1.363936849787763e-10, "ngenes": 17, "description": "SLBP independent Processing of Histone Pre-mRNAs", "id": "6c30e30f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-77588", "value": 0.0005032493971155835, "ngenes": 19, "description": "SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs", "id": "6c30e310-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-77595", "value": 0.26052731337264806, "ngenes": 36, "description": "Processing of Intronless Pre-mRNAs", "id": "6c30e311-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-72203", "value": 0.7893369943369724, "ngenes": 389, "description": "Processing of Capped Intron-Containing Pre-mRNA", "id": "6c30e312-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-72202", "value": 0.5348691360761171, "ngenes": 143, "description": "Transport of Mature Transcript to Cytoplasm", "id": "6c30e313-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-159234", "value": 0.026354574095218315, "ngenes": 76, "description": "Transport of Mature mRNAs Derived from Intronless Transcripts", "id": "6c30e314-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-159227", "value": 0.0007650666372255977, "ngenes": 59, "description": "Transport of the SLBP independent Mature mRNA", "id": "6c30e315-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-159230", "value": 0.001964073471580261, "ngenes": 61, "description": "Transport of the SLBP Dependant Mature mRNA", "id": "6c30e316-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-159231", "value": 0.01709783462939312, "ngenes": 74, "description": "Transport of Mature mRNA Derived from an Intronless Transcript", "id": "6c30e317-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-159236", "value": 0.2020357212235181, "ngenes": 123, "description": "Transport of Mature mRNA derived from an Intron-Containing Transcript", "id": "6c30e318-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-72172", "value": 0.6806363127271342, "ngenes": 293, "description": "mRNA Splicing", "id": "6c30e319-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-72163", "value": 0.7374148386966682, "ngenes": 280, "description": "mRNA Splicing - Major Pathway", "id": "6c30e31a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-72165", "value": 0.07043008697577176, "ngenes": 73, "description": "mRNA Splicing - Minor Pathway", "id": "6c30e31b-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-72187", "value": 0.5390096717819396, "ngenes": 99, "description": "mRNA 3'-end processing", "id": "6c30e31c-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-194441", "value": 0.002784232871307307, "ngenes": 85, "description": "Metabolism of non-coding RNA", "id": "6c30e31d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-191859", "value": 0.002784232871307307, "ngenes": 85, "description": "snRNP Assembly", "id": "6c30e31e-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-429914", "value": 0.012542787677209354, "ngenes": 82, "description": "Deadenylation-dependent mRNA decay", "id": "6c30e31f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-429947", "value": 3.033128227159152e-05, "ngenes": 42, "description": "Deadenylation of mRNA", "id": "6c30e320-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-429958", "value": 0.9034063943315859, "ngenes": 22, "description": "mRNA decay by 3' to 5' exoribonuclease", "id": "6c30e321-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-430039", "value": 0.381884965945311, "ngenes": 18, "description": "mRNA decay by 5' to 3' exoribonuclease", "id": "6c30e322-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-450531", "value": 0.7425883379587369, "ngenes": 151, "description": "Regulation of mRNA stability by proteins that bind AU-rich elements", "id": "6c30e323-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-450385", "value": 0.8921065409809568, "ngenes": 27, "description": "Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA", "id": "6c30e324-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-450408", "value": 0.23180891925074976, "ngenes": 100, "description": "AUF1 (hnRNP D0) binds and destabilizes mRNA", "id": "6c30e325-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-450513", "value": 0.6404568972959231, "ngenes": 28, "description": "Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA", "id": "6c30e326-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-450520", "value": 0.01707323869621459, "ngenes": 10, "description": "HuR (ELAVL1) binds and stabilizes mRNA", "id": "6c30e327-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-450604", "value": 0.8421637022685342, "ngenes": 28, "description": "KSRP (KHSRP) binds and destabilizes mRNA", "id": "6c30e328-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-72306", "value": 0.20998702630317906, "ngenes": 162, "description": "tRNA processing", "id": "6c30e329-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-6782315", "value": 9.978100179972867e-07, "ngenes": 63, "description": "tRNA modification in the nucleus and cytosol", "id": "6c30e32a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-6782861", "value": 0.0022775207958561205, "ngenes": 7, "description": "Synthesis of wybutosine at G37 of tRNA(Phe)", "id": "6c30e32b-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-6784531", "value": 0.01644052010881652, "ngenes": 87, "description": "tRNA processing in the nucleus", "id": "6c30e32c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6785470", "value": 0.8421637022685342, "ngenes": 8, "description": "tRNA processing in the mitochondrion", "id": "6c30e32d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6787450", "value": 9.909025836864475e-08, "ngenes": 16, "description": "tRNA modification in the mitochondrion", "id": "6c30e32e-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-72312", "value": 0.2687215591576288, "ngenes": 360, "description": "rRNA processing", "id": "6c30e32f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8868773", "value": 0.26618720784856725, "ngenes": 348, "description": "rRNA processing in the nucleus and cytosol", "id": "6c30e330-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-6790901", "value": 2.61066548397675e-10, "ngenes": 95, "description": "rRNA modification in the nucleus and cytosol", "id": "6c30e331-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6791226", "value": 0.2622808783522277, "ngenes": 332, "description": "Major pathway of rRNA processing in the nucleolus and cytosol", "id": "6c30e332-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8868766", "value": 0.03813544178410842, "ngenes": 12, "description": "rRNA processing in the mitochondrion", "id": "6c30e333-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-6793080", "value": 0.6778093450716617, "ngenes": 7, "description": "rRNA modification in the mitochondrion", "id": "6c30e334-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-72086", "value": 0.10254390296209774, "ngenes": 42, "description": "mRNA Capping", "id": "6c30e335-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-75072", "value": 0.11373932982454729, "ngenes": 18, "description": "mRNA Editing", "id": "6c30e336-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-72200", "value": 0.015823445905127822, "ngenes": 12, "description": "mRNA Editing: C to U Conversion", "id": "6c30e337-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-75094", "value": 0.015823445905127822, "ngenes": 12, "description": "Formation of the Editosome", "id": "6c30e338-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-75064", "value": 0.4119474552519834, "ngenes": 6, "description": "mRNA Editing: A to I Conversion", "id": "6c30e339-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-75102", "value": 0.4119474552519834, "ngenes": 6, "description": "C6 deamination of adenosine", "id": "6c30e33a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-77042", "value": 0.4119474552519834, "ngenes": 6, "description": "Formation of editosomes by ADAR proteins", "id": "6c30e33b-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-927802", "value": 0.11777630059142877, "ngenes": 241, "description": "Nonsense-Mediated Decay (NMD)", "id": "6c30e33c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-975956", "value": 0.14594540161578948, "ngenes": 206, "description": "Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)", "id": "6c30e33d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-975957", "value": 0.11777630059142877, "ngenes": 241, "description": "Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)", "id": "6c30e33e-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-5357801", "value": 0.618162382018036, "ngenes": 357, "description": "Programmed Cell Death", "id": "6c30e33f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-109581", "value": 0.6540463440545753, "ngenes": 332, "description": "Apoptosis", "id": "6c30e340-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-109606", "value": 0.2590252767244878, "ngenes": 104, "description": "Intrinsic Pathway for Apoptosis", "id": "6c30e341-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-114452", "value": 0.011380636527717817, "ngenes": 53, "description": "Activation of BH3-only proteins", "id": "6c30e342-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-111446", "value": 0.15698226750267408, "ngenes": 7, "description": "Activation of BIM and translocation to mitochondria ", "id": "6c30e343-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-111447", "value": 6.460944543156662e-06, "ngenes": 30, "description": "Activation of BAD and translocation to mitochondria ", "id": "6c30e344-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-111448", "value": 0.3722910397178105, "ngenes": 6, "description": "Activation of NOXA and translocation to mitochondria", "id": "6c30e345-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-139910", "value": 0.01328012074019883, "ngenes": 8, "description": "Activation of BMF and translocation to mitochondria", "id": "6c30e346-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-139915", "value": 0.20736165299822149, "ngenes": 10, "description": "Activation of PUMA and translocation to mitochondria", "id": "6c30e347-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-111452", "value": 0.020956001394623197, "ngenes": 4, "description": "Activation and oligomerization of BAK protein", "id": "6c30e348-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-111453", "value": 4.66275264305397e-13, "ngenes": 22, "description": "BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members", "id": "6c30e349-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-111471", "value": 0.17428378714743548, "ngenes": 39, "description": "Apoptotic factor-mediated response", "id": "6c30e34a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-111457", "value": 0.01111265189782364, "ngenes": 12, "description": "Release of apoptotic factors from the mitochondria", "id": "6c30e34b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-111461", "value": 0.9701668083606931, "ngenes": 26, "description": "Cytochrome c-mediated apoptotic response", "id": "6c30e34c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-111459", "value": 0.00449052787094376, "ngenes": 11, "description": "Activation of caspases through apoptosome-mediated cleavage", "id": "6c30e34d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-111458", "value": 0.40237914886191045, "ngenes": 21, "description": "Formation of apoptosome", "id": "6c30e34e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9627069", "value": 0.40237914886191045, "ngenes": 21, "description": "Regulation of the apoptosome activity", "id": "6c30e34f-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-111469", "value": 0.6651875951883908, "ngenes": 19, "description": "SMAC, XIAP-regulated apoptotic response", "id": "6c30e350-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-111463", "value": 0.2878768830891785, "ngenes": 14, "description": "SMAC (DIABLO) binds to IAPs ", "id": "6c30e351-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-111464", "value": 0.2878768830891785, "ngenes": 14, "description": "SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes ", "id": "6c30e352-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-114294", "value": 0.015495015342095611, "ngenes": 6, "description": "Activation, translocation and oligomerization of BAX", "id": "6c30e353-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-75108", "value": 0.9336226860594022, "ngenes": 10, "description": "Activation, myristolyation of BID and translocation to mitochondria", "id": "6c30e354-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-75153", "value": 0.1878635794312577, "ngenes": 113, "description": "Apoptotic execution phase", "id": "6c30e355-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-140342", "value": 0.1602989345495549, "ngenes": 18, "description": "Apoptosis induced DNA fragmentation", "id": "6c30e356-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-211736", "value": 2.8851821304607344e-05, "ngenes": 4, "description": "Stimulation of the cell death response by PAK-2p34", "id": "6c30e357-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-111465", "value": 0.07737266966335538, "ngenes": 92, "description": "Apoptotic cleavage of cellular proteins", "id": "6c30e358-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-264870", "value": 0.001994180778607186, "ngenes": 35, "description": "Caspase-mediated cleavage of cytoskeletal proteins", "id": "6c30e359-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-351906", "value": 0.3728795113594563, "ngenes": 29, "description": "Apoptotic cleavage of cell adhesion  proteins", "id": "6c30e35a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-352238", "value": 0.0003827467697318267, "ngenes": 6, "description": "Breakdown of the nuclear lamina", "id": "6c30e35b-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-169911", "value": 0.1860475392526308, "ngenes": 93, "description": "Regulation of Apoptosis", "id": "6c30e35c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-211728", "value": 0.030429719063101917, "ngenes": 3, "description": "Regulation of PAK-2p34 activity by PS-GAP/RHG10", "id": "6c30e35d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-211733", "value": 0.15749835937899523, "ngenes": 88, "description": "Regulation of activated PAK-2p34 by proteasome mediated degradation", "id": "6c30e35e-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5357769", "value": 0.6180354017712403, "ngenes": 43, "description": "Caspase activation via extrinsic apoptotic signalling pathway", "id": "6c30e35f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-140534", "value": 0.16890482254738393, "ngenes": 27, "description": "Caspase activation via Death Receptors in the presence of ligand", "id": "6c30e360-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3371378", "value": 0.004136995884992025, "ngenes": 20, "description": "Regulation by c-FLIP", "id": "6c30e361-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-69416", "value": 0.004136995884992025, "ngenes": 20, "description": "Dimerization of procaspase-8", "id": "6c30e362-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-418889", "value": 0.010081270997589657, "ngenes": 16, "description": "Caspase activation via Dependence Receptors in the absence of ligand", "id": "6c30e363-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-5218859", "value": 0.6247979836912028, "ngenes": 58, "description": "Regulated Necrosis", "id": "6c30e364-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5213460", "value": 0.6247979836912028, "ngenes": 58, "description": "RIPK1-mediated regulated necrosis", "id": "6c30e365-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5675482", "value": 0.6247979836912028, "ngenes": 58, "description": "Regulation of necroptotic cell death", "id": "6c30e366-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5218900", "value": 0.004136995884992025, "ngenes": 20, "description": "CASP8 activity is inhibited", "id": "6c30e367-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9686347", "value": 0.4455899614268648, "ngenes": 11, "description": "Microbial modulation of RIPK1-mediated regulated necrosis", "id": "6c30e368-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-112316", "value": 0.08676063595848288, "ngenes": 717, "description": "Neuronal System", "id": "6c30e369-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-112307", "value": 0.6003959376347063, "ngenes": 6, "description": "Transmission across Electrical Synapses ", "id": "6c30e36a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-112303", "value": 0.6003959376347063, "ngenes": 6, "description": "Electric Transmission Across Gap Junctions", "id": "6c30e36b-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-112315", "value": 0.01307339808832479, "ngenes": 460, "description": "Transmission across Chemical Synapses", "id": "6c30e36c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-112308", "value": 0.00835843445205958, "ngenes": 23, "description": "Presynaptic depolarization and calcium channel opening", "id": "6c30e36d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-112314", "value": 0.13051671333614306, "ngenes": 351, "description": "Neurotransmitter receptors and postsynaptic signal transmission", "id": "6c30e36e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-977443", "value": 0.9756359858182779, "ngenes": 84, "description": "GABA receptor activation", "id": "6c30e36f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-977444", "value": 0.48237163011817563, "ngenes": 59, "description": "GABA B receptor activation", "id": "6c30e370-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-991365", "value": 0.48237163011817563, "ngenes": 59, "description": "Activation of GABAB receptors", "id": "6c30e371-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-170670", "value": 0.00014288284850742032, "ngenes": 17, "description": "Adenylate cyclase inhibitory pathway", "id": "6c30e372-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-997272", "value": 0.04617468651161317, "ngenes": 42, "description": "Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits", "id": "6c30e373-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-399721", "value": 0.22122791640199696, "ngenes": 64, "description": "Glutamate binding, activation of AMPA receptors and synaptic plasticity", "id": "6c30e374-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-399710", "value": 0.015554135363387313, "ngenes": 7, "description": "Activation of AMPA receptors", "id": "6c30e375-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-399719", "value": 0.22122791640199696, "ngenes": 64, "description": "Trafficking of AMPA receptors", "id": "6c30e376-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-416993", "value": 0.4871620946744711, "ngenes": 37, "description": "Trafficking of GluR2-containing AMPA receptors", "id": "6c30e377-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-442755", "value": 0.0002004413329336196, "ngenes": 175, "description": "Activation of NMDA receptors and postsynaptic events", "id": "6c30e378-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-438066", "value": 0.0068231832431217875, "ngenes": 42, "description": "Unblocking of NMDA receptors, glutamate binding and activation", "id": "6c30e379-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-438064", "value": 0.0002712237989636623, "ngenes": 156, "description": "Post NMDA receptor activation events", "id": "6c30e37a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-442720", "value": 0.021017933252933167, "ngenes": 23, "description": "CREB1 phosphorylation through the activation of Adenylate Cyclase", "id": "6c30e37b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-442729", "value": 0.002284694329851136, "ngenes": 23, "description": "CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde", "id": "6c30e37c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-442742", "value": 0.1087136304754028, "ngenes": 64, "description": "CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling", "id": "6c30e37d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-442982", "value": 0.023793589182104863, "ngenes": 38, "description": "Ras activation upon Ca2+ influx through NMDA receptor", "id": "6c30e37e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-444257", "value": 0.26052731337264806, "ngenes": 22, "description": "RSK activation", "id": "6c30e37f-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9619229", "value": 0.8646430582683339, "ngenes": 14, "description": "Activation of RAC1 downstream of NMDARs", "id": "6c30e380-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9619483", "value": 6.599857987719939e-12, "ngenes": 40, "description": "Activation of AMPK downstream of NMDARs", "id": "6c30e381-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9620244", "value": 0.029713508787575924, "ngenes": 47, "description": "Long-term potentiation", "id": "6c30e382-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9609736", "value": 1.4366121510379554e-06, "ngenes": 68, "description": "Assembly and cell surface presentation of NMDA receptors", "id": "6c30e383-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9617324", "value": 0.015997750358686964, "ngenes": 40, "description": "Negative regulation of NMDA receptor-mediated neuronal transmission", "id": "6c30e384-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-451326", "value": 0.05043403079198188, "ngenes": 46, "description": "Activation of kainate receptors upon glutamate binding", "id": "6c30e385-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-451306", "value": 0.0825393800360934, "ngenes": 20, "description": "Ionotropic activity of kainate receptors", "id": "6c30e386-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-451307", "value": 0.012126296906130027, "ngenes": 7, "description": "Activation of Na-permeable kainate receptors", "id": "6c30e387-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-451308", "value": 0.0825393800360934, "ngenes": 20, "description": "Activation of Ca-permeable Kainate Receptor", "id": "6c30e388-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-500657", "value": 0.002553432668966539, "ngenes": 28, "description": "Presynaptic function of Kainate receptors", "id": "6c30e389-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-181431", "value": 0.020521906071122527, "ngenes": 21, "description": "Acetylcholine binding and downstream events", "id": "6c30e38a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-622323", "value": 0.021410128172257348, "ngenes": 15, "description": "Presynaptic nicotinic acetylcholine receptors", "id": "6c30e38b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-629587", "value": 0.6180354017712403, "ngenes": 7, "description": "Highly sodium permeable postsynaptic acetylcholine nicotinic receptors", "id": "6c30e38c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-629597", "value": 0.0235855531539651, "ngenes": 12, "description": "Highly calcium permeable nicotinic acetylcholine receptors", "id": "6c30e38d-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-622327", "value": 0.020521906071122527, "ngenes": 21, "description": "Postsynaptic nicotinic acetylcholine receptors", "id": "6c30e38e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-629587", "value": 0.6180354017712403, "ngenes": 7, "description": "Highly sodium permeable postsynaptic acetylcholine nicotinic receptors", "id": "6c30e38f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-629594", "value": 0.022363694818350426, "ngenes": 18, "description": "Highly calcium permeable postsynaptic nicotinic acetylcholine receptors", "id": "6c30e390-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-112310", "value": 0.007049008766829303, "ngenes": 79, "description": "Neurotransmitter release cycle", "id": "6c30e391-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-181429", "value": 0.9113985431425623, "ngenes": 29, "description": "Serotonin Neurotransmitter Release Cycle", "id": "6c30e392-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-181430", "value": 0.0748327116555517, "ngenes": 27, "description": "Norepinephrine Neurotransmitter Release Cycle", "id": "6c30e393-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-210500", "value": 0.9663554336950456, "ngenes": 31, "description": "Glutamate Neurotransmitter Release Cycle", "id": "6c30e394-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-212676", "value": 0.9208765530518377, "ngenes": 36, "description": "Dopamine Neurotransmitter Release Cycle", "id": "6c30e395-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-264642", "value": 0.022717893773565527, "ngenes": 27, "description": "Acetylcholine Neurotransmitter Release Cycle", "id": "6c30e396-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-888590", "value": 0.0004349504562035019, "ngenes": 31, "description": "GABA synthesis, release, reuptake and degradation", "id": "6c30e397-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-888568", "value": 0.030026880108473934, "ngenes": 4, "description": "GABA synthesis", "id": "6c30e398-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-888593", "value": 0.00990106089456824, "ngenes": 4, "description": "Reuptake of GABA", "id": "6c30e399-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-916853", "value": 9.061437231255604e-13, "ngenes": 5, "description": "Degradation of GABA", "id": "6c30e39a-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-112313", "value": 0.0061157314167867745, "ngenes": 7, "description": "Neurotransmitter uptake and metabolism In glial cells", "id": "6c30e39b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-210455", "value": 0.0061157314167867745, "ngenes": 7, "description": "Astrocytic Glutamate-Glutamine Uptake And Metabolism", "id": "6c30e39c-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-112311", "value": 0.0006812788060562404, "ngenes": 15, "description": "Neurotransmitter clearance", "id": "6c30e39d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-379401", "value": 0.0045656507212278475, "ngenes": 4, "description": "Dopamine clearance from the synaptic cleft", "id": "6c30e39e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-379397", "value": 0.0045656507212278475, "ngenes": 4, "description": "Enzymatic degradation of dopamine by COMT", "id": "6c30e39f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-379398", "value": 0.0682703740597573, "ngenes": 3, "description": "Enzymatic degradation of Dopamine by monoamine oxidase", "id": "6c30e3a0-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-380615", "value": 0.007403973476156625, "ngenes": 4, "description": "Serotonin clearance from the synaptic cleft", "id": "6c30e3a1-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-1296071", "value": 0.9280070777613183, "ngenes": 181, "description": "Potassium Channels", "id": "6c30e3a2-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1296065", "value": 0.3679627979500511, "ngenes": 53, "description": "Inwardly rectifying K+ channels", "id": "6c30e3a3-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1296025", "value": 2.826450966013584e-07, "ngenes": 5, "description": "ATP sensitive Potassium channels", "id": "6c30e3a4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1296059", "value": 0.04617468651161317, "ngenes": 42, "description": "G protein gated Potassium channels", "id": "6c30e3a5-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1296041", "value": 0.04617468651161317, "ngenes": 42, "description": "Activation of G protein gated Potassium channels", "id": "6c30e3a6-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1296053", "value": 0.14984797572041342, "ngenes": 7, "description": "Classical Kir channels", "id": "6c30e3a7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1296067", "value": 0.5519286881284385, "ngenes": 6, "description": "Potassium transport channels", "id": "6c30e3a8-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1296052", "value": 0.09036299853764833, "ngenes": 18, "description": "Ca2+ activated K+ channels", "id": "6c30e3a9-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1296061", "value": 0.08354697333853367, "ngenes": 5, "description": "HCN channels", "id": "6c30e3aa-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1296072", "value": 0.5478316916948813, "ngenes": 81, "description": "Voltage gated Potassium channels", "id": "6c30e3ab-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1296346", "value": 2.580883033561106e-06, "ngenes": 24, "description": "Tandem pore domain potassium channels", "id": "6c30e3ac-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1299308", "value": 1.5690607242723255e-06, "ngenes": 6, "description": "Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK)", "id": "6c30e3ad-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1299503", "value": 0.000961649103222661, "ngenes": 12, "description": "TWIK related potassium channel (TREK)", "id": "6c30e3ae-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-6794362", "value": 0.0015040470364868462, "ngenes": 159, "description": "Protein-protein interactions at synapses", "id": "6c30e3af-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-388844", "value": 1.8184802599251908e-05, "ngenes": 38, "description": "Receptor-type tyrosine-protein phosphatases", "id": "6c30e3b0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6794361", "value": 0.013049773881441778, "ngenes": 103, "description": "Neurexins and neuroligins", "id": "6c30e3b1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8849932", "value": 0.7593295667888667, "ngenes": 39, "description": "Synaptic adhesion-like molecules", "id": "6c30e3b2-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-74160", "value": 0.4106042729263482, "ngenes": 2475, "description": "Gene expression (Transcription)", "id": "6c30e3b3-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-73857", "value": 0.4313852229698314, "ngenes": 2246, "description": "RNA Polymerase II Transcription", "id": "6c30e3b4-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-75955", "value": 0.0065888484722175815, "ngenes": 88, "description": "RNA Polymerase II Transcription Elongation", "id": "6c30e3b5-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-112382", "value": 0.0065888484722175815, "ngenes": 88, "description": "Formation of RNA Pol II elongation complex ", "id": "6c30e3b6-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-113418", "value": 0.00134352013304132, "ngenes": 52, "description": "Formation of the Early Elongation Complex", "id": "6c30e3b7-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-212436", "value": 0.5440780712764105, "ngenes": 2054, "description": "Generic Transcription Pathway", "id": "6c30e3b8-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2032785", "value": 0.046295531504758805, "ngenes": 27, "description": "YAP1- and WWTR1 (TAZ)-stimulated gene expression", "id": "6c30e3b9-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2173793", "value": 0.6594729876998179, "ngenes": 83, "description": "Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer", "id": "6c30e3ba-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2173795", "value": 0.18220809876328026, "ngenes": 48, "description": "Downregulation of SMAD2/3:SMAD4 transcriptional activity", "id": "6c30e3bb-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2173796", "value": 0.7779813594787727, "ngenes": 59, "description": "SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription", "id": "6c30e3bc-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-350054", "value": 0.963994649656727, "ngenes": 46, "description": "Notch-HLH transcription pathway", "id": "6c30e3bd-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-383280", "value": 8.298660268029124e-06, "ngenes": 107, "description": "Nuclear Receptor transcription pathway", "id": "6c30e3be-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3700989", "value": 0.056982369985934284, "ngenes": 652, "description": "Transcriptional Regulation by TP53", "id": "6c30e3bf-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5628897", "value": 0.1713663191105792, "ngenes": 129, "description": "TP53 Regulates Metabolic Genes", "id": "6c30e3c0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6796648", "value": 0.0007336425707276065, "ngenes": 107, "description": "TP53 Regulates Transcription of DNA Repair Genes", "id": "6c30e3c1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5633008", "value": 0.06467456653914191, "ngenes": 86, "description": "TP53 Regulates Transcription of Cell Death Genes", "id": "6c30e3c2-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-6803204", "value": 1.156259112230881e-06, "ngenes": 39, "description": "TP53 Regulates Transcription of Genes Involved in Cytochrome C Release", "id": "6c30e3c3-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6803205", "value": 1.112489768673868e-16, "ngenes": 24, "description": "TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain", "id": "6c30e3c4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6803207", "value": 0.052811540238473266, "ngenes": 25, "description": "TP53 Regulates Transcription of Caspase Activators and Caspases", "id": "6c30e3c5-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6803211", "value": 0.7541974866899581, "ngenes": 17, "description": "TP53 Regulates Transcription of Death Receptors and Ligands", "id": "6c30e3c6-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-6791312", "value": 1.3334118075603303e-15, "ngenes": 84, "description": "TP53 Regulates Transcription of Cell Cycle Genes", "id": "6c30e3c7-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-6804114", "value": 3.853501021028184e-12, "ngenes": 31, "description": "TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest", "id": "6c30e3c8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6804115", "value": 1.971910036458601e-08, "ngenes": 35, "description": "TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain", "id": "6c30e3c9-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6804116", "value": 2.7798786742514873e-16, "ngenes": 24, "description": "TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest", "id": "6c30e3ca-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5633007", "value": 0.4901959797992876, "ngenes": 314, "description": "Regulation of TP53 Activity", "id": "6c30e3cb-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-6806003", "value": 0.843026140736762, "ngenes": 91, "description": "Regulation of TP53 Expression and Degradation", "id": "6c30e3cc-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-6804754", "value": 0.5544466027451358, "ngenes": 5, "description": "Regulation of TP53 Expression", "id": "6c30e3cd-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6804757", "value": 0.8432599237749369, "ngenes": 87, "description": "Regulation of TP53 Degradation", "id": "6c30e3ce-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-6804756", "value": 7.393832143122094e-13, "ngenes": 171, "description": "Regulation of TP53 Activity through Phosphorylation", "id": "6c30e3cf-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6804759", "value": 0.001855205316967206, "ngenes": 23, "description": "Regulation of TP53 Activity through Association with Co-factors", "id": "6c30e3d0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6804760", "value": 0.33947861154573034, "ngenes": 40, "description": "Regulation of TP53 Activity through Methylation", "id": "6c30e3d1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6804758", "value": 0.001612334839336191, "ngenes": 58, "description": "Regulation of TP53 Activity through Acetylation", "id": "6c30e3d2-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-6811555", "value": 0.06646056888960032, "ngenes": 13, "description": "PI5P Regulates TP53 Acetylation", "id": "6c30e3d3-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-8853884", "value": 0.5980601496893074, "ngenes": 77, "description": "Transcriptional Regulation by VENTX", "id": "6c30e3d4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8864260", "value": 0.0020390428560717174, "ngenes": 71, "description": "Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors", "id": "6c30e3d5-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8866904", "value": 0.47514038043848866, "ngenes": 22, "description": "Negative regulation of activity of TFAP2 (AP-2) family transcription factors", "id": "6c30e3d6-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8866906", "value": 0.11424128480519892, "ngenes": 11, "description": "TFAP2 (AP-2) family regulates transcription of other transcription factors", "id": "6c30e3d7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8866907", "value": 0.2144051601635095, "ngenes": 21, "description": "Activation of the TFAP2 (AP-2) family of transcription factors", "id": "6c30e3d8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8866910", "value": 1.373043401156215e-08, "ngenes": 29, "description": "TFAP2 (AP-2) family regulates transcription of growth factors and their receptors", "id": "6c30e3d9-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8866911", "value": 0.5678532395717029, "ngenes": 11, "description": "TFAP2 (AP-2) family regulates transcription of cell cycle factors", "id": "6c30e3da-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8869496", "value": 3.2373431096761893e-06, "ngenes": 14, "description": "TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation", "id": "6c30e3db-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8878171", "value": 0.20829428358159363, "ngenes": 387, "description": "Transcriptional regulation by RUNX1", "id": "6c30e3dc-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8877330", "value": 0.021017933252933167, "ngenes": 21, "description": "RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs)", "id": "6c30e3dd-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8931987", "value": 3.5314060641845517e-06, "ngenes": 12, "description": "RUNX1 regulates estrogen receptor mediated transcription", "id": "6c30e3de-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8934593", "value": 0.5649041232743919, "ngenes": 38, "description": "Regulation of RUNX1 Expression and Activity", "id": "6c30e3df-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8935964", "value": 0.057837522850729274, "ngenes": 12, "description": "RUNX1 regulates expression of components of tight junctions", "id": "6c30e3e0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8936459", "value": 0.19033171998059326, "ngenes": 135, "description": "RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function", "id": "6c30e3e1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8939236", "value": 0.174574247897005, "ngenes": 182, "description": "RUNX1 regulates transcription of genes involved in differentiation of HSCs", "id": "6c30e3e2-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8939242", "value": 0.0072233511643681695, "ngenes": 15, "description": "RUNX1 regulates transcription of genes involved in differentiation of keratinocytes", "id": "6c30e3e3-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8939243", "value": 0.0005122302629796587, "ngenes": 74, "description": "RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known", "id": "6c30e3e4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8939245", "value": 0.028885129841134494, "ngenes": 11, "description": "RUNX1 regulates transcription of genes involved in BCR signaling", "id": "6c30e3e5-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8939246", "value": 0.3220677057316782, "ngenes": 16, "description": "RUNX1 regulates transcription of genes involved in differentiation of myeloid cells", "id": "6c30e3e6-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8939247", "value": 0.5681549676133301, "ngenes": 8, "description": "RUNX1 regulates transcription of genes involved in interleukin signaling", "id": "6c30e3e7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8939256", "value": 0.0074283609700200055, "ngenes": 10, "description": "RUNX1 regulates transcription of genes involved in WNT signaling", "id": "6c30e3e8-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8878166", "value": 0.1360573204906213, "ngenes": 201, "description": "Transcriptional regulation by RUNX2", "id": "6c30e3e9-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8939902", "value": 0.07308169200605373, "ngenes": 129, "description": "Regulation of RUNX2 expression and activity", "id": "6c30e3ea-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8941326", "value": 0.7102446998181006, "ngenes": 46, "description": "RUNX2 regulates bone development", "id": "6c30e3eb-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8940973", "value": 0.19179531513228557, "ngenes": 38, "description": "RUNX2 regulates osteoblast differentiation", "id": "6c30e3ec-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8941284", "value": 0.44098529044062196, "ngenes": 8, "description": "RUNX2 regulates chondrocyte maturation", "id": "6c30e3ed-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8941332", "value": 0.056299966498717366, "ngenes": 16, "description": "RUNX2 regulates genes involved in cell migration", "id": "6c30e3ee-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8941333", "value": 0.16133620801284904, "ngenes": 10, "description": "RUNX2 regulates genes involved in differentiation of myeloid cells", "id": "6c30e3ef-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8878159", "value": 0.23670600436336778, "ngenes": 176, "description": "Transcriptional regulation by RUNX3", "id": "6c30e3f0-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8941855", "value": 0.018942031440574887, "ngenes": 10, "description": "RUNX3 regulates CDKN1A transcription", "id": "6c30e3f1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8941856", "value": 0.0008796610724689507, "ngenes": 19, "description": "RUNX3 regulates NOTCH signaling", "id": "6c30e3f2-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8941858", "value": 0.11281334127113246, "ngenes": 102, "description": "Regulation of RUNX3 expression and activity", "id": "6c30e3f3-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8949275", "value": 4.134370878248157e-05, "ngenes": 12, "description": "RUNX3 Regulates Immune Response and Cell Migration", "id": "6c30e3f4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8951430", "value": 0.8989715613064501, "ngenes": 21, "description": "RUNX3 regulates WNT signaling", "id": "6c30e3f5-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8951671", "value": 0.0006761301884331578, "ngenes": 12, "description": "RUNX3 regulates YAP1-mediated transcription", "id": "6c30e3f6-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8951911", "value": 0.013092250383894118, "ngenes": 7, "description": "RUNX3 regulates RUNX1-mediated transcription", "id": "6c30e3f7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8951936", "value": 0.0008455413326766953, "ngenes": 17, "description": "RUNX3 regulates p14-ARF", "id": "6c30e3f8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8952158", "value": 0.2111019893330746, "ngenes": 11, "description": "RUNX3 regulates BCL2L11 (BIM) transcription", "id": "6c30e3f9-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8953750", "value": 0.4997500712929101, "ngenes": 69, "description": "Transcriptional Regulation by E2F6", "id": "6c30e3fa-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8986944", "value": 0.011346579726776357, "ngenes": 122, "description": "Transcriptional Regulation by MECP2", "id": "6c30e3fb-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9022692", "value": 0.11373932982454729, "ngenes": 62, "description": "Regulation of MECP2 expression and activity", "id": "6c30e3fc-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9022699", "value": 0.0197347614529516, "ngenes": 30, "description": "MECP2 regulates neuronal receptors and channels", "id": "6c30e3fd-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9022702", "value": 0.20385151918139757, "ngenes": 18, "description": "MECP2 regulates transcription of neuronal ligands", "id": "6c30e3fe-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9022707", "value": 0.2135219970482858, "ngenes": 15, "description": "MECP2 regulates transcription factors", "id": "6c30e3ff-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9022927", "value": 0.025809338127354725, "ngenes": 6, "description": "MECP2 regulates transcription of genes involved in GABA signaling", "id": "6c30e400-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9614085", "value": 0.4240083561210291, "ngenes": 110, "description": "FOXO-mediated transcription", "id": "6c30e401-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9614399", "value": 0.976086516152444, "ngenes": 22, "description": "Regulation of localization of FOXO transcription factors", "id": "6c320fd0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9614657", "value": 0.9238875645072664, "ngenes": 23, "description": "FOXO-mediated transcription of cell death genes", "id": "6c320fd1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9615017", "value": 0.4876318677758104, "ngenes": 52, "description": "FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes", "id": "6c320fd2-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9617629", "value": 0.09175661430669817, "ngenes": 15, "description": "Regulation of FOXO transcriptional activity by acetylation", "id": "6c320fd3-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9617828", "value": 0.000795025193741623, "ngenes": 31, "description": "FOXO-mediated transcription of cell cycle genes", "id": "6c320fd4-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-674695", "value": 0.01014098822671821, "ngenes": 117, "description": "RNA Polymerase II Pre-transcription Events", "id": "6c320fd5-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6807505", "value": 0.13309945886289337, "ngenes": 106, "description": "RNA polymerase II transcribes snRNA genes", "id": "6c320fd6-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-76042", "value": 0.08275044825080018, "ngenes": 64, "description": "RNA Polymerase II Transcription Initiation And Promoter Clearance", "id": "6c320fd7-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-73776", "value": 0.08275044825080018, "ngenes": 64, "description": "RNA Polymerase II Promoter Escape", "id": "6c320fd8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-75953", "value": 0.08275044825080018, "ngenes": 64, "description": "RNA Polymerase II Transcription Initiation", "id": "6c320fd9-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-73779", "value": 0.08275044825080018, "ngenes": 64, "description": "RNA Polymerase II Transcription Pre-Initiation And Promoter Opening", "id": "6c320fda-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-73856", "value": 0.8011300174520065, "ngenes": 114, "description": "RNA Polymerase II Transcription Termination", "id": "6c320fdb-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-77075", "value": 0.0338617131580787, "ngenes": 38, "description": "RNA Pol II CTD phosphorylation and interaction with CE", "id": "6c320fdc-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-75944", "value": 0.5808223478652172, "ngenes": 6, "description": "Transcription from mitochondrial promoters", "id": "6c320fdd-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-163282", "value": 0.6020527621851909, "ngenes": 4, "description": "Mitochondrial transcription initiation", "id": "6c320fde-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-211000", "value": 0.3134315886816355, "ngenes": 186, "description": "Gene Silencing by RNA", "id": "6c320fdf-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-203927", "value": 0.000435306534529907, "ngenes": 34, "description": "MicroRNA (miRNA) biogenesis", "id": "6c320fe0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-426486", "value": 0.0009159848110867152, "ngenes": 17, "description": "Small interfering RNA (siRNA) biogenesis", "id": "6c320fe1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-426496", "value": 0.2912911842971027, "ngenes": 16, "description": "Post-transcriptional silencing by small RNAs", "id": "6c320fe2-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5578749", "value": 0.13808999101968444, "ngenes": 135, "description": "Transcriptional regulation by small RNAs", "id": "6c320fe3-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5601884", "value": 0.048581704410858004, "ngenes": 39, "description": "PIWI-interacting RNA (piRNA) biogenesis", "id": "6c320fe4-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-212165", "value": 0.32714712797868034, "ngenes": 216, "description": "Epigenetic regulation of gene expression", "id": "6c320fe5-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-212300", "value": 0.13795356767983102, "ngenes": 93, "description": "PRC2 methylates histones and DNA", "id": "6c320fe6-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5250941", "value": 0.7335981615402589, "ngenes": 151, "description": "Negative epigenetic regulation of rRNA expression", "id": "6c320fe7-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-427359", "value": 0.2675922675321366, "ngenes": 82, "description": "SIRT1 negatively regulates rRNA expression", "id": "6c320fe8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-427413", "value": 0.670224346160836, "ngenes": 148, "description": "NoRC negatively regulates rRNA expression", "id": "6c320fe9-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5250913", "value": 0.6316821673965827, "ngenes": 139, "description": "Positive epigenetic regulation of rRNA expression", "id": "6c320fea-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-427389", "value": 0.3147425490288081, "ngenes": 92, "description": "ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression", "id": "6c320feb-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5250924", "value": 0.37408492199398546, "ngenes": 116, "description": "B-WICH complex positively regulates rRNA expression", "id": "6c320fec-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5221030", "value": 2.314792736790433e-13, "ngenes": 6, "description": "TET1,2,3 and TDG demethylate DNA", "id": "6c320fed-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5334118", "value": 0.16869757366048074, "ngenes": 79, "description": "DNA methylation", "id": "6c320fee-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-73864", "value": 0.7540201497240838, "ngenes": 153, "description": "RNA Polymerase I Transcription", "id": "6c320fef-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-73854", "value": 0.7541974866899581, "ngenes": 152, "description": "RNA Polymerase I Promoter Clearance", "id": "6c320ff0-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-73728", "value": 0.2194412507194543, "ngenes": 77, "description": "RNA Polymerase I Promoter Opening", "id": "6c320ff1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-73762", "value": 0.024349918566241423, "ngenes": 76, "description": "RNA Polymerase I Transcription Initiation", "id": "6c320ff2-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-73772", "value": 0.431814262296479, "ngenes": 122, "description": "RNA Polymerase I Promoter Escape", "id": "6c320ff3-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-73863", "value": 0.07473743625090015, "ngenes": 54, "description": "RNA Polymerase I Transcription Termination", "id": "6c320ff4-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-74158", "value": 0.5070120758810073, "ngenes": 61, "description": "RNA Polymerase III Transcription", "id": "6c320ff5-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-73780", "value": 2.7048173930150398e-09, "ngenes": 23, "description": "RNA Polymerase III Chain Elongation", "id": "6c320ff6-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-73980", "value": 0.05385907748777972, "ngenes": 35, "description": "RNA Polymerase III Transcription Termination", "id": "6c320ff7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-749476", "value": 0.5070120758810073, "ngenes": 61, "description": "RNA Polymerase III Abortive And Retractive Initiation", "id": "6c320ff8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-76046", "value": 0.014484194870334333, "ngenes": 49, "description": "RNA Polymerase III Transcription Initiation", "id": "6c320ff9-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-76061", "value": 1.703991228396662e-11, "ngenes": 38, "description": "RNA Polymerase III Transcription Initiation From Type 1 Promoter", "id": "6c320ffa-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-76066", "value": 1.5784681202576779e-10, "ngenes": 37, "description": "RNA Polymerase III Transcription Initiation From Type 2 Promoter", "id": "6c320ffb-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-76071", "value": 0.0013621971397830648, "ngenes": 36, "description": "RNA Polymerase III Transcription Initiation From Type 3 Promoter", "id": "6c320ffc-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-1640170", "value": 1.6997699095077686e-14, "ngenes": 1161, "description": "Cell Cycle", "id": "6c320ffd-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-69278", "value": 6.78394574181802e-16, "ngenes": 907, "description": "Cell Cycle, Mitotic", "id": "6c320ffe-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-453279", "value": 4.368153408256814e-07, "ngenes": 258, "description": "Mitotic G1 phase and G1/S transition", "id": "6c320fff-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-69206", "value": 3.992651819022154e-06, "ngenes": 222, "description": "G1/S Transition", "id": "6c321000-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-113510", "value": 0.2675922675321366, "ngenes": 39, "description": "E2F mediated regulation of DNA replication", "id": "6c321001-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-113501", "value": 0.16890482254738393, "ngenes": 24, "description": "Inhibition of replication initiation of damaged DNA by RB1/E2F1", "id": "6c321002-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-113507", "value": 6.815552106851809e-13, "ngenes": 15, "description": "E2F-enabled inhibition of pre-replication complex formation", "id": "6c321003-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-69202", "value": 0.08614469049708676, "ngenes": 146, "description": "Cyclin E associated events during G1/S transition ", "id": "6c321004-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-187577", "value": 0.0024348302445445272, "ngenes": 109, "description": "SCF(Skp2)-mediated degradation of p27/p21", "id": "6c321005-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-69200", "value": 1.1068867967277736e-14, "ngenes": 9, "description": "Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes", "id": "6c321006-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-68962", "value": 3.5096712062002506e-13, "ngenes": 47, "description": "Activation of the pre-replicative complex", "id": "6c321007-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-69205", "value": 2.565230946507537e-15, "ngenes": 43, "description": "G1/S-Specific Transcription", "id": "6c321008-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1538133", "value": 6.701775598543569e-09, "ngenes": 49, "description": "G0 and Early G1", "id": "6c321009-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1362277", "value": 0.38521206932687446, "ngenes": 30, "description": "Transcription of E2F targets under negative control by DREAM complex", "id": "6c32100a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1362300", "value": 3.340395188327373e-08, "ngenes": 20, "description": "Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1", "id": "6c32100b-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-69236", "value": 6.815552106851809e-13, "ngenes": 87, "description": "G1 Phase", "id": "6c32100c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-69231", "value": 6.815552106851809e-13, "ngenes": 87, "description": "Cyclin D associated events in G1", "id": "6c32100d-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-453276", "value": 2.5228989071151555e-08, "ngenes": 161, "description": "Regulation of mitotic cell cycle", "id": "6c32100e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-174143", "value": 2.5228989071151555e-08, "ngenes": 161, "description": "APC/C-mediated degradation of cell cycle proteins", "id": "6c32100f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-176408", "value": 0.0011921944070574528, "ngenes": 144, "description": "Regulation of APC/C activators between G1/S and early anaphase", "id": "6c321010-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-141405", "value": 2.7087232747698085e-13, "ngenes": 41, "description": "Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components", "id": "6c321011-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-141430", "value": 2.7087232747698085e-13, "ngenes": 41, "description": "Inactivation of APC/C via direct inhibition of the APC/C complex", "id": "6c321012-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-174113", "value": 0.0782228105791333, "ngenes": 96, "description": "SCF-beta-TrCP mediated degradation of Emi1", "id": "6c321013-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-176417", "value": 3.966784113511337e-17, "ngenes": 8, "description": "Phosphorylation of Emi1", "id": "6c321014-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-176814", "value": 7.969560221348972e-05, "ngenes": 137, "description": "Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins", "id": "6c321015-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-176409", "value": 0.00022143730808669976, "ngenes": 136, "description": "APC/C:Cdc20 mediated degradation of mitotic proteins", "id": "6c321016-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-174048", "value": 4.877114081619995e-16, "ngenes": 46, "description": "APC/C:Cdc20 mediated degradation of Cyclin B", "id": "6c321017-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-174154", "value": 0.03489052667150318, "ngenes": 122, "description": "APC/C:Cdc20 mediated degradation of Securin", "id": "6c321018-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-179419", "value": 0.0049331336868452084, "ngenes": 133, "description": "APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint", "id": "6c321019-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-174184", "value": 0.01371245708081897, "ngenes": 131, "description": "Cdc20:Phospho-APC/C mediated degradation of Cyclin A", "id": "6c32101a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-179409", "value": 4.4679666082259825e-12, "ngenes": 52, "description": "APC-Cdc20 mediated degradation of Nek2A", "id": "6c32101b-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-176412", "value": 3.66543715752481e-17, "ngenes": 37, "description": "Phosphorylation of the APC/C", "id": "6c32101c-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-174084", "value": 0.14723214865682144, "ngenes": 117, "description": "Autodegradation of Cdh1 by Cdh1:APC/C", "id": "6c32101d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-174178", "value": 0.00027081698366711955, "ngenes": 131, "description": "APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1", "id": "6c32101e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-176407", "value": 4.313049592178439e-21, "ngenes": 41, "description": "Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase", "id": "6c32101f-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-453274", "value": 0.447022874441219, "ngenes": 317, "description": "Mitotic G2-G2/M phases", "id": "6c321020-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-69275", "value": 0.44174881337412786, "ngenes": 315, "description": "G2/M Transition", "id": "6c321021-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-156711", "value": 5.236078112249962e-19, "ngenes": 22, "description": "Polo-like kinase mediated events", "id": "6c321022-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-69273", "value": 2.032232044916209e-19, "ngenes": 43, "description": "Cyclin A/B1/B2 associated events during G2/M transition", "id": "6c321023-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-170145", "value": 2.6182307018323907e-12, "ngenes": 4, "description": "Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes", "id": "6c321024-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-2565942", "value": 8.113292369416294e-08, "ngenes": 142, "description": "Regulation of PLK1 Activity at G2/M Transition", "id": "6c321025-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-380287", "value": 0.025973240869027133, "ngenes": 130, "description": "Centrosome maturation", "id": "6c321026-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-380284", "value": 0.00034828142562946254, "ngenes": 109, "description": "Loss of proteins required for interphase microtubule organization from the centrosome", "id": "6c321027-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-380259", "value": 0.00034828142562946254, "ngenes": 109, "description": "Loss of Nlp from mitotic centrosomes", "id": "6c321028-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-380270", "value": 0.025973240869027133, "ngenes": 130, "description": "Recruitment of mitotic centrosome proteins and complexes", "id": "6c321029-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8852276", "value": 0.004955642178353048, "ngenes": 121, "description": "The role of GTSE1 in G2/M progression after G2 checkpoint", "id": "6c32102a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8854050", "value": 0.07278402928320828, "ngenes": 94, "description": "FBXL7 down-regulates AURKA during mitotic entry and in early mitosis", "id": "6c32102b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8854518", "value": 1.2510872596723586e-19, "ngenes": 114, "description": "AURKA Activation by TPX2", "id": "6c32102c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8854521", "value": 1.3521255086696617e-21, "ngenes": 3, "description": "Interaction between PHLDA1 and AURKA", "id": "6c32102d-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-68911", "value": 1.315685124888794e-11, "ngenes": 6, "description": "G2 Phase", "id": "6c32102e-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-68886", "value": 4.132444218957552e-09, "ngenes": 664, "description": "M Phase", "id": "6c32102f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-68875", "value": 0.006695490974997732, "ngenes": 203, "description": "Mitotic Prophase", "id": "6c321030-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-162658", "value": 2.8160297629231856e-09, "ngenes": 20, "description": "Golgi Cisternae Pericentriolar Stack Reorganization", "id": "6c321031-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2299718", "value": 0.04929049517314089, "ngenes": 90, "description": "Condensation of Prophase Chromosomes", "id": "6c321032-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2465910", "value": 0.5413625301048183, "ngenes": 22, "description": "MASTL Facilitates Mitotic Progression", "id": "6c321033-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2980766", "value": 3.1116844700145346e-05, "ngenes": 81, "description": "Nuclear Envelope Breakdown", "id": "6c321034-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2980767", "value": 3.73221414068852e-15, "ngenes": 9, "description": "Activation of NIMA Kinases NEK9, NEK6, NEK7", "id": "6c321035-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3301854", "value": 0.00022549270833334685, "ngenes": 55, "description": "Nuclear Pore Complex (NPC) Disassembly", "id": "6c321036-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-4419969", "value": 0.0003941340980660373, "ngenes": 24, "description": "Depolymerisation of the Nuclear Lamina", "id": "6c321037-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-2555396", "value": 2.9192091113737565e-13, "ngenes": 396, "description": "Mitotic Metaphase and Anaphase", "id": "6c321038-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-68882", "value": 4.847439801066163e-13, "ngenes": 394, "description": "Mitotic Anaphase", "id": "6c321039-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2467813", "value": 1.7015688284925193e-15, "ngenes": 308, "description": "Separation of Sister Chromatids", "id": "6c32103a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2995410", "value": 0.010754842798333775, "ngenes": 128, "description": "Nuclear Envelope (NE) Reassembly", "id": "6c32103b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2995383", "value": 1.0420020375973149e-09, "ngenes": 37, "description": "Initiation of Nuclear Envelope (NE) Reformation", "id": "6c32103c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9615933", "value": 0.13914027739519652, "ngenes": 49, "description": "Postmitotic nuclear pore complex (NPC) reformation", "id": "6c32103d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9668328", "value": 0.710197450976291, "ngenes": 44, "description": "Sealing of the nuclear envelope (NE) by ESCRT-III", "id": "6c32103e-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-68881", "value": 1.0653515501995213e-17, "ngenes": 3, "description": "Mitotic Metaphase/Anaphase Transition", "id": "6c32103f-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-68884", "value": 6.6225598472702e-09, "ngenes": 22, "description": "Mitotic Telophase/Cytokinesis", "id": "6c321040-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2470946", "value": 0.14764047580253006, "ngenes": 18, "description": "Cohesin Loading onto Chromatin", "id": "6c321041-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-68877", "value": 1.6993743722654624e-18, "ngenes": 321, "description": "Mitotic Prometaphase", "id": "6c321042-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2500257", "value": 1.6993743722654624e-18, "ngenes": 190, "description": "Resolution of Sister Chromatid Cohesion", "id": "6c321043-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2514853", "value": 3.636944480258146e-17, "ngenes": 20, "description": "Condensation of Prometaphase Chromosomes", "id": "6c321044-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-380320", "value": 0.4142631816037877, "ngenes": 145, "description": "Recruitment of NuMA to mitotic centrosomes", "id": "6c321045-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9648025", "value": 6.982758126805201e-19, "ngenes": 175, "description": "EML4 and NUDC in mitotic spindle formation", "id": "6c321046-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-69242", "value": 1.649188811568203e-07, "ngenes": 273, "description": "S Phase", "id": "6c321047-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-69239", "value": 2.3575674703788227e-10, "ngenes": 206, "description": "Synthesis of DNA", "id": "6c321048-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-69190", "value": 1.3789620622265962e-12, "ngenes": 54, "description": "DNA strand elongation", "id": "6c321049-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-176974", "value": 1.6515975144447306e-13, "ngenes": 18, "description": "Unwinding of DNA", "id": "6c32104a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-69109", "value": 0.0004439150088424428, "ngenes": 28, "description": "Leading Strand Synthesis", "id": "6c32104b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-69091", "value": 0.0004439150088424428, "ngenes": 28, "description": "Polymerase switching", "id": "6c32104c-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-69186", "value": 1.6307240466831002e-06, "ngenes": 36, "description": "Lagging Strand Synthesis", "id": "6c32104d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-69091", "value": 0.0004439150088424428, "ngenes": 28, "description": "Polymerase switching", "id": "6c32104e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-69183", "value": 3.929526243965144e-09, "ngenes": 24, "description": "Processive synthesis on the lagging strand", "id": "6c32104f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-69166", "value": 2.6892531473764623e-06, "ngenes": 23, "description": "Removal of the Flap Intermediate", "id": "6c321050-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-69052", "value": 2.482692656523164e-08, "ngenes": 161, "description": "Switching of origins to a post-replicative state", "id": "6c321051-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-68949", "value": 0.0001106439826535499, "ngenes": 121, "description": "Orc1 removal from chromatin", "id": "6c321052-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-69017", "value": 0.008326222944761206, "ngenes": 131, "description": "CDK-mediated phosphorylation and removal of Cdc6", "id": "6c321053-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-68952", "value": 0.0004260760590762161, "ngenes": 11, "description": "DNA replication initiation", "id": "6c321054-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-69656", "value": 0.08458710065191619, "ngenes": 149, "description": "Cyclin A:Cdk2-associated events at S phase entry", "id": "6c321055-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-187577", "value": 0.0024348302445445272, "ngenes": 109, "description": "SCF(Skp2)-mediated degradation of p27/p21", "id": "6c321056-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-2468052", "value": 0.1559389710801302, "ngenes": 17, "description": "Establishment of Sister Chromatid Cohesion", "id": "6c321057-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-75815", "value": 0.17671235846508257, "ngenes": 89, "description": "Ubiquitin-dependent degradation of Cyclin D", "id": "6c321058-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-1500620", "value": 0.1680620593338384, "ngenes": 189, "description": "Meiosis", "id": "6c321059-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1221632", "value": 0.5337564528080727, "ngenes": 117, "description": "Meiotic synapsis", "id": "6c32105a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-912446", "value": 0.15130701413144074, "ngenes": 126, "description": "Meiotic recombination", "id": "6c32105b-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-69620", "value": 6.78394574181802e-16, "ngenes": 493, "description": "Cell Cycle Checkpoints", "id": "6c32105c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-69618", "value": 5.236078112249962e-19, "ngenes": 181, "description": "Mitotic Spindle Checkpoint", "id": "6c32105d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-141405", "value": 2.7087232747698085e-13, "ngenes": 41, "description": "Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components", "id": "6c32105e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-141430", "value": 2.7087232747698085e-13, "ngenes": 41, "description": "Inactivation of APC/C via direct inhibition of the APC/C complex", "id": "6c32105f-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-141424", "value": 1.6907582430200675e-18, "ngenes": 148, "description": "Amplification of signal from the kinetochores", "id": "6c321060-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-141444", "value": 1.6907582430200675e-18, "ngenes": 148, "description": "Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal", "id": "6c321061-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-69481", "value": 9.557603488796533e-09, "ngenes": 283, "description": "G2/M Checkpoints", "id": "6c321062-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-176187", "value": 1.208648737881326e-13, "ngenes": 69, "description": "Activation of ATR in response to replication stress", "id": "6c321063-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-69478", "value": 1.4922205999703255e-17, "ngenes": 7, "description": "G2/M DNA replication checkpoint", "id": "6c321064-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-69473", "value": 1.2983446150110395e-07, "ngenes": 160, "description": "G2/M DNA damage checkpoint", "id": "6c321065-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-75035", "value": 8.983803384652234e-11, "ngenes": 22, "description": "Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex", "id": "6c321066-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-69615", "value": 0.0020061680048528204, "ngenes": 128, "description": "G1/S DNA Damage Checkpoints", "id": "6c321067-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-69580", "value": 0.011105557399037657, "ngenes": 125, "description": "p53-Dependent G1/S DNA damage checkpoint", "id": "6c321068-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-69563", "value": 0.011105557399037657, "ngenes": 125, "description": "p53-Dependent G1 DNA Damage Response", "id": "6c321069-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-69541", "value": 0.12316638577584904, "ngenes": 106, "description": "Stabilization of p53", "id": "6c32106a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-349425", "value": 0.19467526087665185, "ngenes": 94, "description": "Autodegradation of the E3 ubiquitin ligase COP1", "id": "6c32106b-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-69560", "value": 0.6977030010249148, "ngenes": 8, "description": "Transcriptional activation of p53 responsive genes  ", "id": "6c32106c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-69895", "value": 0.6977030010249148, "ngenes": 8, "description": "Transcriptional  activation of  cell cycle inhibitor p21 ", "id": "6c32106d-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-69613", "value": 0.05711874686208369, "ngenes": 92, "description": "p53-Independent G1/S DNA damage checkpoint", "id": "6c32106e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-69610", "value": 0.05711874686208369, "ngenes": 92, "description": "p53-Independent DNA Damage Response", "id": "6c32106f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-69601", "value": 0.05711874686208369, "ngenes": 92, "description": "Ubiquitin Mediated Degradation of Phosphorylated Cdc25A", "id": "6c321070-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}]}, {"source": "R-HSA-73886", "value": 8.559019229501091e-11, "ngenes": 202, "description": "Chromosome Maintenance", "id": "6c321071-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-157579", "value": 0.0009732308721091178, "ngenes": 161, "description": "Telomere Maintenance", "id": "6c321072-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-171306", "value": 0.48991914326300806, "ngenes": 58, "description": "Packaging Of Telomere Ends", "id": "6c321073-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-180786", "value": 4.0825991662192255e-07, "ngenes": 86, "description": "Extension of Telomeres", "id": "6c321074-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-171319", "value": 1.98393199878606e-05, "ngenes": 39, "description": "Telomere Extension By Telomerase", "id": "6c321075-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-174417", "value": 1.729596533346487e-05, "ngenes": 55, "description": "Telomere C-strand (Lagging Strand) Synthesis", "id": "6c321076-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-174411", "value": 0.017669510557020183, "ngenes": 45, "description": "Polymerase switching on the C-strand of the telomere", "id": "6c321077-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-174430", "value": 0.24181918964467283, "ngenes": 19, "description": "Telomere C-strand synthesis initiation", "id": "6c321078-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-174414", "value": 3.9436924256719384e-17, "ngenes": 27, "description": "Processive synthesis on the C-strand of the telomere", "id": "6c321079-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-174437", "value": 0.5587714499057822, "ngenes": 25, "description": "Removal of the Flap Intermediate from the C-strand", "id": "6c32107a-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-9670095", "value": 0.381884965945311, "ngenes": 83, "description": "Inhibition of DNA recombination at telomere", "id": "6c32107b-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-774815", "value": 2.0880263566165566e-06, "ngenes": 94, "description": "Nucleosome assembly", "id": "6c32107c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-606279", "value": 2.0880263566165566e-06, "ngenes": 94, "description": "Deposition of new CENPA-containing nucleosomes at the centromere", "id": "6c32107d-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-109582", "value": 0.7467969317832588, "ngenes": 1025, "description": "Hemostasis", "id": "6c32107e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-76002", "value": 0.892117185936382, "ngenes": 441, "description": "Platelet activation, signaling and aggregation", "id": "6c32107f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-76005", "value": 0.8668733224953472, "ngenes": 218, "description": "Response to elevated platelet cytosolic Ca2+", "id": "6c321080-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-114516", "value": 0.982815647411855, "ngenes": 7, "description": "Disinhibition of SNARE formation", "id": "6c321081-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-114608", "value": 0.8752683584370036, "ngenes": 211, "description": "Platelet degranulation ", "id": "6c321082-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-114604", "value": 0.1412015407456566, "ngenes": 75, "description": "GPVI-mediated activation cascade", "id": "6c321083-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-76009", "value": 0.00012367477381652352, "ngenes": 65, "description": "Platelet Aggregation (Plug Formation)", "id": "6c321084-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-354192", "value": 3.883605354354573e-07, "ngenes": 55, "description": "Integrin signaling", "id": "6c321085-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-354194", "value": 7.852385342734759e-06, "ngenes": 29, "description": "GRB2:SOS provides linkage to MAPK signaling for Integrins ", "id": "6c321086-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-372708", "value": 2.5404816941260024e-06, "ngenes": 30, "description": "p130Cas linkage to MAPK signaling for integrins", "id": "6c321087-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-392023", "value": 2.482692656523164e-08, "ngenes": 3, "description": "Adrenaline signalling through Alpha-2 adrenergic receptor", "id": "6c321088-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-392518", "value": 0.027375812857883396, "ngenes": 48, "description": "Signal amplification", "id": "6c321089-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-392170", "value": 0.004442340306233403, "ngenes": 28, "description": "ADP signalling through P2Y purinoceptor 12", "id": "6c32108a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-418592", "value": 0.012200450734394451, "ngenes": 36, "description": "ADP signalling through P2Y purinoceptor 1", "id": "6c32108b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-428930", "value": 0.02882432680499419, "ngenes": 33, "description": "Thromboxane signalling through TP receptor", "id": "6c32108c-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-114508", "value": 0.7076076934348605, "ngenes": 49, "description": "Effects of PIP2 hydrolysis", "id": "6c32108d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-426048", "value": 0.7186022398507529, "ngenes": 10, "description": "Arachidonate production from DAG", "id": "6c32108e-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-430116", "value": 0.5230517267136107, "ngenes": 19, "description": "GP1b-IX-V activation signalling", "id": "6c32108f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-456926", "value": 0.07754947086790777, "ngenes": 49, "description": "Thrombin signalling through proteinase activated receptors (PARs)", "id": "6c321090-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-418346", "value": 5.4188024761213915e-06, "ngenes": 161, "description": "Platelet homeostasis", "id": "6c321091-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-418360", "value": 2.2157330425111127e-07, "ngenes": 53, "description": "Platelet calcium homeostasis", "id": "6c321092-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-139853", "value": 1.3941783527376531e-05, "ngenes": 21, "description": "Elevation of cytosolic Ca2+ levels", "id": "6c321093-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-418359", "value": 3.574078193624712e-05, "ngenes": 32, "description": "Reduction of cytosolic Ca++ levels", "id": "6c321094-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-392851", "value": 0.00041850865288774696, "ngenes": 26, "description": "Prostacyclin signalling through prostacyclin receptor", "id": "6c321095-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-392154", "value": 0.14984797572041342, "ngenes": 48, "description": "Nitric oxide stimulates guanylate cyclase", "id": "6c321096-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-418457", "value": 0.0006700198332673885, "ngenes": 38, "description": "cGMP effects", "id": "6c321097-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-432142", "value": 0.030026880108473934, "ngenes": 34, "description": "Platelet sensitization by LDL", "id": "6c321098-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-140877", "value": 0.21183929705454527, "ngenes": 54, "description": "Formation of Fibrin Clot (Clotting Cascade)", "id": "6c321099-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-140834", "value": 0.48934076327756926, "ngenes": 9, "description": "Extrinsic Pathway of Fibrin Clot Formation", "id": "6c32109a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-140837", "value": 0.01009748053669823, "ngenes": 27, "description": "Intrinsic Pathway of Fibrin Clot Formation", "id": "6c32109b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-140875", "value": 8.378345129339897e-07, "ngenes": 31, "description": "Common Pathway of Fibrin Clot Formation", "id": "6c32109c-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-202733", "value": 0.5600647272778162, "ngenes": 245, "description": "Cell surface interactions at the vascular wall", "id": "6c32109d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-210990", "value": 0.136770363145748, "ngenes": 22, "description": "PECAM1 interactions", "id": "6c32109e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-210991", "value": 0.004987292705458967, "ngenes": 50, "description": "Basigin interactions", "id": "6c32109f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-210993", "value": 0.000997704720326576, "ngenes": 35, "description": "Tie2 Signaling", "id": "6c3210a0-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-75205", "value": 0.0012322239300802862, "ngenes": 23, "description": "Dissolution of Fibrin Clot", "id": "6c3210a1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-75892", "value": 0.019244362697786253, "ngenes": 23, "description": "Platelet Adhesion to exposed collagen", "id": "6c3210a2-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-983231", "value": 6.708273567052712e-20, "ngenes": 233, "description": "Factors involved in megakaryocyte development and platelet production", "id": "6c3210a3-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-983189", "value": 1.71464679472499e-21, "ngenes": 89, "description": "Kinesins", "id": "6c3210a4-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-1474165", "value": 0.227062431011895, "ngenes": 221, "description": "Reproduction", "id": "6c3210a5-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1500620", "value": 0.1680620593338384, "ngenes": 189, "description": "Meiosis", "id": "6c3210a6-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1221632", "value": 0.5337564528080727, "ngenes": 117, "description": "Meiotic synapsis", "id": "6c3210a7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-912446", "value": 0.15130701413144074, "ngenes": 126, "description": "Meiotic recombination", "id": "6c3210a8-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1187000", "value": 0.27140893919963927, "ngenes": 32, "description": "Fertilization", "id": "6c3210a9-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1300642", "value": 0.9378112762654217, "ngenes": 11, "description": "Sperm Motility And Taxes", "id": "6c3210aa-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1300645", "value": 0.0030195715586628143, "ngenes": 7, "description": "Acrosome Reaction and Sperm:Oocyte Membrane Binding", "id": "6c3210ab-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2534343", "value": 0.5482692636492207, "ngenes": 14, "description": "Interaction With Cumulus Cells And The Zona Pellucida", "id": "6c3210ac-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-8953897", "value": 0.47910293314870767, "ngenes": 1034, "description": "Cellular responses to external stimuli", "id": "6c3210ad-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2262752", "value": 0.4679326534333106, "ngenes": 1016, "description": "Cellular responses to stress", "id": "6c3210ae-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1234174", "value": 0.4335743497863355, "ngenes": 140, "description": "Cellular response to hypoxia", "id": "6c3210af-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1234158", "value": 1.5072712994441813e-05, "ngenes": 24, "description": "Regulation of gene expression by Hypoxia-inducible Factor", "id": "6c3210b0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1234176", "value": 0.17020998918817007, "ngenes": 125, "description": "Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha", "id": "6c3210b1-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-2559583", "value": 0.003708318872311859, "ngenes": 327, "description": "Cellular Senescence", "id": "6c3210b2-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2559580", "value": 0.09727008564199993, "ngenes": 199, "description": "Oxidative Stress Induced Senescence", "id": "6c3210b3-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2559582", "value": 0.036867334238393445, "ngenes": 168, "description": "Senescence-Associated Secretory Phenotype (SASP)", "id": "6c3210b4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2559586", "value": 0.38310042264624133, "ngenes": 108, "description": "DNA Damage/Telomere Stress Induced Senescence", "id": "6c3210b5-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2559584", "value": 0.9439099697859671, "ngenes": 23, "description": "Formation of Senescence-Associated Heterochromatin Foci (SAHF)", "id": "6c3210b6-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-2559585", "value": 0.005048907636582251, "ngenes": 65, "description": "Oncogene Induced Senescence", "id": "6c3210b7-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-3299685", "value": 0.3774124463978933, "ngenes": 59, "description": "Detoxification of Reactive Oxygen Species", "id": "6c3210b8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3371556", "value": 0.24916944737656072, "ngenes": 171, "description": "Cellular response to heat stress", "id": "6c3210b9-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3371453", "value": 0.14710071408082087, "ngenes": 139, "description": "Regulation of HSF1-mediated heat shock response", "id": "6c3210ba-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3371511", "value": 0.7021606323151024, "ngenes": 49, "description": "HSF1 activation", "id": "6c3210bb-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3371571", "value": 0.10044168276923554, "ngenes": 67, "description": "HSF1-dependent transactivation", "id": "6c3210bc-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3371568", "value": 0.18459533967608108, "ngenes": 48, "description": "Attenuation phase", "id": "6c3210bd-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-3371497", "value": 1.0, "ngenes": 70, "description": "HSP90 chaperone cycle for steroid hormone receptors (SHR)", "id": "6c3210be-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9633012", "value": 0.14518948415085434, "ngenes": 213, "description": "Response of EIF2AK4 (GCN2) to amino acid deficiency", "id": "6c3210bf-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9639288", "value": 0.04141028470738186, "ngenes": 83, "description": "Amino acids regulate mTORC1", "id": "6c3210c0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9648895", "value": 1.117811909602374e-08, "ngenes": 23, "description": "Response of EIF2AK1 (HRI) to heme deficiency", "id": "6c3210c1-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5660526", "value": 0.12469267791980854, "ngenes": 18, "description": "Response to metal ions", "id": "6c3210c2-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5660489", "value": 1.0, "ngenes": 7, "description": "MTF1 activates gene expression", "id": "6c3210c3-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5661231", "value": 0.11616577408309922, "ngenes": 11, "description": "Metallothioneins bind metals", "id": "6c3210c4-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-1643685", "value": 0.19082099768853497, "ngenes": 2643, "description": "Disease", "id": "6c3210c5-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5663202", "value": 0.7295309326889653, "ngenes": 698, "description": "Diseases of signal transduction by growth factor receptors and second messengers", "id": "6c3210c6-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1643713", "value": 0.0661620871813186, "ngenes": 48, "description": "Signaling by EGFR in Cancer", "id": "6c3210c7-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5637815", "value": 0.5070120758810073, "ngenes": 42, "description": "Signaling by Ligand-Responsive EGFR Variants in Cancer", "id": "6c3210c8-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1236382", "value": 0.5070120758810073, "ngenes": 42, "description": "Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants", "id": "6c3210c9-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5637812", "value": 0.48991914326300806, "ngenes": 33, "description": "Signaling by EGFRvIII in Cancer", "id": "6c3210ca-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5637810", "value": 0.48991914326300806, "ngenes": 33, "description": "Constitutive Signaling by EGFRvIII", "id": "6c3210cb-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5638302", "value": 1.2562368133197659e-07, "ngenes": 11, "description": "Signaling by Overexpressed Wild-Type EGFR in Cancer", "id": "6c3210cc-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5638303", "value": 1.2562368133197659e-07, "ngenes": 11, "description": "Inhibition of Signaling by Overexpressed EGFR", "id": "6c3210cd-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-1226099", "value": 2.3294815475224334e-06, "ngenes": 117, "description": "Signaling by FGFR in disease", "id": "6c3210ce-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5655302", "value": 0.04153074098663353, "ngenes": 82, "description": "Signaling by FGFR1 in disease", "id": "6c3210cf-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1839124", "value": 0.11588041692976198, "ngenes": 67, "description": "FGFR1 mutant receptor activation", "id": "6c3210d0-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1839117", "value": 2.5756892065179275e-07, "ngenes": 40, "description": "Signaling by cytosolic FGFR1 fusion mutants", "id": "6c3210d1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1839120", "value": 0.4527664845143371, "ngenes": 3, "description": "Signaling by FGFR1 amplification mutants", "id": "6c3210d2-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1839122", "value": 0.052998926432569704, "ngenes": 22, "description": "Signaling by activated point mutants of FGFR1", "id": "6c3210d3-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8853336", "value": 0.39170524179149224, "ngenes": 8, "description": "Signaling by plasma membrane FGFR1 fusions", "id": "6c3210d4-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-5655291", "value": 3.43945171826658e-06, "ngenes": 27, "description": "Signaling by FGFR4 in disease", "id": "6c3210d5-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1839128", "value": 1.5080552638038695e-08, "ngenes": 3, "description": "FGFR4 mutant receptor activation", "id": "6c3210d6-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5655332", "value": 0.006051251035021077, "ngenes": 46, "description": "Signaling by FGFR3 in disease", "id": "6c3210d7-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8853338", "value": 0.006051251035021077, "ngenes": 46, "description": "Signaling by FGFR3 point mutants in cancer", "id": "6c3210d8-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2033514", "value": 7.670282285333512e-05, "ngenes": 22, "description": "FGFR3 mutant receptor activation", "id": "6c3210d9-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1839130", "value": 7.670282285333512e-05, "ngenes": 22, "description": "Signaling by activated point mutants of FGFR3", "id": "6c3210da-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-8853334", "value": 0.025973240869027133, "ngenes": 24, "description": "Signaling by FGFR3 fusions in cancer", "id": "6c3210db-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5655253", "value": 0.00014020724784531195, "ngenes": 73, "description": "Signaling by FGFR2 in disease", "id": "6c3210dc-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1839126", "value": 8.137011067863445e-05, "ngenes": 49, "description": "FGFR2 mutant receptor activation", "id": "6c3210dd-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2033519", "value": 0.0002507073819704896, "ngenes": 29, "description": "Activated point mutants of FGFR2", "id": "6c3210de-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8851708", "value": 6.994733101762963e-05, "ngenes": 26, "description": "Signaling by FGFR2 IIIa TM", "id": "6c3210df-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-2219528", "value": 0.094402319339291, "ngenes": 205, "description": "PI3K/AKT Signaling in Cancer", "id": "6c3210e0-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2219530", "value": 0.04101500546212591, "ngenes": 144, "description": "Constitutive Signaling by Aberrant PI3K in Cancer", "id": "6c3210e1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5674400", "value": 0.005974954005694179, "ngenes": 59, "description": "Constitutive Signaling by AKT1 E17K in Cancer", "id": "6c3210e2-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-2644603", "value": 0.4679326534333106, "ngenes": 94, "description": "Signaling by NOTCH1 in Cancer", "id": "6c3210e3-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2644602", "value": 0.4679326534333106, "ngenes": 94, "description": "Signaling by NOTCH1 PEST Domain Mutants in Cancer", "id": "6c3210e4-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2644606", "value": 0.4679326534333106, "ngenes": 94, "description": "Constitutive Signaling by NOTCH1 PEST Domain Mutants", "id": "6c3210e5-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-2644605", "value": 4.9102899920862884e-05, "ngenes": 10, "description": "FBXW7 Mutants and NOTCH1 in Cancer", "id": "6c3210e6-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2644607", "value": 4.9102899920862884e-05, "ngenes": 10, "description": "Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling", "id": "6c3210e7-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-2660825", "value": 0.00032325980475484496, "ngenes": 11, "description": "Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant", "id": "6c3210e8-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2660826", "value": 0.00032325980475484496, "ngenes": 11, "description": "Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant", "id": "6c3210e9-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-2691230", "value": 0.03238396205700727, "ngenes": 23, "description": "Signaling by NOTCH1 HD Domain Mutants in Cancer", "id": "6c3210ea-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2691232", "value": 0.03238396205700727, "ngenes": 23, "description": "Constitutive Signaling by NOTCH1 HD Domain Mutants", "id": "6c3210eb-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-2894858", "value": 0.4679326534333106, "ngenes": 94, "description": "Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer", "id": "6c3210ec-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2894862", "value": 0.4679326534333106, "ngenes": 94, "description": "Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants", "id": "6c3210ed-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-3304351", "value": 0.6410363842981289, "ngenes": 18, "description": "Signaling by TGF-beta Receptor Complex in Cancer", "id": "6c3210ee-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3304349", "value": 0.056204209481287126, "ngenes": 14, "description": "Loss of Function of SMAD2/3 in Cancer", "id": "6c3210ef-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3304356", "value": 0.11718463292876465, "ngenes": 13, "description": "SMAD2/3 Phosphorylation Motif Mutants in Cancer", "id": "6c3210f0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3315487", "value": 0.8421637022685342, "ngenes": 5, "description": "SMAD2/3 MH2 Domain Mutants in Cancer", "id": "6c3210f1-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-3304347", "value": 0.8421637022685342, "ngenes": 5, "description": "Loss of Function of SMAD4 in Cancer", "id": "6c3210f2-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3311021", "value": 0.8421637022685342, "ngenes": 5, "description": "SMAD4 MH2 Domain Mutants in Cancer", "id": "6c3210f3-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-3642278", "value": 0.11891375282316931, "ngenes": 5, "description": "Loss of Function of TGFBR2 in Cancer", "id": "6c3210f4-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3642279", "value": 0.10932349172467745, "ngenes": 4, "description": "TGFBR2 MSI Frameshift Mutants in Cancer", "id": "6c3210f5-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3645790", "value": 0.11891375282316931, "ngenes": 5, "description": "TGFBR2 Kinase Domain Mutants in Cancer", "id": "6c3210f6-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-3656534", "value": 0.43504951299049294, "ngenes": 17, "description": "Loss of Function of TGFBR1 in Cancer", "id": "6c3210f7-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3656532", "value": 0.11718463292876465, "ngenes": 13, "description": "TGFBR1 KD Mutants in Cancer", "id": "6c3210f8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3656535", "value": 0.3297641666272556, "ngenes": 9, "description": "TGFBR1 LBD Mutants in Cancer", "id": "6c3210f9-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-4791275", "value": 0.0012804969157249452, "ngenes": 63, "description": "Signaling by WNT in cancer", "id": "6c3210fa-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5339700", "value": 0.8040573385055674, "ngenes": 5, "description": "Signaling by TCF7L2 mutants", "id": "6c3210fb-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5339716", "value": 0.0006377445611500331, "ngenes": 34, "description": "Signaling by GSK3beta mutants", "id": "6c3210fc-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5339717", "value": 0.22244939914919934, "ngenes": 14, "description": "Signaling by LRP5 mutants ", "id": "6c3210fd-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5340588", "value": 0.4328856722025898, "ngenes": 9, "description": "Signaling by RNF43 mutants", "id": "6c3210fe-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-4839743", "value": 0.0006377445611500331, "ngenes": 34, "description": "Signaling by CTNNB1 phospho-site mutants", "id": "6c3210ff-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5358747", "value": 0.0006377445611500331, "ngenes": 34, "description": "S33 mutants of beta-catenin aren't phosphorylated", "id": "6c321100-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5358749", "value": 0.0006377445611500331, "ngenes": 34, "description": "S37 mutants of beta-catenin aren't phosphorylated", "id": "6c321101-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5358751", "value": 0.0006377445611500331, "ngenes": 34, "description": "S45 mutants of beta-catenin aren't phosphorylated", "id": "6c321102-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5358752", "value": 0.0006377445611500331, "ngenes": 34, "description": "T41 mutants of beta-catenin aren't phosphorylated", "id": "6c321103-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-4839744", "value": 1.444969044222668e-05, "ngenes": 27, "description": "Signaling by APC mutants", "id": "6c321104-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5467337", "value": 1.444969044222668e-05, "ngenes": 27, "description": "APC truncation mutants have impaired AXIN binding", "id": "6c321105-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-4839735", "value": 1.444969044222668e-05, "ngenes": 27, "description": "Signaling by AXIN mutants", "id": "6c321106-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5467340", "value": 1.444969044222668e-05, "ngenes": 27, "description": "AXIN missense mutants destabilize the destruction complex", "id": "6c321107-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-4839748", "value": 1.444969044222668e-05, "ngenes": 27, "description": "Signaling by AMER1 mutants", "id": "6c321108-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5467348", "value": 1.444969044222668e-05, "ngenes": 27, "description": "Truncations of AMER1 destabilize the destruction complex", "id": "6c321109-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-5387390", "value": 0.18186987380351224, "ngenes": 98, "description": "Hh mutants abrogate ligand secretion", "id": "6c32110a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5362768", "value": 0.20424498812019948, "ngenes": 95, "description": "Hh mutants are degraded by ERAD", "id": "6c32110b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5658034", "value": 0.09825035891061265, "ngenes": 4, "description": "HHAT G278V doesn't palmitoylate Hh-Np", "id": "6c32110c-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-6802957", "value": 0.017013639009951585, "ngenes": 145, "description": "Oncogenic MAPK signaling", "id": "6c32110d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-6802946", "value": 0.004094059178167002, "ngenes": 78, "description": "Signaling by moderate kinase activity BRAF mutants", "id": "6c32110e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6802948", "value": 0.017114779597088424, "ngenes": 62, "description": "Signaling by high-kinase activity BRAF mutants", "id": "6c32110f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6802952", "value": 0.0003123477232599604, "ngenes": 122, "description": "Signaling by BRAF and RAF fusions", "id": "6c321110-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6802953", "value": 0.8008596371577961, "ngenes": 11, "description": "RAS signaling downstream of NF1 loss-of-function variants", "id": "6c321111-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6802955", "value": 0.004094059178167002, "ngenes": 78, "description": "Paradoxical activation of RAF signaling by kinase inactive BRAF", "id": "6c321112-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6802949", "value": 0.004094059178167002, "ngenes": 78, "description": "Signaling by RAS mutants", "id": "6c321113-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9649913", "value": 0.742812794368386, "ngenes": 5, "description": "RAS GTPase cycle mutants", "id": "6c321114-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9649948", "value": 0.004094059178167002, "ngenes": 78, "description": "Signaling downstream of RAS mutants", "id": "6c321115-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9652169", "value": 0.07603333403030835, "ngenes": 7, "description": "Signaling by MAP2K mutants", "id": "6c321116-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9652817", "value": 0.3263372370401939, "ngenes": 13, "description": "Signaling by MAPK mutants", "id": "6c321117-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9656223", "value": 0.0018023359574022802, "ngenes": 75, "description": "Signaling by RAF1 mutants", "id": "6c321118-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9660537", "value": 0.0014115511753387184, "ngenes": 10, "description": "Signaling by MRAS-complex mutants", "id": "6c321119-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1227990", "value": 0.005769715756936594, "ngenes": 54, "description": "Signaling by ERBB2 in Cancer", "id": "6c32111a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9634285", "value": 0.05144128715072389, "ngenes": 21, "description": "Constitutive Signaling by Overexpressed ERBB2", "id": "6c32111b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9664565", "value": 0.0034912702401104505, "ngenes": 52, "description": "Signaling by ERBB2 KD Mutants", "id": "6c32111c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9665230", "value": 0.0006761301884331578, "ngenes": 8, "description": "Drug resistance in ERBB2 KD mutants", "id": "6c32111d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9665233", "value": 0.0006761301884331578, "ngenes": 8, "description": "Resistance of ERBB2 KD mutants to trastuzumab", "id": "6c32111e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9665244", "value": 0.0006761301884331578, "ngenes": 8, "description": "Resistance of ERBB2 KD mutants to sapitinib", "id": "6c32111f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9665245", "value": 0.0006761301884331578, "ngenes": 8, "description": "Resistance of ERBB2 KD mutants to tesevatinib", "id": "6c321120-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9665246", "value": 0.0006761301884331578, "ngenes": 8, "description": "Resistance of ERBB2 KD mutants to neratinib", "id": "6c321121-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9665247", "value": 0.0006761301884331578, "ngenes": 8, "description": "Resistance of ERBB2 KD mutants to osimertinib", "id": "6c321122-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9665249", "value": 0.0006761301884331578, "ngenes": 8, "description": "Resistance of ERBB2 KD mutants to afatinib", "id": "6c321123-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9665250", "value": 0.0006761301884331578, "ngenes": 8, "description": "Resistance of ERBB2 KD mutants to AEE788", "id": "6c321124-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9665251", "value": 0.0006761301884331578, "ngenes": 8, "description": "Resistance of ERBB2 KD mutants to lapatinib", "id": "6c321125-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9665348", "value": 0.40175448564092703, "ngenes": 36, "description": "Signaling by ERBB2 ECD mutants", "id": "6c321126-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9665686", "value": 0.008203727857990959, "ngenes": 42, "description": "Signaling by ERBB2 TMD/JMD mutants", "id": "6c321127-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9665737", "value": 0.0006761301884331578, "ngenes": 8, "description": "Drug resistance in ERBB2 TMD/JMD mutants", "id": "6c321128-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9669938", "value": 0.03416025190354604, "ngenes": 39, "description": "Signaling by KIT in disease", "id": "6c321129-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9670439", "value": 0.03416025190354604, "ngenes": 39, "description": "Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants", "id": "6c32112a-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9671555", "value": 4.8232258608901426e-09, "ngenes": 37, "description": "Signaling by PDGFR in disease", "id": "6c32112b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9673766", "value": 0.012393955086495045, "ngenes": 5, "description": "Signaling by cytosolic PDGFRA and PDGFRB fusion proteins", "id": "6c32112c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9673767", "value": 2.461222086965114e-07, "ngenes": 25, "description": "Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants", "id": "6c32112d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9673768", "value": 0.5788705064194933, "ngenes": 7, "description": "Signaling by membrane-tethered fusions of PDGFRA or PDGFRB", "id": "6c32112e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9673770", "value": 2.461222086965114e-07, "ngenes": 25, "description": "Signaling by PDGFRA extracellular domain mutants", "id": "6c32112f-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-5663205", "value": 0.23670600436336778, "ngenes": 1418, "description": "Infectious disease", "id": "6c321130-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-162906", "value": 0.5519286881284385, "ngenes": 380, "description": "HIV Infection", "id": "6c321131-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-162587", "value": 0.1360573204906213, "ngenes": 232, "description": "HIV Life Cycle", "id": "6c321132-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-162599", "value": 0.10044168276923554, "ngenes": 208, "description": "Late Phase of HIV Life Cycle", "id": "6c321133-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-162588", "value": 0.007123741252570998, "ngenes": 46, "description": "Budding and maturation of HIV virion", "id": "6c321134-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-165054", "value": 0.0009274246996469895, "ngenes": 55, "description": "Rev-mediated nuclear export of HIV RNA", "id": "6c321135-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-167172", "value": 0.011861373001636474, "ngenes": 104, "description": "Transcription of the HIV genome", "id": "6c321136-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-167152", "value": 0.008438551518270518, "ngenes": 73, "description": "Formation of HIV elongation complex in the absence of HIV Tat", "id": "6c321137-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-167169", "value": 0.009467191535751167, "ngenes": 69, "description": "HIV Transcription Elongation", "id": "6c321138-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-167158", "value": 0.00134352013304132, "ngenes": 52, "description": "Formation of the HIV-1 Early Elongation Complex", "id": "6c321139-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-167246", "value": 0.009467191535751167, "ngenes": 69, "description": "Tat-mediated elongation of the HIV-1 transcript", "id": "6c32113a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-167200", "value": 0.009467191535751167, "ngenes": 69, "description": "Formation of HIV-1 elongation complex containing HIV-1 Tat", "id": "6c32113b-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-167242", "value": 0.0009728672546418526, "ngenes": 33, "description": "Abortive elongation of HIV-1 transcript in the absence of Tat", "id": "6c32113c-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-167160", "value": 0.0338617131580787, "ngenes": 38, "description": "RNA Pol II CTD phosphorylation and interaction with CE during HIV infection", "id": "6c32113d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-167161", "value": 0.08275044825080018, "ngenes": 64, "description": "HIV Transcription Initiation", "id": "6c32113e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-167162", "value": 0.08275044825080018, "ngenes": 64, "description": "RNA Polymerase II HIV Promoter Escape", "id": "6c32113f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-167238", "value": 0.04955718125803417, "ngenes": 46, "description": "Pausing and recovery of Tat-mediated HIV elongation", "id": "6c321140-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-167243", "value": 0.04955718125803417, "ngenes": 46, "description": "Tat-mediated HIV elongation arrest and recovery", "id": "6c321141-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-167287", "value": 0.04204814790043037, "ngenes": 50, "description": "HIV elongation arrest and recovery", "id": "6c321142-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-167290", "value": 0.04204814790043037, "ngenes": 50, "description": "Pausing and recovery of HIV elongation", "id": "6c321143-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-175474", "value": 0.0033728323284001245, "ngenes": 26, "description": "Assembly Of The HIV Virion", "id": "6c321144-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-174495", "value": 0.0068231832431217875, "ngenes": 24, "description": "Synthesis And Processing Of GAG, GAGPOL Polyproteins", "id": "6c321145-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-174490", "value": 0.0068231832431217875, "ngenes": 24, "description": "Membrane binding and targetting of GAG proteins", "id": "6c321146-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-162594", "value": 3.6656525557660275e-10, "ngenes": 25, "description": "Early Phase of HIV Life Cycle", "id": "6c321147-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-162592", "value": 0.7997587736282339, "ngenes": 16, "description": "Integration of provirus", "id": "6c321148-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-164843", "value": 0.3885736542535376, "ngenes": 14, "description": "2-LTR circle formation", "id": "6c321149-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-175567", "value": 1.373043401156215e-08, "ngenes": 7, "description": "Integration of viral DNA into host genomic DNA", "id": "6c32114a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-177539", "value": 1.373043401156215e-08, "ngenes": 7, "description": "Autointegration results in viral DNA circles", "id": "6c32114b-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-173107", "value": 0.033768654253581894, "ngenes": 7, "description": "Binding and entry of HIV virion", "id": "6c32114c-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-162909", "value": 0.32740783684522706, "ngenes": 229, "description": "Host Interactions of HIV factors", "id": "6c32114d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-164952", "value": 0.3265976861780325, "ngenes": 56, "description": "The role of Nef in HIV-1 replication and disease pathogenesis", "id": "6c32114e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-164938", "value": 0.5975015502052744, "ngenes": 40, "description": "Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters", "id": "6c32114f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-164939", "value": 6.701775598543569e-09, "ngenes": 3, "description": "Nef mediated downregulation of CD28 cell surface expression", "id": "6c321150-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-164940", "value": 0.6653087965821359, "ngenes": 17, "description": "Nef mediated downregulation of MHC class I complex cell surface expression", "id": "6c321151-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-167590", "value": 1.3663663960990364e-06, "ngenes": 19, "description": "Nef Mediated CD4 Down-regulation", "id": "6c321152-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-182218", "value": 0.036909550265282816, "ngenes": 15, "description": "Nef Mediated CD8 Down-regulation", "id": "6c321153-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-164944", "value": 0.2197887896284813, "ngenes": 19, "description": "Nef and signal transduction", "id": "6c321154-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-177243", "value": 0.002497670324039673, "ngenes": 58, "description": "Interactions of Rev with host cellular proteins", "id": "6c321155-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-165054", "value": 0.0009274246996469895, "ngenes": 55, "description": "Rev-mediated nuclear export of HIV RNA", "id": "6c321156-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-180746", "value": 0.009621742219540836, "ngenes": 54, "description": "Nuclear import of Rev protein", "id": "6c321157-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-176034", "value": 0.027424415704063284, "ngenes": 3, "description": "Interactions of Tat with host cellular proteins", "id": "6c321158-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-180534", "value": 0.13795356767983102, "ngenes": 92, "description": "Vpu mediated degradation of CD4", "id": "6c321159-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-180585", "value": 0.17671235846508257, "ngenes": 95, "description": "Vif-mediated degradation of APOBEC3G", "id": "6c32115a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-180689", "value": 0.728180159456524, "ngenes": 11, "description": "APOBEC3G mediated resistance to HIV-1 infection", "id": "6c32115b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-176033", "value": 0.00034828142562946254, "ngenes": 58, "description": "Interactions of Vpr with host cellular proteins", "id": "6c32115c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-180897", "value": 0.3398926150402077, "ngenes": 3, "description": "Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization", "id": "6c32115d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-180910", "value": 7.187827146957771e-05, "ngenes": 55, "description": "Vpr-mediated nuclear import of PICs", "id": "6c32115e-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-168255", "value": 0.27932578358991195, "ngenes": 286, "description": "Influenza Infection", "id": "6c32115f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-168271", "value": 0.0021658468966878567, "ngenes": 49, "description": "Transport of Ribonucleoproteins into the Host Nucleus", "id": "6c321160-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-168275", "value": 0.02731845292622579, "ngenes": 4, "description": "Entry of Influenza Virion into Host Cell via Endocytosis", "id": "6c321161-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-168276", "value": 0.00016217300672399882, "ngenes": 63, "description": "NS1 Mediated Effects on Host Pathways", "id": "6c321162-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-168315", "value": 0.2912911842971027, "ngenes": 3, "description": "Inhibition of Host mRNA Processing and RNA Silencing", "id": "6c321163-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-168273", "value": 0.24701031067045967, "ngenes": 261, "description": "Influenza Viral RNA Transcription and Replication", "id": "6c321164-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-168325", "value": 0.0016626297212658848, "ngenes": 63, "description": "Viral Messenger RNA Synthesis", "id": "6c321165-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-192823", "value": 0.1529232367007565, "ngenes": 195, "description": "Viral mRNA Translation", "id": "6c321166-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-192905", "value": 0.0013890503505556344, "ngenes": 3, "description": "vRNP Assembly", "id": "6c321167-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-168274", "value": 0.0029523231132840273, "ngenes": 50, "description": "Export of Viral Ribonucleoproteins from Nucleus", "id": "6c321168-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-168333", "value": 0.002542927881397695, "ngenes": 49, "description": "NEP/NS2 Interacts with the Cellular Export Machinery", "id": "6c321169-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-5339562", "value": 0.009131908463906565, "ngenes": 45, "description": "Uptake and actions of bacterial toxins", "id": "6c32116a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5210891", "value": 0.009157915254119445, "ngenes": 21, "description": "Uptake and function of anthrax toxins", "id": "6c32116b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-168799", "value": 0.9783421323306113, "ngenes": 14, "description": "Neurotoxicity of clostridium toxins", "id": "6c32116c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5250955", "value": 0.0012370873479027153, "ngenes": 7, "description": "Toxicity of botulinum toxin type D (botD)", "id": "6c32116d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5250958", "value": 0.0005689357316607626, "ngenes": 4, "description": "Toxicity of botulinum toxin type B (botB)", "id": "6c32116e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5250968", "value": 0.6600838226832625, "ngenes": 5, "description": "Toxicity of botulinum toxin type A (botA)", "id": "6c32116f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5250971", "value": 0.2540040238709466, "ngenes": 4, "description": "Toxicity of botulinum toxin type C (botC)", "id": "6c321170-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5250981", "value": 0.0012370873479027153, "ngenes": 7, "description": "Toxicity of botulinum toxin type F (botF)", "id": "6c321171-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5250989", "value": 0.0007957741605477439, "ngenes": 6, "description": "Toxicity of botulinum toxin type G (botG)", "id": "6c321172-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5250992", "value": 0.679714283195988, "ngenes": 4, "description": "Toxicity of botulinum toxin type E (botE)", "id": "6c321173-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5336415", "value": 1.4642603702410217e-09, "ngenes": 8, "description": "Uptake and function of diphtheria toxin", "id": "6c321174-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8876384", "value": 0.11685743932982966, "ngenes": 41, "description": "Listeria monocytogenes entry into host cells", "id": "6c321175-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8875360", "value": 0.39041710600825313, "ngenes": 24, "description": "InlB-mediated entry of Listeria monocytogenes into host cell", "id": "6c321176-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8876493", "value": 0.2940069079357214, "ngenes": 26, "description": "InlA-mediated entry of Listeria monocytogenes into host cells", "id": "6c321177-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9609646", "value": 0.8516267918003223, "ngenes": 220, "description": "HCMV Infection", "id": "6c321178-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9609690", "value": 0.23972231143445005, "ngenes": 183, "description": "HCMV Early Events", "id": "6c321179-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9610379", "value": 0.7646066581508797, "ngenes": 146, "description": "HCMV Late Events", "id": "6c32117a-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9635486", "value": 0.4119474552519834, "ngenes": 46, "description": "Infection with Mycobacterium tuberculosis", "id": "6c32117b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9637690", "value": 0.11891375282316931, "ngenes": 40, "description": "Response of Mtb to phagocytosis", "id": "6c32117c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9635465", "value": 0.33808340370136025, "ngenes": 13, "description": "Suppression of apoptosis", "id": "6c32117d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9637687", "value": 0.026178858669801523, "ngenes": 23, "description": "Suppression of phagosomal maturation", "id": "6c32117e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9636249", "value": 4.161559872634383e-06, "ngenes": 5, "description": "Inhibition of nitric oxide production", "id": "6c32117f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9636383", "value": 0.47508926437913696, "ngenes": 16, "description": "Prevention of phagosomal-lysosomal fusion", "id": "6c321180-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9636667", "value": 3.190336752989482e-12, "ngenes": 3, "description": "Manipulation of host energy metabolism", "id": "6c321181-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9637628", "value": 0.8175879950700005, "ngenes": 13, "description": "Modulation by Mtb of host immune system", "id": "6c321182-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9658195", "value": 0.253640749951792, "ngenes": 411, "description": "Leishmania infection", "id": "6c321183-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9664433", "value": 0.060380200309922985, "ngenes": 256, "description": "Leishmania parasite growth and survival", "id": "6c321184-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9662851", "value": 0.060380200309922985, "ngenes": 256, "description": "Anti-inflammatory response favouring Leishmania parasite infection", "id": "6c321185-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9660821", "value": 0.7425883379587369, "ngenes": 178, "description": "ADORA2B mediated anti-inflammatory cytokines production", "id": "6c321186-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9662834", "value": 0.013845102511564393, "ngenes": 18, "description": "CD163 mediating an anti-inflammatory response", "id": "6c321187-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9664323", "value": 0.036299292595599573, "ngenes": 79, "description": "FCGR3A-mediated IL10 synthesis", "id": "6c321188-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9664535", "value": 0.006695490974997732, "ngenes": 15, "description": "LTC4-CYSLTR mediated IL4 production", "id": "6c321189-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-9664424", "value": 0.145649593864941, "ngenes": 37, "description": "Cell recruitment (pro-inflammatory response)", "id": "6c32118a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9660826", "value": 0.145649593864941, "ngenes": 37, "description": "Purinergic signaling in leishmaniasis infection", "id": "6c32118b-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9664407", "value": 0.03136150935399528, "ngenes": 129, "description": "Parasite infection", "id": "6c32118c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9664417", "value": 0.03136150935399528, "ngenes": 129, "description": "Leishmania phagocytosis", "id": "6c32118d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9664422", "value": 0.03136150935399528, "ngenes": 129, "description": "FCGR3A-mediated phagocytosis", "id": "6c32118e-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-9664420", "value": 0.9919044817697824, "ngenes": 25, "description": "Killing mechanisms", "id": "6c32118f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9673324", "value": 0.9919044817697824, "ngenes": 25, "description": "WNT5:FZD7-mediated leishmania damping", "id": "6c321190-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-9679506", "value": 0.022946118775935095, "ngenes": 245, "description": "SARS-CoV Infections", "id": "6c321191-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9678108", "value": 0.015826811928589486, "ngenes": 83, "description": "SARS-CoV-1 Infection", "id": "6c321192-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9678110", "value": 0.00016340446475120028, "ngenes": 6, "description": "Attachment and Entry", "id": "6c321193-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9679504", "value": 0.0035696297376074763, "ngenes": 19, "description": "Translation of Replicase and Assembly of the Replication Transcription Complex", "id": "6c321194-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9679514", "value": 0.0002004413329336196, "ngenes": 8, "description": "SARS-CoV-1 Genome Replication and Transcription", "id": "6c321195-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9682706", "value": 0.0002004413329336196, "ngenes": 8, "description": "Replication of the SARS-CoV-1 genome", "id": "6c321196-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9683701", "value": 0.0005513852925855286, "ngenes": 51, "description": "Translation of structural proteins", "id": "6c321197-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9683610", "value": 0.003900138141989245, "ngenes": 20, "description": "Maturation of nucleoprotein", "id": "6c321198-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9683673", "value": 0.027424415704063284, "ngenes": 15, "description": "Maturation of protein 3a", "id": "6c321199-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9683683", "value": 0.09080701255022758, "ngenes": 9, "description": "Maturation of protein E", "id": "6c32119a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9683686", "value": 0.000424156615218982, "ngenes": 7, "description": "Maturation of spike protein", "id": "6c32119b-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-9679191", "value": 0.022771680290448022, "ngenes": 140, "description": "Potential therapeutics for SARS", "id": "6c32119c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9694516", "value": 0.02019213021111179, "ngenes": 107, "description": "SARS-CoV-2 Infection", "id": "6c32119d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9694635", "value": 0.0020679508475048088, "ngenes": 74, "description": "Translation of structural proteins", "id": "6c32119e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9694493", "value": 0.09080701255022758, "ngenes": 9, "description": "Maturation of protein E", "id": "6c32119f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9694548", "value": 0.0015040470364868462, "ngenes": 44, "description": "Maturation of spike protein", "id": "6c3211a0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9694631", "value": 0.003900138141989245, "ngenes": 20, "description": "Maturation of nucleoprotein", "id": "6c3211a1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9694719", "value": 0.027424415704063284, "ngenes": 15, "description": "Maturation of protein 3a", "id": "6c3211a2-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9694614", "value": 0.000540738227602736, "ngenes": 7, "description": "Attachment and Entry", "id": "6c3211a3-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9694676", "value": 0.0035696297376074763, "ngenes": 19, "description": "Translation of Replicase and Assembly of the Replication Transcription Complex", "id": "6c3211a4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9694682", "value": 0.0002004413329336196, "ngenes": 8, "description": "SARS-CoV-2 Genome Replication and Transcription", "id": "6c3211a5-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9694686", "value": 0.0002004413329336196, "ngenes": 8, "description": "Replication of the SARS-CoV-2 genome", "id": "6c3211a6-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}]}, {"source": "R-HSA-5668914", "value": 0.11777630059142877, "ngenes": 406, "description": "Diseases of metabolism", "id": "6c3211a7-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2160456", "value": 0.7530455862611115, "ngenes": 3, "description": "Phenylketonuria", "id": "6c3211a8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5663084", "value": 0.6281127492810145, "ngenes": 61, "description": "Diseases of carbohydrate metabolism", "id": "6c3211a9-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2206281", "value": 0.16220132676016383, "ngenes": 22, "description": "Mucopolysaccharidoses", "id": "6c3211aa-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2206280", "value": 0.655093677084329, "ngenes": 4, "description": "MPS IX - Natowicz syndrome", "id": "6c3211ab-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2206285", "value": 0.006753257432110538, "ngenes": 3, "description": "MPS VI - Maroteaux-Lamy syndrome", "id": "6c3211ac-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2206296", "value": 0.6988742953213298, "ngenes": 4, "description": "MPS II - Hunter syndrome", "id": "6c3211ad-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2206308", "value": 0.6358440082541856, "ngenes": 3, "description": "MPS IV - Morquio syndrome B", "id": "6c3211ae-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-3229121", "value": 0.6164745735261488, "ngenes": 25, "description": "Glycogen storage diseases", "id": "6c3211af-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3785653", "value": 0.9727468885142295, "ngenes": 15, "description": "Myoclonic epilepsy of Lafora", "id": "6c3211b0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3858516", "value": 0.21319071659816835, "ngenes": 4, "description": "Glycogen storage disease type 0 (liver GYS2)", "id": "6c3211b1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3878781", "value": 0.21025976397122137, "ngenes": 5, "description": "Glycogen storage disease type IV (GBE1)", "id": "6c3211b2-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5357609", "value": 0.37216776961487413, "ngenes": 3, "description": "Glycogen storage disease type II (GAA)", "id": "6c3211b3-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5657562", "value": 0.9701668083606931, "ngenes": 4, "description": "Essential fructosuria", "id": "6c3211b4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5659898", "value": 1.0778872308270539e-05, "ngenes": 4, "description": "Intestinal saccharidase deficiencies", "id": "6c3211b5-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6791465", "value": 0.0008796610724689507, "ngenes": 3, "description": "Pentose phosphate pathway disease", "id": "6c3211b6-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-3296482", "value": 0.3667341547371899, "ngenes": 34, "description": "Defects in vitamin and cofactor metabolism", "id": "6c3211b7-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3296469", "value": 0.37408492199398546, "ngenes": 22, "description": "Defects in cobalamin (B12) metabolism", "id": "6c3211b8-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3359462", "value": 0.32322614155989415, "ngenes": 3, "description": "Defective AMN causes hereditary megaloblastic anemia 1", "id": "6c3211b9-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3359463", "value": 0.32322614155989415, "ngenes": 3, "description": "Defective CUBN causes hereditary megaloblastic anemia 1", "id": "6c3211ba-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3359467", "value": 0.16435139191461046, "ngenes": 5, "description": "Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE", "id": "6c3211bb-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3359469", "value": 0.16435139191461046, "ngenes": 5, "description": "Defective MTR causes methylmalonic aciduria and homocystinuria type cblG", "id": "6c3211bc-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3359473", "value": 0.3604924443953326, "ngenes": 3, "description": "Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD", "id": "6c3211bd-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5683329", "value": 0.6629570380066973, "ngenes": 4, "description": "Defective ABCD4 causes MAHCJ", "id": "6c3211be-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-3323169", "value": 0.3563022603089679, "ngenes": 12, "description": "Defects in biotin (Btn) metabolism", "id": "6c3211bf-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3371599", "value": 0.6258454394659866, "ngenes": 11, "description": "Defective HLCS causes multiple carboxylase deficiency", "id": "6c3211c0-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-3781865", "value": 0.01799865075864799, "ngenes": 237, "description": "Diseases of glycosylation", "id": "6c3211c1-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3560782", "value": 0.007037912395753229, "ngenes": 62, "description": "Diseases associated with glycosaminoglycan metabolism", "id": "6c3211c2-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3560783", "value": 0.19406199240275038, "ngenes": 32, "description": "Defective B4GALT7 causes EDS, progeroid type", "id": "6c3211c3-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3560801", "value": 0.1187122997589825, "ngenes": 32, "description": "Defective B3GAT3 causes JDSSDHD", "id": "6c3211c4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3595172", "value": 0.10413009912241283, "ngenes": 13, "description": "Defective CHST3 causes SEDCJD", "id": "6c3211c5-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3595174", "value": 0.08710121845340599, "ngenes": 13, "description": "Defective CHST14 causes EDS, musculocontractural type", "id": "6c3211c6-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3595177", "value": 0.07754947086790777, "ngenes": 13, "description": "Defective CHSY1 causes TPBS", "id": "6c3211c7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3656225", "value": 1.139096755134177e-05, "ngenes": 15, "description": "Defective CHST6 causes MCDC1", "id": "6c3211c8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3656237", "value": 0.21183929705454527, "ngenes": 23, "description": "Defective EXT2 causes exostoses 2", "id": "6c3211c9-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3656243", "value": 1.0317554357978041e-05, "ngenes": 16, "description": "Defective ST3GAL3 causes MCT12 and EIEE15", "id": "6c3211ca-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3656244", "value": 8.63400145277346e-06, "ngenes": 14, "description": "Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)", "id": "6c3211cb-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3656253", "value": 0.21183929705454527, "ngenes": 23, "description": "Defective EXT1 causes exostoses 1, TRPS2 and CHDS", "id": "6c3211cc-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-4420332", "value": 0.20663090963419464, "ngenes": 32, "description": "Defective B3GALT6 causes EDSP2 and SEMDJL1", "id": "6c3211cd-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5609975", "value": 0.6978886835795346, "ngenes": 35, "description": "Diseases associated with glycosylation precursor biosynthesis", "id": "6c3211ce-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-4341670", "value": 0.08354697333853367, "ngenes": 8, "description": "Defective NEU1 causes sialidosis", "id": "6c3211cf-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-4717374", "value": 0.06639095317036248, "ngenes": 6, "description": "Defective DPM1 causes DPM1-CDG (CDG-1e)", "id": "6c3211d0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-4719360", "value": 0.06639095317036248, "ngenes": 6, "description": "Defective DPM3 causes DPM3-CDG (CDG-1o)", "id": "6c3211d1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-4719377", "value": 0.06639095317036248, "ngenes": 6, "description": "Defective DPM2 causes DPM2-CDG (CDG-1u)", "id": "6c3211d2-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-4755609", "value": 0.300348199301906, "ngenes": 6, "description": "Defective DHDDS causes retinitis pigmentosa 59", "id": "6c3211d3-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5609977", "value": 0.01790006501351592, "ngenes": 3, "description": "Defective GALE can cause Epimerase-deficiency galactosemia (EDG)", "id": "6c3211d4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5609978", "value": 0.0011247449778186837, "ngenes": 3, "description": "Defective GALT can cause Galactosemia", "id": "6c3211d5-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-3781860", "value": 0.0015482687984796019, "ngenes": 27, "description": "Diseases associated with N-glycosylation of proteins", "id": "6c3211d6-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-4724325", "value": 0.4721793683557928, "ngenes": 3, "description": "Defective ALG8 causes ALG8-CDG (CDG-1h)", "id": "6c3211d7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-4793952", "value": 0.2090341306639524, "ngenes": 3, "description": "Defective MGAT2 causes MGAT2-CDG (CDG-2a)", "id": "6c3211d8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5633231", "value": 0.002458492348850156, "ngenes": 5, "description": "Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)", "id": "6c3211d9-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-3906995", "value": 0.022676079085006417, "ngenes": 113, "description": "Diseases associated with O-glycosylation of proteins", "id": "6c3211da-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5083625", "value": 0.07814476626772582, "ngenes": 31, "description": "Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)", "id": "6c3211db-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5083627", "value": 0.401724673834549, "ngenes": 4, "description": "Defective LARGE causes MDDGA6 and MDDGB6", "id": "6c3211dc-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5083628", "value": 0.0017806080475732742, "ngenes": 4, "description": "Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3", "id": "6c3211dd-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5083629", "value": 0.3347632233317687, "ngenes": 4, "description": "Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2", "id": "6c3211de-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5083630", "value": 0.6724975734843992, "ngenes": 12, "description": "Defective LFNG causes SCDO3", "id": "6c3211df-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5083632", "value": 0.06499533248205235, "ngenes": 34, "description": "Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)", "id": "6c3211e0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5083633", "value": 0.3347632233317687, "ngenes": 4, "description": "Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1", "id": "6c3211e1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5083635", "value": 0.3882310888024776, "ngenes": 56, "description": "Defective B3GALTL causes Peters-plus syndrome (PpS)", "id": "6c3211e2-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5083636", "value": 0.04141163230994763, "ngenes": 32, "description": "Defective GALNT12 causes colorectal cancer 1 (CRCS1)", "id": "6c3211e3-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-5579029", "value": 0.06524958245822576, "ngenes": 56, "description": "Metabolic disorders of biological oxidation enzymes", "id": "6c3211e4-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5578999", "value": 0.007086914432335896, "ngenes": 4, "description": "Defective GCLC causes Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency (HAGGSD)", "id": "6c3211e5-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5579022", "value": 0.007524394084503153, "ngenes": 9, "description": "Defective GGT1 causes Glutathionuria (GLUTH)", "id": "6c3211e6-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5579026", "value": 0.0006901535386479429, "ngenes": 6, "description": "Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)", "id": "6c3211e7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5579030", "value": 0.6210223527902673, "ngenes": 4, "description": "Defective CYP19A1 causes Aromatase excess syndrome (AEXS)", "id": "6c3211e8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5579031", "value": 0.7545689250795384, "ngenes": 3, "description": "Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)", "id": "6c3211e9-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9035968", "value": 0.007524394084503153, "ngenes": 9, "description": "Defective GGT1 causes Glutathionuria (GLUTH)", "id": "6c3211ea-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5687613", "value": 0.41522455244533674, "ngenes": 16, "description": "Diseases associated with surfactant metabolism", "id": "6c3211eb-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5687868", "value": 0.5393146810253107, "ngenes": 3, "description": "Defective SFTPA2 causes IPF", "id": "6c3211ec-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5688849", "value": 0.07043008697577176, "ngenes": 14, "description": "Defective CSF2RB causes SMDP5", "id": "6c3211ed-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5688890", "value": 0.07043008697577176, "ngenes": 14, "description": "Defective CSF2RA causes SMDP4", "id": "6c3211ee-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-9675143", "value": 0.01834612936855869, "ngenes": 13, "description": "Diseases of the neuronal system", "id": "6c3211ef-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2474795", "value": 0.01834612936855869, "ngenes": 13, "description": "Diseases associated with visual transduction", "id": "6c3211f0-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2453864", "value": 0.01834612936855869, "ngenes": 13, "description": "Retinoid cycle disease events", "id": "6c3211f1-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-9675135", "value": 0.0066698777263044925, "ngenes": 25, "description": "Diseases of DNA repair", "id": "6c3211f2-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5423599", "value": 0.7087412261075305, "ngenes": 11, "description": "Diseases of Mismatch Repair (MMR)", "id": "6c3211f3-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5545483", "value": 0.0006088011254049382, "ngenes": 6, "description": "Defective Mismatch Repair Associated With MLH1", "id": "6c3211f4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5632927", "value": 0.5738990775519193, "ngenes": 3, "description": "Defective Mismatch Repair Associated With MSH3", "id": "6c3211f5-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5632928", "value": 0.02460933689664858, "ngenes": 5, "description": "Defective Mismatch Repair Associated With MSH2", "id": "6c3211f6-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5632968", "value": 0.03753292487920767, "ngenes": 4, "description": "Defective Mismatch Repair Associated With MSH6", "id": "6c3211f7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5632987", "value": 0.0006088011254049382, "ngenes": 6, "description": "Defective Mismatch Repair Associated With PMS2", "id": "6c3211f8-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9605308", "value": 0.6619202262907589, "ngenes": 9, "description": "Diseases of Base Excision Repair", "id": "6c3211f9-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9605310", "value": 0.02484181616743973, "ngenes": 3, "description": "Defective Base Excision Repair Associated with MUTYH", "id": "6c3211fa-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9608287", "value": 0.02484181616743973, "ngenes": 3, "description": "Defective MUTYH substrate binding", "id": "6c3211fb-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9608290", "value": 0.02484181616743973, "ngenes": 3, "description": "Defective MUTYH substrate processing", "id": "6c3211fc-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-5260271", "value": 0.6276703758544226, "ngenes": 39, "description": "Diseases of Immune System", "id": "6c3211fd-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5602358", "value": 0.6276703758544226, "ngenes": 39, "description": "Diseases associated with the TLR signaling cascade", "id": "6c3211fe-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5602415", "value": 0.00012576089909754678, "ngenes": 4, "description": "UNC93B1 deficiency - HSE", "id": "6c3211ff-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5602498", "value": 0.7197012316167373, "ngenes": 17, "description": "MyD88 deficiency (TLR2/4)", "id": "6c321200-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5602566", "value": 0.0012336332931540063, "ngenes": 4, "description": "TICAM1 deficiency - HSE", "id": "6c321201-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5602571", "value": 7.187827146957771e-05, "ngenes": 5, "description": "TRAF3 deficiency - HSE", "id": "6c321202-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5602636", "value": 0.01106170271979886, "ngenes": 4, "description": "IKBKB deficiency causes SCID", "id": "6c321203-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5603027", "value": 0.01106170271979886, "ngenes": 4, "description": "IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)", "id": "6c321204-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5603029", "value": 0.11057485348328724, "ngenes": 10, "description": "IkBA variant leads to EDA-ID", "id": "6c321205-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5603037", "value": 0.29192319568573727, "ngenes": 6, "description": "IRAK4 deficiency (TLR5)", "id": "6c321206-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5603041", "value": 0.742812794368386, "ngenes": 18, "description": "IRAK4 deficiency (TLR2/4)", "id": "6c321207-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-5619115", "value": 0.13575574011933744, "ngenes": 276, "description": "Disorders of transmembrane transporters", "id": "6c321208-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5619102", "value": 0.0010238479704531309, "ngenes": 146, "description": "SLC transporter disorders", "id": "6c321209-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5619047", "value": 0.7893897975358737, "ngenes": 4, "description": "Defective SLC2A9 causes hypouricemia renal 2 (RHUC2)", "id": "6c32120a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5619049", "value": 2.5929343530315085e-06, "ngenes": 3, "description": "Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages)", "id": "6c32120b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5619055", "value": 0.37924176668899345, "ngenes": 3, "description": "Defective SLC24A4 causes hypomineralized amelogenesis imperfecta (AI)", "id": "6c32120c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5619056", "value": 0.7831178166337464, "ngenes": 3, "description": "Defective HK1 causes hexokinase deficiency (HK deficiency)", "id": "6c32120d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5619060", "value": 2.5929343530315085e-06, "ngenes": 3, "description": "Defective CP causes aceruloplasminemia (ACERULOP)", "id": "6c32120e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5619066", "value": 0.004280224270346522, "ngenes": 3, "description": "Defective SLC22A18 causes lung cancer (LNCR) and embryonal rhabdomyosarcoma 1 (RMSE1)", "id": "6c32120f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5619070", "value": 0.4160269568822072, "ngenes": 3, "description": "Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT)", "id": "6c321210-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5619071", "value": 0.599088410265782, "ngenes": 3, "description": "Defective SLC22A12 causes renal hypouricemia 1 (RHUC1)", "id": "6c321211-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5619072", "value": 0.04133823092700737, "ngenes": 4, "description": "Defective SLC35A2 causes congenital disorder of glycosylation 2M (CDG2M)", "id": "6c321212-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5619073", "value": 0.49486909322321965, "ngenes": 3, "description": "Defective GCK causes maturity-onset diabetes of the young 2 (MODY2)", "id": "6c321213-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5619092", "value": 0.1052044660230919, "ngenes": 4, "description": "Defective SLC9A6 causes  X-linked, syndromic mental retardation,, Christianson type (MRXSCH)", "id": "6c321214-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5619099", "value": 0.9339076215870432, "ngenes": 4, "description": "Defective AVP does not bind AVPR1A,B and causes neurohypophyseal diabetes insipidus (NDI)", "id": "6c321215-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5619101", "value": 0.5870192671275326, "ngenes": 3, "description": "Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG)", "id": "6c321216-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5619107", "value": 0.0016499535841182956, "ngenes": 51, "description": "Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)", "id": "6c321217-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5655799", "value": 6.9880122450361735e-06, "ngenes": 4, "description": "Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum)", "id": "6c321218-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5660686", "value": 0.5870192671275326, "ngenes": 3, "description": "Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG)", "id": "6c321219-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5660862", "value": 0.0023219791538030225, "ngenes": 4, "description": "Defective SLC7A7 causes lysinuric protein intolerance (LPI)", "id": "6c32121a-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5619084", "value": 0.200807889029552, "ngenes": 130, "description": "ABC transporter disorders", "id": "6c32121b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5678420", "value": 0.0027656009799502845, "ngenes": 3, "description": "Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome", "id": "6c32121c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5678895", "value": 0.2278266915518267, "ngenes": 103, "description": "Defective CFTR causes cystic fibrosis", "id": "6c32121d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5679090", "value": 0.8773966903222201, "ngenes": 3, "description": "Defective ABCG8 causes GBD4 and sitosterolemia", "id": "6c32121e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5679096", "value": 0.8773966903222201, "ngenes": 3, "description": "Defective ABCG5 causes sitosterolemia", "id": "6c32121f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5683329", "value": 0.6629570380066973, "ngenes": 4, "description": "Defective ABCD4 causes MAHCJ", "id": "6c321220-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5690338", "value": 0.42177034538554015, "ngenes": 6, "description": "Defective ABCC6 causes PXE", "id": "6c321221-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-9645723", "value": 5.751652236395521e-12, "ngenes": 63, "description": "Diseases of programmed cell death", "id": "6c321222-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8863678", "value": 4.056947353228383e-13, "ngenes": 48, "description": "Neurodegenerative Diseases", "id": "6c321223-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8862803", "value": 4.056947353228383e-13, "ngenes": 48, "description": "Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models", "id": "6c321224-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9645722", "value": 0.009580133840582265, "ngenes": 4, "description": "Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function", "id": "6c321225-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9693928", "value": 0.003900138141989245, "ngenes": 11, "description": "Defective RIPK1-mediated regulated necrosis", "id": "6c321226-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9675151", "value": 0.4997500712929101, "ngenes": 25, "description": "Disorders of Developmental Biology", "id": "6c321227-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9697154", "value": 0.4997500712929101, "ngenes": 25, "description": "Disorders of Nervous System Development", "id": "6c321228-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9005895", "value": 0.4997500712929101, "ngenes": 25, "description": "Pervasive developmental disorders", "id": "6c321229-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9005891", "value": 0.4997500712929101, "ngenes": 25, "description": "Loss of function of MECP2 in Rett syndrome", "id": "6c32122a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9022535", "value": 0.2009976625436391, "ngenes": 7, "description": "Loss of phosphorylation of MECP2 at T308", "id": "6c32122b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9022537", "value": 0.5629005751269436, "ngenes": 11, "description": "Loss of MECP2 binding ability to the NCoR/SMRT complex", "id": "6c32122c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9022538", "value": 0.441944419315339, "ngenes": 11, "description": "Loss of MECP2 binding ability to 5mC-DNA", "id": "6c32122d-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}]}, {"source": "R-HSA-9675132", "value": 0.00018260766141667314, "ngenes": 5, "description": "Diseases of cellular response to stress", "id": "6c32122e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9630747", "value": 0.00018260766141667314, "ngenes": 5, "description": "Diseases of Cellular Senescence", "id": "6c32122f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9630750", "value": 0.00018260766141667314, "ngenes": 5, "description": "Evasion of Oncogene Induced Senescence Due to p16INK4A Defects", "id": "6c321230-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9630791", "value": 0.000795025193741623, "ngenes": 4, "description": "Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4", "id": "6c321231-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9630794", "value": 0.00018260766141667314, "ngenes": 5, "description": "Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6", "id": "6c321232-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9632693", "value": 0.00018260766141667314, "ngenes": 5, "description": "Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects", "id": "6c321233-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9632697", "value": 0.000795025193741623, "ngenes": 4, "description": "Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4", "id": "6c321234-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9632700", "value": 0.00018260766141667314, "ngenes": 5, "description": "Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6", "id": "6c321235-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9646303", "value": 0.0033585422654606304, "ngenes": 3, "description": "Evasion of Oncogene Induced Senescence Due to p14ARF Defects", "id": "6c321236-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9646304", "value": 0.0033585422654606304, "ngenes": 3, "description": "Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects", "id": "6c321237-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-9671793", "value": 0.0014794979664735813, "ngenes": 21, "description": "Diseases of hemostasis", "id": "6c321238-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9651496", "value": 0.0014794979664735813, "ngenes": 21, "description": "Defects of contact activation system (CAS) and kallikrein/kinin system (KKS)", "id": "6c321239-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9657689", "value": 0.03200849162881629, "ngenes": 4, "description": "Defective SERPING1 causes hereditary angioedema", "id": "6c32123a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9672383", "value": 4.644153686254098e-09, "ngenes": 6, "description": "Defective factor IX causes thrombophilia", "id": "6c32123b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9662001", "value": 1.0869381340033802e-05, "ngenes": 11, "description": "Defective factor VIII causes hemophilia A", "id": "6c32123c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9672387", "value": 5.720143229806291e-09, "ngenes": 4, "description": "Defective F8 accelerates dissociation of the A2 domain", "id": "6c32123d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9672391", "value": 7.466951101903827e-09, "ngenes": 5, "description": "Defective F8 cleavage by thrombin", "id": "6c32123e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9672393", "value": 7.466951101903827e-09, "ngenes": 5, "description": "Defective F8 binding to von Willebrand factor", "id": "6c32123f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9672395", "value": 5.720143229806291e-09, "ngenes": 4, "description": "Defective F8 binding to the cell membrane", "id": "6c321240-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9672396", "value": 4.644153686254098e-09, "ngenes": 6, "description": "Defective cofactor function of FVIIIa variant", "id": "6c321241-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9672397", "value": 5.720143229806291e-09, "ngenes": 4, "description": "Defective F8 secretion", "id": "6c321242-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9674519", "value": 1.1335243376079856e-05, "ngenes": 8, "description": "Defective F8 sulfation at Y1699", "id": "6c321243-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9668250", "value": 8.129561620385191e-09, "ngenes": 12, "description": "Defective factor IX causes hemophilia B", "id": "6c321244-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9673202", "value": 4.644153686254098e-09, "ngenes": 6, "description": "Defective F9 variant does not activate FX", "id": "6c321245-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9673221", "value": 0.13544610530037454, "ngenes": 6, "description": "Defective F9 activation", "id": "6c321246-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-9675126", "value": 1.3172241040965642e-18, "ngenes": 68, "description": "Diseases of mitotic cell cycle", "id": "6c321247-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9687139", "value": 1.4068117093534665e-18, "ngenes": 63, "description": "Aberrant regulation of mitotic cell cycle due to RB1 defects", "id": "6c321248-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9659787", "value": 3.3990912657079446e-14, "ngenes": 26, "description": "Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects", "id": "6c321249-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9661069", "value": 3.3990912657079446e-14, "ngenes": 26, "description": "Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)", "id": "6c32124a-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9687136", "value": 1.5874068920222422e-19, "ngenes": 38, "description": "Aberrant regulation of mitotic exit in cancer due to RB1 defects", "id": "6c32124b-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-382551", "value": 0.4251346429677399, "ngenes": 1163, "description": "Transport of small molecules", "id": "6c32124c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1480926", "value": 0.0024348302445445272, "ngenes": 16, "description": "O2/CO2 exchange in erythrocytes", "id": "6c32124d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1237044", "value": 0.0024348302445445272, "ngenes": 16, "description": "Erythrocytes take up carbon dioxide and release oxygen", "id": "6c32124e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1247673", "value": 0.001676468697031404, "ngenes": 10, "description": "Erythrocytes take up oxygen and release carbon dioxide", "id": "6c32124f-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-382556", "value": 0.7012110436520436, "ngenes": 179, "description": "ABC-family proteins mediated transport", "id": "6c321250-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1369007", "value": 0.0914115733302693, "ngenes": 5, "description": "Mitochondrial ABC transporters", "id": "6c321251-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1369062", "value": 2.432068295805748e-05, "ngenes": 34, "description": "ABC transporters in lipid homeostasis", "id": "6c321252-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-425407", "value": 1.5413018398416391e-09, "ngenes": 370, "description": "SLC-mediated transmembrane transport", "id": "6c321253-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-189200", "value": 0.11685753035634956, "ngenes": 33, "description": "Cellular hexose transport", "id": "6c321254-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-425393", "value": 1.7880487808961204e-11, "ngenes": 156, "description": "Transport of inorganic cations/anions and amino acids/oligopeptides", "id": "6c321255-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-352230", "value": 2.143333994131961e-11, "ngenes": 48, "description": "Amino acid transport across the plasma membrane", "id": "6c321256-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-425381", "value": 1.1009899085725054e-10, "ngenes": 16, "description": "Bicarbonate transporters", "id": "6c321257-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-425561", "value": 8.964497654948616e-06, "ngenes": 20, "description": "Sodium/Calcium exchangers", "id": "6c321258-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-425986", "value": 0.3516344422591895, "ngenes": 14, "description": "Sodium/Proton exchangers", "id": "6c321259-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-426117", "value": 0.4270541421617548, "ngenes": 9, "description": "Cation-coupled Chloride cotransporters", "id": "6c32125a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-427652", "value": 0.05959685319265916, "ngenes": 6, "description": "Sodium-coupled phosphate cotransporters", "id": "6c32125b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-427589", "value": 0.6807569487647356, "ngenes": 4, "description": "Type II Na+/Pi cotransporters", "id": "6c32125c-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-427601", "value": 0.0992012447783749, "ngenes": 20, "description": "Multifunctional anion exchangers", "id": "6c32125d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-427975", "value": 0.0005704748231757991, "ngenes": 3, "description": "Proton/oligopeptide cotransporters", "id": "6c32125e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-428643", "value": 0.023045193130033153, "ngenes": 9, "description": "Organic anion transporters", "id": "6c32125f-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-425366", "value": 9.610898255312691e-11, "ngenes": 127, "description": "Transport of bile salts and organic acids, metal ions and amine compounds", "id": "6c321260-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-429593", "value": 0.002263189683934334, "ngenes": 3, "description": "Inositol transporters", "id": "6c321261-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-433137", "value": 0.32441122481185514, "ngenes": 8, "description": "Sodium-coupled sulphate, di- and tri-carboxylate transporters", "id": "6c321262-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-433692", "value": 0.00027719597303105454, "ngenes": 9, "description": "Proton-coupled monocarboxylate transport", "id": "6c321263-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-425410", "value": 6.068518107677134e-07, "ngenes": 42, "description": "Metal ion SLC transporters", "id": "6c321264-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-435354", "value": 5.1722295922323094e-05, "ngenes": 30, "description": "Zinc transporters", "id": "6c321265-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-435368", "value": 0.023307899673574516, "ngenes": 13, "description": "Zinc efflux and compartmentalization by the SLC30 family", "id": "6c321266-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-442380", "value": 2.0184059913660382e-07, "ngenes": 17, "description": "Zinc influx into cells by the SLC39 gene family", "id": "6c321267-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-442660", "value": 0.0001282034198537759, "ngenes": 26, "description": "Na+/Cl- dependent neurotransmitter transporters", "id": "6c321268-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-444411", "value": 0.3846906360470156, "ngenes": 3, "description": "Rhesus glycoproteins mediate ammonium transport.", "id": "6c321269-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-549132", "value": 4.5531470402918185e-05, "ngenes": 26, "description": "Organic cation/anion/zwitterion transport", "id": "6c32126a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-549127", "value": 2.0165384176479855e-05, "ngenes": 16, "description": "Organic cation transport", "id": "6c32126b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-561048", "value": 0.2647201964708679, "ngenes": 10, "description": "Organic anion transport", "id": "6c32126c-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-425397", "value": 0.19500151028717513, "ngenes": 64, "description": "Transport of vitamins, nucleosides, and related molecules", "id": "6c32126d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-727802", "value": 0.0037353910324250564, "ngenes": 13, "description": "Transport of nucleotide sugars", "id": "6c32126e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-804914", "value": 9.060950452086658e-09, "ngenes": 10, "description": "Transport of fatty acids", "id": "6c32126f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-83936", "value": 0.758976270741969, "ngenes": 14, "description": "Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane", "id": "6c321270-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-879518", "value": 0.8499245143086585, "ngenes": 25, "description": "Transport of organic anions", "id": "6c321271-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-983712", "value": 0.9918138628754422, "ngenes": 320, "description": "Ion channel transport", "id": "6c321272-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2672351", "value": 0.5874812675413783, "ngenes": 175, "description": "Stimuli-sensing channels", "id": "6c321273-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3295583", "value": 6.16086894817342e-06, "ngenes": 43, "description": "TRP channels", "id": "6c321274-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-936837", "value": 0.007833111555706188, "ngenes": 110, "description": "Ion transport by P-type ATPases", "id": "6c321275-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-445717", "value": 0.03579237812743641, "ngenes": 74, "description": "Aquaporin-mediated transport", "id": "6c321276-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-432030", "value": 0.008115639184787716, "ngenes": 3, "description": "Transport of glycerol from adipocytes to the liver by Aquaporins", "id": "6c321277-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-432040", "value": 0.03559600724930123, "ngenes": 64, "description": "Vasopressin regulates renal water homeostasis via Aquaporins", "id": "6c321278-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-432047", "value": 0.0005575926325393357, "ngenes": 16, "description": "Passive transport by Aquaporins", "id": "6c321279-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5223345", "value": 7.547328965470539e-05, "ngenes": 45, "description": "Miscellaneous transport and binding events", "id": "6c32127a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-174824", "value": 0.37804777452335026, "ngenes": 127, "description": "Plasma lipoprotein assembly, remodeling, and clearance", "id": "6c32127b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8963898", "value": 0.03644538653527017, "ngenes": 31, "description": "Plasma lipoprotein assembly", "id": "6c32127c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8866423", "value": 0.0002255262442441535, "ngenes": 5, "description": "VLDL assembly", "id": "6c32127d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8963888", "value": 0.5267937594572715, "ngenes": 12, "description": "Chylomicron assembly", "id": "6c32127e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8963896", "value": 0.030557231605882695, "ngenes": 18, "description": "HDL assembly", "id": "6c32127f-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8964043", "value": 0.6191771331621133, "ngenes": 49, "description": "Plasma lipoprotein clearance", "id": "6c321280-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8866427", "value": 0.36764469877191447, "ngenes": 21, "description": "VLDLR internalisation and degradation", "id": "6c321281-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8964011", "value": 0.343147906942479, "ngenes": 7, "description": "HDL clearance", "id": "6c321282-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8964026", "value": 0.00950148224689402, "ngenes": 6, "description": "Chylomicron clearance", "id": "6c321283-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8964038", "value": 0.4147901423947125, "ngenes": 30, "description": "LDL clearance", "id": "6c321284-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8964046", "value": 7.470370207149331e-10, "ngenes": 9, "description": "VLDL clearance", "id": "6c321285-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8963899", "value": 0.655093677084329, "ngenes": 61, "description": "Plasma lipoprotein remodeling", "id": "6c321286-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8963889", "value": 0.2229433725368772, "ngenes": 36, "description": "Assembly of active LPL and LIPC lipase complexes", "id": "6c321287-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8963901", "value": 0.00027999023450677384, "ngenes": 12, "description": "Chylomicron remodeling", "id": "6c321288-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8964041", "value": 0.3298554697899262, "ngenes": 8, "description": "LDL remodeling", "id": "6c321289-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8964058", "value": 0.0019100924209210003, "ngenes": 19, "description": "HDL remodeling", "id": "6c32128a-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-8949215", "value": 0.021410128172257348, "ngenes": 33, "description": "Mitochondrial calcium ion transport", "id": "6c32128b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8949664", "value": 0.006753257432110538, "ngenes": 23, "description": "Processing of SMDT1", "id": "6c32128c-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8981607", "value": 0.6077894607103952, "ngenes": 6, "description": "Intracellular oxygen transport", "id": "6c32128d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-917937", "value": 0.0006472411949168041, "ngenes": 95, "description": "Iron uptake and transport", "id": "6c32128e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-917977", "value": 0.0579904020062995, "ngenes": 54, "description": "Transferrin endocytosis and recycling", "id": "6c32128f-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-1430728", "value": 0.3104251810423078, "ngenes": 3335, "description": "Metabolism", "id": "6c321290-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-71291", "value": 0.13765281848519964, "ngenes": 627, "description": "Metabolism of amino acids and derivatives", "id": "6c321291-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1614635", "value": 0.3679627979500511, "ngenes": 44, "description": "Sulfur amino acid metabolism", "id": "6c321292-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1237112", "value": 0.04800902487248985, "ngenes": 10, "description": "Methionine salvage pathway", "id": "6c321293-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1614558", "value": 0.8047508559542009, "ngenes": 23, "description": "Degradation of cysteine and homocysteine", "id": "6c321294-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1614517", "value": 0.00496276019317787, "ngenes": 9, "description": "Sulfide oxidation to sulfate", "id": "6c321295-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1614603", "value": 0.06287099450490469, "ngenes": 4, "description": "Cysteine formation from homocysteine", "id": "6c321296-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-209776", "value": 1.3573322902199594e-05, "ngenes": 23, "description": "Metabolism of amine-derived hormones", "id": "6c321297-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-209905", "value": 1.6015201154239026e-06, "ngenes": 5, "description": "Catecholamine biosynthesis", "id": "6c321298-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-209931", "value": 0.2772235070400647, "ngenes": 5, "description": "Serotonin and melatonin biosynthesis", "id": "6c321299-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-209968", "value": 0.0012446301666836498, "ngenes": 14, "description": "Thyroxine biosynthesis", "id": "6c32129a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-350864", "value": 0.0008173023969524309, "ngenes": 6, "description": "Regulation of thyroid hormone activity", "id": "6c32129b-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-2408522", "value": 0.13720944744777774, "ngenes": 235, "description": "Selenoamino acid metabolism", "id": "6c32129c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2408508", "value": 1.3478606691567957e-07, "ngenes": 14, "description": "Metabolism of ingested SeMet, Sec, MeSec into H2Se", "id": "6c32129d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2408550", "value": 1.8202247808332793e-10, "ngenes": 7, "description": "Metabolism of ingested H2SeO4 and H2SeO3 into H2Se", "id": "6c32129e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2408557", "value": 0.14929934185427537, "ngenes": 200, "description": "Selenocysteine synthesis", "id": "6c32129f-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-351202", "value": 0.06254688102556091, "ngenes": 99, "description": "Metabolism of polyamines", "id": "6c3212a0-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-350562", "value": 0.0923902054306673, "ngenes": 85, "description": "Regulation of ornithine decarboxylase (ODC)", "id": "6c3212a1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-351200", "value": 2.461222086965114e-07, "ngenes": 7, "description": "Interconversion of polyamines", "id": "6c3212a2-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5662702", "value": 0.4225815272081348, "ngenes": 8, "description": "Melanin biosynthesis", "id": "6c3212a3-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-389661", "value": 0.0004822307966384137, "ngenes": 51, "description": "Glyoxylate metabolism and glycine degradation", "id": "6c3212a4-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-6783984", "value": 0.10044168276923554, "ngenes": 7, "description": "Glycine degradation", "id": "6c3212a5-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-6798163", "value": 0.017114779597088424, "ngenes": 9, "description": "Choline catabolism", "id": "6c3212a6-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-70635", "value": 0.142374219334051, "ngenes": 13, "description": "Urea cycle", "id": "6c3212a7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-70688", "value": 0.9247252751985672, "ngenes": 6, "description": "Proline catabolism", "id": "6c3212a8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-70895", "value": 1.1456877898654346e-11, "ngenes": 27, "description": "Branched-chain amino acid catabolism", "id": "6c3212a9-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-70921", "value": 1.9438853986323557e-08, "ngenes": 15, "description": "Histidine catabolism", "id": "6c3212aa-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-71064", "value": 0.7000215433551404, "ngenes": 23, "description": "Lysine catabolism", "id": "6c3212ab-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-71240", "value": 1.7602944615264855e-10, "ngenes": 24, "description": "Tryptophan catabolism", "id": "6c3212ac-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-71262", "value": 0.008199537115256086, "ngenes": 9, "description": "Carnitine synthesis", "id": "6c3212ad-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-71288", "value": 0.004094059178167002, "ngenes": 13, "description": "Creatine metabolism", "id": "6c3212ae-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8849175", "value": 0.4633171627873081, "ngenes": 6, "description": "Threonine catabolism", "id": "6c3212af-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8963691", "value": 0.0011120390973886306, "ngenes": 19, "description": "Phenylalanine and tyrosine metabolism", "id": "6c3212b0-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8963684", "value": 0.023307899673574516, "ngenes": 10, "description": "Tyrosine catabolism", "id": "6c3212b1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8964208", "value": 0.009763154032339572, "ngenes": 9, "description": "Phenylalanine metabolism", "id": "6c3212b2-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8963693", "value": 2.0987746513940744e-09, "ngenes": 11, "description": "Aspartate and asparagine metabolism", "id": "6c3212b3-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8964539", "value": 0.36637729884820325, "ngenes": 22, "description": "Glutamate and glutamine metabolism", "id": "6c3212b4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-977347", "value": 7.325742047438563e-08, "ngenes": 12, "description": "Serine biosynthesis", "id": "6c3212b5-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-211859", "value": 0.9706537128838664, "ngenes": 340, "description": "Biological oxidations", "id": "6c3212b6-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-211945", "value": 0.6697973918363818, "ngenes": 142, "description": "Phase I - Functionalization of compounds", "id": "6c3212b7-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-140179", "value": 1.3699213227055476e-08, "ngenes": 8, "description": "Amine Oxidase reactions", "id": "6c3212b8-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-141334", "value": 6.810833922963124e-07, "ngenes": 6, "description": "PAOs oxidise polyamines to amines", "id": "6c3212b9-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-211897", "value": 0.04139764907362981, "ngenes": 84, "description": "Cytochrome P450 - arranged by substrate type", "id": "6c3212ba-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-211916", "value": 0.14910435641452108, "ngenes": 8, "description": "Vitamins", "id": "6c3212bb-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-211935", "value": 1.4625886444500023e-05, "ngenes": 21, "description": "Fatty acids", "id": "6c3212bc-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-211958", "value": 0.0017297727041074148, "ngenes": 17, "description": "Miscellaneous substrates", "id": "6c3212bd-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-211976", "value": 0.3618776759765842, "ngenes": 37, "description": "Endogenous sterols", "id": "6c3212be-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-211979", "value": 0.0005856070494258818, "ngenes": 13, "description": "Eicosanoids", "id": "6c3212bf-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-211981", "value": 0.0030021034999647114, "ngenes": 29, "description": "Xenobiotics", "id": "6c3212c0-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-211999", "value": 0.014398359345212271, "ngenes": 17, "description": "CYP2E1 reactions", "id": "6c3212c1-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-217271", "value": 0.6270469080675736, "ngenes": 3, "description": "FMO oxidises nucleophiles", "id": "6c3212c2-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-71384", "value": 0.00016302486600973327, "ngenes": 19, "description": "Ethanol oxidation", "id": "6c3212c3-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8937144", "value": 0.013345094098209562, "ngenes": 7, "description": "Aryl hydrocarbon receptor signalling", "id": "6c3212c4-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-156580", "value": 0.5680626832438362, "ngenes": 189, "description": "Phase II - Conjugation of compounds", "id": "6c3212c5-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-156581", "value": 0.20980323787699734, "ngenes": 22, "description": "Methylation", "id": "6c3212c6-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-156582", "value": 6.8738065604868465e-09, "ngenes": 4, "description": "Acetylation", "id": "6c3212c7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-156588", "value": 0.8542967522140738, "ngenes": 39, "description": "Glucuronidation", "id": "6c3212c8-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-173599", "value": 0.4997500712929101, "ngenes": 7, "description": "Formation of the active cofactor, UDP-glucuronate", "id": "6c3212c9-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-156584", "value": 0.9455582063988855, "ngenes": 45, "description": "Cytosolic sulfonation of small molecules", "id": "6c3212ca-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-174362", "value": 0.993553805964897, "ngenes": 11, "description": "Transport and synthesis of PAPS", "id": "6c3212cb-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-156590", "value": 1.2295678690439702e-06, "ngenes": 65, "description": "Glutathione conjugation", "id": "6c3212cc-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-174403", "value": 0.005974954005694179, "ngenes": 24, "description": "Glutathione synthesis and recycling", "id": "6c3212cd-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-156587", "value": 0.0010363597174473528, "ngenes": 16, "description": "Amino Acid conjugation", "id": "6c3212ce-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-159424", "value": 0.0010363597174473528, "ngenes": 16, "description": "Conjugation of carboxylic acids", "id": "6c3212cf-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-177128", "value": 0.0010309137148568157, "ngenes": 15, "description": "Conjugation of salicylate with glycine", "id": "6c3212d0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-177135", "value": 0.027424415704063284, "ngenes": 10, "description": "Conjugation of benzoate with glycine", "id": "6c3212d1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-177162", "value": 0.6003959376347063, "ngenes": 5, "description": "Conjugation of phenylacetate with glutamine", "id": "6c3212d2-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-5423646", "value": 0.01825177421083989, "ngenes": 32, "description": "Aflatoxin activation and detoxification", "id": "6c3212d3-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-196854", "value": 0.9455582063988855, "ngenes": 285, "description": "Metabolism of vitamins and cofactors", "id": "6c3212d4-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8978934", "value": 0.0008173023969524309, "ngenes": 31, "description": "Metabolism of cofactors", "id": "6c3212d5-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1474151", "value": 0.14646669593272832, "ngenes": 18, "description": "Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation", "id": "6c3212d6-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2142789", "value": 1.710462886770876e-11, "ngenes": 11, "description": "Ubiquinol biosynthesis", "id": "6c3212d7-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-196849", "value": 0.5853740837706992, "ngenes": 193, "description": "Metabolism of water-soluble vitamins and cofactors", "id": "6c3212d8-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-196741", "value": 0.16561890807811652, "ngenes": 32, "description": "Cobalamin (Cbl, vitamin B12) transport and metabolism", "id": "6c3212d9-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-196757", "value": 4.66275264305397e-13, "ngenes": 26, "description": "Metabolism of folate and pterines", "id": "6c3212da-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-196780", "value": 0.26052731337264806, "ngenes": 14, "description": "Biotin transport and metabolism", "id": "6c3212db-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-199220", "value": 0.9337425876449743, "ngenes": 27, "description": "Vitamin B5 (pantothenate) metabolism", "id": "6c3212dc-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-196783", "value": 0.2273676479792263, "ngenes": 15, "description": "Coenzyme A biosynthesis", "id": "6c3212dd-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-196819", "value": 0.025348993515356952, "ngenes": 6, "description": "Vitamin B1 (thiamin) metabolism", "id": "6c3212de-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-196836", "value": 1.453762103516737e-05, "ngenes": 14, "description": "Vitamin C (ascorbate) metabolism", "id": "6c3212df-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-196843", "value": 2.461222086965114e-07, "ngenes": 10, "description": "Vitamin B2 (riboflavin) metabolism", "id": "6c3212e0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-196807", "value": 0.5315394915888634, "ngenes": 49, "description": "Nicotinate metabolism", "id": "6c3212e1-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-197264", "value": 0.13544610530037454, "ngenes": 32, "description": "Nicotinamide salvaging", "id": "6c3212e2-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-947581", "value": 0.06639095317036248, "ngenes": 13, "description": "Molybdenum cofactor biosynthesis", "id": "6c3212e3-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-964975", "value": 0.0008700633693565755, "ngenes": 4, "description": "Vitamins B6 activation to pyridoxal phosphate", "id": "6c3212e4-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-6806667", "value": 2.3485762220358017e-05, "ngenes": 64, "description": "Metabolism of fat-soluble vitamins", "id": "6c3212e5-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-6806664", "value": 0.9439099697859671, "ngenes": 4, "description": "Metabolism of vitamin K", "id": "6c3212e6-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8877627", "value": 0.7484042954703755, "ngenes": 3, "description": "Vitamin E", "id": "6c3212e7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-975634", "value": 1.6615644682680222e-06, "ngenes": 57, "description": "Retinoid metabolism and transport", "id": "6c3212e8-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-1475029", "value": 2.4453615784850258e-08, "ngenes": 16, "description": "Reversible hydration of carbon dioxide", "id": "6c3212e9-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-556833", "value": 0.24555322668551738, "ngenes": 1171, "description": "Metabolism of lipids", "id": "6c3212ea-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1483257", "value": 0.002769033300069138, "ngenes": 340, "description": "Phospholipid metabolism", "id": "6c3212eb-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1483206", "value": 0.010808439146368046, "ngenes": 200, "description": "Glycerophospholipid biosynthesis", "id": "6c3212ec-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1482788", "value": 0.4247338650518724, "ngenes": 34, "description": "Acyl chain remodelling of PC", "id": "6c3212ed-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1482798", "value": 0.9701668083606931, "ngenes": 10, "description": "Acyl chain remodeling of CL", "id": "6c3212ee-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1482801", "value": 0.5356039320231837, "ngenes": 28, "description": "Acyl chain remodelling of PS", "id": "6c3212ef-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1482839", "value": 0.03961411279588464, "ngenes": 36, "description": "Acyl chain remodelling of PE", "id": "6c3212f0-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1482883", "value": 0.9439099697859671, "ngenes": 9, "description": "Acyl chain remodeling of DAG and TAG", "id": "6c3212f1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1482922", "value": 0.10204685416276443, "ngenes": 21, "description": "Acyl chain remodelling of PI", "id": "6c3212f2-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1482925", "value": 0.3113527086591612, "ngenes": 22, "description": "Acyl chain remodelling of PG", "id": "6c3212f3-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1483115", "value": 0.007674918911813854, "ngenes": 11, "description": "Hydrolysis of LPC", "id": "6c3212f4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1483148", "value": 0.0014614749732837287, "ngenes": 10, "description": "Synthesis of PG", "id": "6c3212f5-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1483166", "value": 0.002806176550506911, "ngenes": 57, "description": "Synthesis of PA", "id": "6c3212f6-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1483191", "value": 6.085538580452918e-05, "ngenes": 58, "description": "Synthesis of PC", "id": "6c3212f7-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1483213", "value": 0.001676468697031404, "ngenes": 29, "description": "Synthesis of PE", "id": "6c3212f8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1483226", "value": 0.18615434945851148, "ngenes": 6, "description": "Synthesis of PI", "id": "6c3212f9-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1483255", "value": 0.000995684099128516, "ngenes": 141, "description": "PI Metabolism", "id": "6c3212fa-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1483248", "value": 0.019244362697786253, "ngenes": 10, "description": "Synthesis of PIPs at the ER membrane", "id": "6c3212fb-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1660499", "value": 0.000841415834070435, "ngenes": 91, "description": "Synthesis of PIPs at the plasma membrane", "id": "6c3212fc-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1660514", "value": 8.298660268029124e-06, "ngenes": 32, "description": "Synthesis of PIPs at the Golgi membrane", "id": "6c3212fd-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1660516", "value": 0.09916536199769871, "ngenes": 25, "description": "Synthesis of PIPs at the early endosome membrane", "id": "6c3212fe-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1660517", "value": 0.02397361751555376, "ngenes": 15, "description": "Synthesis of PIPs at the late endosome membrane", "id": "6c3212ff-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6814848", "value": 0.8765989588243446, "ngenes": 12, "description": "Glycerophospholipid catabolism", "id": "6c321300-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8847453", "value": 0.7484042954703755, "ngenes": 6, "description": "Synthesis of PIPs in the nucleus", "id": "6c321301-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-8957322", "value": 0.6522142160471123, "ngenes": 241, "description": "Metabolism of steroids", "id": "6c321302-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-194068", "value": 5.7481252425572667e-05, "ngenes": 70, "description": "Bile acid and bile salt metabolism", "id": "6c321303-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-159418", "value": 0.00892253568505788, "ngenes": 25, "description": "Recycling of bile acids and salts", "id": "6c321304-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-192105", "value": 0.4602164342858426, "ngenes": 54, "description": "Synthesis of bile acids and bile salts", "id": "6c321305-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-193368", "value": 0.0031803980656150916, "ngenes": 33, "description": "Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol", "id": "6c321306-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-193775", "value": 0.5866278933953386, "ngenes": 21, "description": "Synthesis of bile acids and bile salts via 24-hydroxycholesterol", "id": "6c321307-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-193807", "value": 0.4936861547376233, "ngenes": 21, "description": "Synthesis of bile acids and bile salts via 27-hydroxycholesterol", "id": "6c321308-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-196071", "value": 0.8123457972362099, "ngenes": 51, "description": "Metabolism of steroid hormones", "id": "6c321309-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-193048", "value": 0.16841984072091365, "ngenes": 13, "description": "Androgen biosynthesis", "id": "6c32130a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-193144", "value": 0.5510832640633075, "ngenes": 11, "description": "Estrogen biosynthesis", "id": "6c32130b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-193993", "value": 0.6027917537033094, "ngenes": 6, "description": "Mineralocorticoid biosynthesis", "id": "6c32130c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-194002", "value": 0.8732442040360847, "ngenes": 14, "description": "Glucocorticoid biosynthesis", "id": "6c32130d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-196108", "value": 0.7293707254845762, "ngenes": 18, "description": "Pregnenolone biosynthesis", "id": "6c32130e-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-196791", "value": 0.023307899673574516, "ngenes": 18, "description": "Vitamin D (calciferol) metabolism", "id": "6c32130f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1655829", "value": 0.16522327467338443, "ngenes": 89, "description": "Regulation of cholesterol biosynthesis by SREBP (SREBF)", "id": "6c321310-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2426168", "value": 7.301721375903254e-08, "ngenes": 64, "description": "Activation of gene expression by SREBF (SREBP)", "id": "6c321311-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-191273", "value": 9.764523224732009e-09, "ngenes": 41, "description": "Cholesterol biosynthesis", "id": "6c321312-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-6807047", "value": 4.37500812393164e-10, "ngenes": 7, "description": "Cholesterol biosynthesis via desmosterol", "id": "6c321313-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6807062", "value": 4.37500812393164e-10, "ngenes": 7, "description": "Cholesterol biosynthesis via lathosterol", "id": "6c321314-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-8979227", "value": 0.00115440433836826, "ngenes": 56, "description": "Triglyceride metabolism", "id": "6c321315-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-163560", "value": 0.0011998857183011873, "ngenes": 40, "description": "Triglyceride catabolism", "id": "6c321316-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-75109", "value": 0.3105000347204391, "ngenes": 16, "description": "Triglyceride biosynthesis", "id": "6c321317-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-428157", "value": 0.5295378514782596, "ngenes": 151, "description": "Sphingolipid metabolism", "id": "6c321318-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1660661", "value": 0.8921065409809568, "ngenes": 74, "description": "Sphingolipid de novo biosynthesis", "id": "6c321319-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1660662", "value": 0.00012585780474087672, "ngenes": 77, "description": "Glycosphingolipid metabolism", "id": "6c32131a-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-400206", "value": 0.8064061164118486, "ngenes": 184, "description": "Regulation of lipid metabolism by PPARalpha", "id": "6c32131b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1989781", "value": 0.79011905696921, "ngenes": 182, "description": "PPARA activates gene expression", "id": "6c32131c-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8978868", "value": 4.420528339870442e-05, "ngenes": 266, "description": "Fatty acid metabolism", "id": "6c32131d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-200425", "value": 0.7087412261075305, "ngenes": 25, "description": "Carnitine metabolism", "id": "6c32131e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2046104", "value": 7.737634226113512e-18, "ngenes": 16, "description": "alpha-linolenic (omega3) and linoleic (omega6) acid metabolism", "id": "6c32131f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2046105", "value": 7.46667755288766e-12, "ngenes": 8, "description": "Linoleic acid (LA) metabolism", "id": "6c321320-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2046106", "value": 7.737634226113512e-18, "ngenes": 16, "description": "alpha-linolenic acid (ALA) metabolism", "id": "6c321321-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-2142753", "value": 0.015755523564464403, "ngenes": 84, "description": "Arachidonic acid metabolism", "id": "6c321322-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2142670", "value": 1.4954761315564221e-05, "ngenes": 6, "description": "Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)", "id": "6c321323-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2142688", "value": 1.2455193974803574e-05, "ngenes": 15, "description": "Synthesis of 5-eicosatetraenoic acids", "id": "6c321324-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2142691", "value": 7.878634833424266e-06, "ngenes": 38, "description": "Synthesis of Leukotrienes (LT) and Eoxins (EX)", "id": "6c321325-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2142712", "value": 0.019244362697786253, "ngenes": 11, "description": "Synthesis of 12-eicosatetraenoic acid derivatives", "id": "6c321326-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2142770", "value": 0.4997500712929101, "ngenes": 13, "description": "Synthesis of 15-eicosatetraenoic acid derivatives", "id": "6c321327-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2142816", "value": 0.8433823400973777, "ngenes": 7, "description": "Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)", "id": "6c321328-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2162123", "value": 0.027286801854009706, "ngenes": 19, "description": "Synthesis of Prostaglandins (PG) and Thromboxanes (TX)", "id": "6c321329-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-390918", "value": 8.086703178407538e-11, "ngenes": 41, "description": "Peroxisomal lipid metabolism", "id": "6c32132a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-389599", "value": 1.070809201616469e-09, "ngenes": 10, "description": "Alpha-oxidation of phytanate", "id": "6c32132b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-389887", "value": 0.0011290473116810794, "ngenes": 12, "description": "Beta-oxidation of pristanoyl-CoA", "id": "6c32132c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-390247", "value": 3.1760954286916635e-10, "ngenes": 15, "description": "Beta-oxidation of very long chain fatty acids", "id": "6c32132d-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-77289", "value": 0.02046741226709847, "ngenes": 52, "description": "Mitochondrial Fatty Acid Beta-Oxidation", "id": "6c32132e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-71032", "value": 0.000994966885808964, "ngenes": 5, "description": "Propionyl-CoA catabolism", "id": "6c32132f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-77286", "value": 3.912318845934111e-05, "ngenes": 17, "description": "mitochondrial fatty acid beta-oxidation of saturated fatty acids", "id": "6c321330-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-77285", "value": 0.5048004908887065, "ngenes": 3, "description": "Beta oxidation of myristoyl-CoA to lauroyl-CoA", "id": "6c321331-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-77305", "value": 0.0002210712002991336, "ngenes": 5, "description": "Beta oxidation of palmitoyl-CoA to myristoyl-CoA", "id": "6c321332-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-77310", "value": 0.1600367098569704, "ngenes": 5, "description": "Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA", "id": "6c321333-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-77346", "value": 2.948908946116606e-07, "ngenes": 8, "description": "Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA", "id": "6c321334-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-77348", "value": 1.2209392127005842e-07, "ngenes": 6, "description": "Beta oxidation of octanoyl-CoA to hexanoyl-CoA", "id": "6c321335-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-77350", "value": 0.17428378714743548, "ngenes": 4, "description": "Beta oxidation of hexanoyl-CoA to butanoyl-CoA", "id": "6c321336-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-77352", "value": 0.10065965002907747, "ngenes": 7, "description": "Beta oxidation of butanoyl-CoA to acetyl-CoA", "id": "6c321337-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-77288", "value": 1.2761187309886375e-06, "ngenes": 7, "description": "mitochondrial fatty acid beta-oxidation of unsaturated fatty acids", "id": "6c321338-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-75105", "value": 0.25749615433632317, "ngenes": 65, "description": "Fatty acyl-CoA biosynthesis", "id": "6c321339-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-75876", "value": 0.16108324272905952, "ngenes": 44, "description": "Synthesis of very long-chain fatty acyl-CoAs", "id": "6c32133a-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-9018678", "value": 2.1302115860177944e-13, "ngenes": 29, "description": "Biosynthesis of specialized proresolving mediators (SPMs)", "id": "6c32133b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2142700", "value": 6.36015242690228e-06, "ngenes": 10, "description": "Synthesis of Lipoxins (LX)", "id": "6c32133c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9018677", "value": 3.515912596544605e-15, "ngenes": 26, "description": "Biosynthesis of DHA-derived SPMs", "id": "6c32133d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9018676", "value": 0.2700325429441112, "ngenes": 7, "description": "Biosynthesis of D-series resolvins", "id": "6c32133e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9018681", "value": 0.24555322668551738, "ngenes": 4, "description": "Biosynthesis of protectins", "id": "6c32133f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9020265", "value": 0.3450040970371225, "ngenes": 6, "description": "Biosynthesis of aspirin-triggered D-series resolvins", "id": "6c321340-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9026395", "value": 8.976228733470007e-15, "ngenes": 6, "description": "Biosynthesis of DHA-derived sulfido conjugates", "id": "6c321341-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9026762", "value": 8.976228733470007e-15, "ngenes": 6, "description": "Biosynthesis of maresin conjugates in tissue regeneration (MCTR)", "id": "6c321342-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9018682", "value": 0.8418799186667777, "ngenes": 10, "description": "Biosynthesis of maresins", "id": "6c321343-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9027307", "value": 0.23029172075031987, "ngenes": 6, "description": "Biosynthesis of maresin-like SPMs", "id": "6c321344-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-9018679", "value": 0.9366924407915055, "ngenes": 12, "description": "Biosynthesis of EPA-derived SPMs", "id": "6c321345-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9018896", "value": 0.30004045629673287, "ngenes": 10, "description": "Biosynthesis of E-series 18(S)-resolvins", "id": "6c321346-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9023661", "value": 0.3854004220289867, "ngenes": 9, "description": "Biosynthesis of E-series 18(R)-resolvins", "id": "6c321347-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9018683", "value": 0.157444001676096, "ngenes": 9, "description": "Biosynthesis of DPA-derived SPMs", "id": "6c321348-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9025106", "value": 0.6323881002309694, "ngenes": 4, "description": "Biosynthesis of DPAn-6 SPMs", "id": "6c321349-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9025094", "value": 0.157444001676096, "ngenes": 9, "description": "Biosynthesis of DPAn-3 SPMs", "id": "6c32134a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9026286", "value": 0.11777630059142877, "ngenes": 6, "description": "Biosynthesis of DPAn-3-derived protectins and resolvins", "id": "6c32134b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9026290", "value": 0.17442485089385398, "ngenes": 4, "description": "Biosynthesis of DPAn-3-derived maresins", "id": "6c32134c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9026403", "value": 0.14263913782518275, "ngenes": 3, "description": "Biosynthesis of DPAn-3-derived 13-series resolvins", "id": "6c32134d-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-9027604", "value": 0.13647587336968972, "ngenes": 5, "description": "Biosynthesis of electrophilic \u03c9-3 PUFA oxo-derivatives", "id": "6c32134e-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8848584", "value": 0.0005856070494258818, "ngenes": 8, "description": "Wax and plasmalogen biosynthesis", "id": "6c32134f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-75896", "value": 0.8499245143086585, "ngenes": 3, "description": "Plasmalogen biosynthesis", "id": "6c321350-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9640463", "value": 0.00023443563145130388, "ngenes": 5, "description": "Wax biosynthesis", "id": "6c321351-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-74182", "value": 1.1102916100547196e-05, "ngenes": 13, "description": "Ketone body metabolism", "id": "6c321352-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-77108", "value": 0.0025921201064921726, "ngenes": 6, "description": "Utilization of Ketone Bodies", "id": "6c321353-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-77111", "value": 5.383960803641842e-06, "ngenes": 11, "description": "Synthesis of Ketone Bodies", "id": "6c321354-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8964572", "value": 0.00039099638878606287, "ngenes": 11, "description": "Lipid particle organization", "id": "6c321355-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1428517", "value": 0.445456177069717, "ngenes": 239, "description": "The citric acid (TCA) cycle and respiratory electron transport", "id": "6c321356-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-163200", "value": 0.5731260007449505, "ngenes": 161, "description": "Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.", "id": "6c321357-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-163210", "value": 0.45848355457383183, "ngenes": 32, "description": "Formation of ATP by chemiosmotic coupling", "id": "6c321358-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-166187", "value": 0.026405857553150763, "ngenes": 13, "description": "Mitochondrial Uncoupling", "id": "6c321359-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-167826", "value": 0.02565101788834865, "ngenes": 8, "description": "The fatty acid cycling model", "id": "6c32135a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-167827", "value": 0.02565101788834865, "ngenes": 8, "description": "The proton buffering model", "id": "6c32135b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9673163", "value": 0.9757291263195212, "ngenes": 5, "description": "Oleoyl-phe metabolism", "id": "6c32135c-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-611105", "value": 0.6813472276670933, "ngenes": 116, "description": "Respiratory electron transport", "id": "6c32135d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-6799198", "value": 0.6404568972959231, "ngenes": 63, "description": "Complex I biogenesis", "id": "6c32135e-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-71406", "value": 0.24103292013951555, "ngenes": 85, "description": "Pyruvate metabolism and Citric Acid (TCA) cycle", "id": "6c32135f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-70268", "value": 0.3023214968465769, "ngenes": 44, "description": "Pyruvate metabolism", "id": "6c321360-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-204174", "value": 0.0021570919567969297, "ngenes": 23, "description": "Regulation of pyruvate dehydrogenase (PDH) complex", "id": "6c321361-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-71403", "value": 0.02076856288555962, "ngenes": 39, "description": "Citric acid cycle (TCA cycle)", "id": "6c321362-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-880009", "value": 1.8190190867169435e-08, "ngenes": 3, "description": "Interconversion of 2-oxoglutarate and 2-hydroxyglutarate", "id": "6c321363-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-163685", "value": 0.6806363127271342, "ngenes": 178, "description": "Integration of energy metabolism", "id": "6c321364-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-163358", "value": 0.9142497083471408, "ngenes": 11, "description": "PKA-mediated phosphorylation of key metabolic factors", "id": "6c321365-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-163680", "value": 3.338340406404864e-05, "ngenes": 13, "description": "AMPK inhibits chREBP transcriptional activation activity", "id": "6c321366-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-163754", "value": 0.00029033614926257906, "ngenes": 3, "description": "Insulin effects increased synthesis of Xylulose-5-Phosphate", "id": "6c321367-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-163765", "value": 0.660073871379324, "ngenes": 20, "description": "ChREBP activates metabolic gene expression", "id": "6c321368-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-163767", "value": 4.8476142023191094e-05, "ngenes": 15, "description": "PP2A-mediated dephosphorylation of key metabolic factors", "id": "6c321369-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-163359", "value": 0.0301971209721257, "ngenes": 47, "description": "Glucagon signaling in metabolic regulation", "id": "6c32136a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-164378", "value": 0.0005494507171056156, "ngenes": 28, "description": "PKA activation in glucagon signalling", "id": "6c32136b-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-422356", "value": 0.5066321850001506, "ngenes": 123, "description": "Regulation of insulin secretion", "id": "6c32136c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-381676", "value": 0.0004572213955196494, "ngenes": 62, "description": "Glucagon-like Peptide-1 (GLP1) regulates insulin secretion", "id": "6c32136d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-399997", "value": 0.1265768261212451, "ngenes": 14, "description": "Acetylcholine regulates insulin secretion", "id": "6c32136e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-400042", "value": 0.3108777057960798, "ngenes": 42, "description": "Adrenaline,noradrenaline inhibits insulin secretion", "id": "6c32136f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-400451", "value": 0.6323881002309694, "ngenes": 21, "description": "Free fatty acids regulate insulin secretion", "id": "6c321370-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-434313", "value": 0.7087412261075305, "ngenes": 11, "description": "Intracellular metabolism of fatty acids regulates insulin secretion", "id": "6c321371-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-434316", "value": 0.7695440834018823, "ngenes": 10, "description": "Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion", "id": "6c321372-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-71387", "value": 0.432330476397308, "ngenes": 479, "description": "Metabolism of carbohydrates", "id": "6c321373-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-70326", "value": 0.3959633767095228, "ngenes": 162, "description": "Glucose metabolism", "id": "6c321374-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-70171", "value": 0.28787321091475343, "ngenes": 134, "description": "Glycolysis", "id": "6c321375-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-170822", "value": 0.0016499535841182956, "ngenes": 51, "description": "Regulation of Glucokinase by Glucokinase Regulatory Protein", "id": "6c321376-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9634600", "value": 1.4213008756133132e-05, "ngenes": 28, "description": "Regulation of glycolysis by fructose 2,6-bisphosphate metabolism", "id": "6c321377-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-70263", "value": 1.9346610082148592e-07, "ngenes": 54, "description": "Gluconeogenesis", "id": "6c321378-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1630316", "value": 0.23654313376360642, "ngenes": 193, "description": "Glycosaminoglycan metabolism", "id": "6c321379-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-174362", "value": 0.993553805964897, "ngenes": 11, "description": "Transport and synthesis of PAPS", "id": "6c32137a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1638091", "value": 0.9280070777613183, "ngenes": 83, "description": "Heparan sulfate/heparin (HS-GAG) metabolism", "id": "6c32137b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1971475", "value": 0.1187122997589825, "ngenes": 43, "description": "A tetrasaccharide linker sequence is required for GAG synthesis", "id": "6c32137c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2022928", "value": 0.05480660879995323, "ngenes": 42, "description": "HS-GAG biosynthesis", "id": "6c32137d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2024096", "value": 0.06755630227210874, "ngenes": 36, "description": "HS-GAG degradation", "id": "6c32137e-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1793185", "value": 0.447022874441219, "ngenes": 78, "description": "Chondroitin sulfate/dermatan sulfate metabolism", "id": "6c32137f-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1971475", "value": 0.1187122997589825, "ngenes": 43, "description": "A tetrasaccharide linker sequence is required for GAG synthesis", "id": "6c321380-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2022870", "value": 0.16791555485192297, "ngenes": 25, "description": "Chondroitin sulfate biosynthesis", "id": "6c321381-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2022923", "value": 0.11718463292876465, "ngenes": 19, "description": "Dermatan sulfate biosynthesis", "id": "6c321382-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2024101", "value": 0.33927529506040544, "ngenes": 27, "description": "CS/DS degradation", "id": "6c321383-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1638074", "value": 0.0006849788342241478, "ngenes": 52, "description": "Keratan sulfate/keratin metabolism", "id": "6c321384-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2022854", "value": 3.4940874490405674e-05, "ngenes": 44, "description": "Keratan sulfate biosynthesis", "id": "6c321385-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2022857", "value": 0.0001442979143887523, "ngenes": 22, "description": "Keratan sulfate degradation", "id": "6c321386-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-2142845", "value": 4.710283438802975e-05, "ngenes": 32, "description": "Hyaluronan metabolism", "id": "6c321387-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2142850", "value": 0.09090540658505405, "ngenes": 12, "description": "Hyaluronan biosynthesis and export", "id": "6c321388-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2160916", "value": 1.362149072946137e-05, "ngenes": 20, "description": "Hyaluronan uptake and degradation", "id": "6c321389-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-8982491", "value": 0.5478316916948813, "ngenes": 49, "description": "Glycogen metabolism", "id": "6c32138a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3322077", "value": 0.4548853639457626, "ngenes": 28, "description": "Glycogen synthesis", "id": "6c32138b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-70221", "value": 0.9197823057002393, "ngenes": 27, "description": "Glycogen breakdown (glycogenolysis)", "id": "6c32138c-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5652084", "value": 0.969605135009698, "ngenes": 15, "description": "Fructose metabolism", "id": "6c32138d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5652227", "value": 0.6276958857482052, "ngenes": 5, "description": "Fructose biosynthesis", "id": "6c32138e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-70350", "value": 0.07967401376606636, "ngenes": 10, "description": "Fructose catabolism", "id": "6c32138f-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5661270", "value": 0.3618776759765842, "ngenes": 10, "description": "Formation of xylulose-5-phosphate", "id": "6c321390-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-70370", "value": 0.0011134534270382244, "ngenes": 9, "description": "Galactose catabolism", "id": "6c321391-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-71336", "value": 0.03611934230049237, "ngenes": 20, "description": "Pentose phosphate pathway", "id": "6c321392-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-73843", "value": 0.7546990512190225, "ngenes": 5, "description": "5-Phosphoribose 1-diphosphate biosynthesis", "id": "6c321393-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8853383", "value": 0.38244916110738214, "ngenes": 4, "description": "Lysosomal oligosaccharide catabolism", "id": "6c321394-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9033658", "value": 0.25646815310629645, "ngenes": 29, "description": "Blood group systems biosynthesis", "id": "6c321395-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9037628", "value": 0.8430084220644185, "ngenes": 3, "description": "Rhesus blood group biosynthesis", "id": "6c321396-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9037629", "value": 0.25646815310629645, "ngenes": 25, "description": "Lewis blood group biosynthesis", "id": "6c321397-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-1483249", "value": 4.536296562881903e-06, "ngenes": 74, "description": "Inositol phosphate metabolism", "id": "6c321398-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1855167", "value": 0.004371424814020711, "ngenes": 22, "description": "Synthesis of pyrophosphates in the cytosol", "id": "6c321399-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1855183", "value": 0.004851609196800493, "ngenes": 21, "description": "Synthesis of IP2, IP, and Ins in the cytosol", "id": "6c32139a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1855191", "value": 4.438511835701178e-05, "ngenes": 7, "description": "Synthesis of IPs in the nucleus", "id": "6c32139b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1855204", "value": 0.009772795147492562, "ngenes": 36, "description": "Synthesis of IP3 and IP4 in the cytosol", "id": "6c32139c-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-189445", "value": 0.4997500712929101, "ngenes": 41, "description": "Metabolism of porphyrins", "id": "6c32139d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-189451", "value": 0.7091663888358887, "ngenes": 24, "description": "Heme biosynthesis", "id": "6c32139e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-189483", "value": 0.7033464737510121, "ngenes": 20, "description": "Heme degradation", "id": "6c32139f-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-202131", "value": 0.0014100111681960028, "ngenes": 22, "description": "Metabolism of nitric oxide: NOS3 activation and regulation", "id": "6c3213a0-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-203615", "value": 0.032128471812583784, "ngenes": 17, "description": "eNOS activation", "id": "6c3213a1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-203641", "value": 6.291215891693747e-06, "ngenes": 7, "description": "NOSTRIN mediated eNOS trafficking", "id": "6c3213a2-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-2161522", "value": 3.8257359762936025e-06, "ngenes": 13, "description": "Abacavir transport and metabolism", "id": "6c3213a3-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2161517", "value": 0.0009381701762869766, "ngenes": 7, "description": "Abacavir transmembrane transport", "id": "6c3213a4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2161541", "value": 3.308286392989076e-09, "ngenes": 6, "description": "Abacavir metabolism", "id": "6c3213a5-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-15869", "value": 2.83079164598137e-06, "ngenes": 178, "description": "Metabolism of nucleotides", "id": "6c3213a6-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8956319", "value": 1.6317760016151596e-05, "ngenes": 57, "description": "Nucleobase catabolism", "id": "6c3213a7-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-74259", "value": 8.362820928448448e-15, "ngenes": 27, "description": "Purine catabolism", "id": "6c3213a8-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2393930", "value": 6.599519748480745e-12, "ngenes": 11, "description": "Phosphate bond hydrolysis by NUDT proteins", "id": "6c3213a9-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-73621", "value": 0.04821757385857541, "ngenes": 17, "description": "Pyrimidine catabolism", "id": "6c3213aa-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8850843", "value": 0.7653969541177527, "ngenes": 14, "description": "Phosphate bond hydrolysis by NTPDase proteins", "id": "6c3213ab-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-499943", "value": 0.00012328791375445028, "ngenes": 58, "description": "Interconversion of nucleotide di- and triphosphates", "id": "6c3213ac-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8956320", "value": 7.818787704535976e-06, "ngenes": 26, "description": "Nucleobase biosynthesis", "id": "6c3213ad-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-500753", "value": 0.0037352313881067623, "ngenes": 4, "description": "Pyrimidine biosynthesis", "id": "6c3213ae-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-73817", "value": 0.00016531462249847926, "ngenes": 22, "description": "Purine ribonucleoside monophosphate biosynthesis", "id": "6c3213af-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8956321", "value": 3.173367211339042e-10, "ngenes": 45, "description": "Nucleotide salvage", "id": "6c3213b0-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-73614", "value": 1.0639739290291853e-10, "ngenes": 17, "description": "Pyrimidine salvage", "id": "6c3213b1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-74217", "value": 0.0019806836652023828, "ngenes": 30, "description": "Purine salvage", "id": "6c3213b2-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-1362409", "value": 0.0006472546711892059, "ngenes": 25, "description": "Mitochondrial iron-sulfur cluster biogenesis", "id": "6c3213b3-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2395516", "value": 0.0015021359057197559, "ngenes": 5, "description": "Electron transport from NADPH to Ferredoxin", "id": "6c3213b4-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-2564830", "value": 0.044005047047102175, "ngenes": 19, "description": "Cytosolic iron-sulfur cluster assembly", "id": "6c3213b5-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-71737", "value": 0.40175448564092703, "ngenes": 4, "description": "Pyrophosphate hydrolysis", "id": "6c3213b6-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9609507", "value": 0.03178459562078518, "ngenes": 260, "description": "Protein localization", "id": "6c3213b7-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1268020", "value": 0.5245947058567042, "ngenes": 90, "description": "Mitochondrial protein import", "id": "6c332852-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9033241", "value": 0.0022775207958561205, "ngenes": 102, "description": "Peroxisomal protein import", "id": "6c332853-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9033500", "value": 0.003440671556649675, "ngenes": 14, "description": "TYSND1 cleaves peroxisomal proteins", "id": "6c332854-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9603798", "value": 6.640211320821973e-10, "ngenes": 34, "description": "Class I peroxisomal membrane protein import", "id": "6c332855-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9609523", "value": 0.011272830081864723, "ngenes": 44, "description": "Insertion of tail-anchored proteins into the endoplasmic reticulum membrane", "id": "6c332856-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-400253", "value": 0.5140963847020531, "ngenes": 124, "description": "Circadian Clock", "id": "6c332857-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1368071", "value": 0.010411127560062202, "ngenes": 4, "description": "NR1D1 (REV-ERBA) represses gene expression", "id": "6c332858-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1368082", "value": 0.08439444295690958, "ngenes": 35, "description": "RORA activates gene expression", "id": "6c332859-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1368108", "value": 0.17680032959233957, "ngenes": 41, "description": "BMAL1:CLOCK,NPAS2 activates circadian gene expression", "id": "6c33285a-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1266738", "value": 0.5143080464812152, "ngenes": 1869, "description": "Developmental Biology", "id": "6c33285b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1181150", "value": 0.4926655641915395, "ngenes": 44, "description": "Signaling by NODAL", "id": "6c33285c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1433617", "value": 0.28483358835677475, "ngenes": 23, "description": "Regulation of signaling by NODAL", "id": "6c33285d-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-186712", "value": 0.2476528757401993, "ngenes": 70, "description": "Regulation of beta-cell development", "id": "6c33285e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-210744", "value": 0.0301971209721257, "ngenes": 24, "description": "Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells", "id": "6c33285f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-210746", "value": 0.04169289353399354, "ngenes": 5, "description": "Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells", "id": "6c332860-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-210747", "value": 0.7425883379587369, "ngenes": 15, "description": "Regulation of gene expression in early pancreatic precursor cells", "id": "6c332861-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-210745", "value": 0.004284324668402769, "ngenes": 39, "description": "Regulation of gene expression in beta cells", "id": "6c332862-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-211163", "value": 0.0013679447301256876, "ngenes": 9, "description": "AKT-mediated inactivation of FOXO1A", "id": "6c332863-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-452723", "value": 0.0022752335655974163, "ngenes": 56, "description": "Transcriptional regulation of pluripotent stem cells", "id": "6c332864-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2892245", "value": 0.05215580754894654, "ngenes": 18, "description": "POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation", "id": "6c332865-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2892247", "value": 0.00016623923382960967, "ngenes": 22, "description": "POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation", "id": "6c332866-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9675108", "value": 0.2898846497751084, "ngenes": 1076, "description": "Nervous system development", "id": "6c332867-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-422475", "value": 0.31046978694958793, "ngenes": 1040, "description": "Axon guidance", "id": "6c332868-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-373752", "value": 0.20877577970458766, "ngenes": 85, "description": "Netrin-1 signaling", "id": "6c332869-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-376172", "value": 0.5218793249329207, "ngenes": 22, "description": "DSCAM interactions", "id": "6c33286a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-418885", "value": 0.025244264416957925, "ngenes": 29, "description": "DCC mediated attractive signaling", "id": "6c33286b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-418886", "value": 0.28680591556885204, "ngenes": 11, "description": "Netrin mediated repulsion signals", "id": "6c33286c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-418890", "value": 0.026688437945305267, "ngenes": 12, "description": "Role of second messengers in netrin-1 signaling", "id": "6c33286d-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-2682334", "value": 0.6134619645168028, "ngenes": 176, "description": "EPH-Ephrin signaling", "id": "6c33286e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3928662", "value": 0.0006761301884331578, "ngenes": 82, "description": "EPHB-mediated forward signaling", "id": "6c33286f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3928663", "value": 0.6344999494816514, "ngenes": 56, "description": "EPHA-mediated growth cone collapse", "id": "6c332870-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3928664", "value": 0.005299203166254685, "ngenes": 34, "description": "Ephrin signaling", "id": "6c332871-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3928665", "value": 9.150740803209031e-07, "ngenes": 93, "description": "EPH-ephrin mediated repulsion of cells", "id": "6c332872-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-373755", "value": 0.8022941980938589, "ngenes": 112, "description": "Semaphorin interactions", "id": "6c332873-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-399954", "value": 0.1778730365844268, "ngenes": 27, "description": "Sema3A PAK dependent Axon repulsion", "id": "6c332874-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-399955", "value": 0.09080701255022758, "ngenes": 21, "description": "SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion", "id": "6c332875-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-399956", "value": 0.2622947865578019, "ngenes": 24, "description": "CRMPs in Sema3A signaling", "id": "6c332876-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-400685", "value": 0.8111422677179204, "ngenes": 48, "description": "Sema4D in semaphorin signaling", "id": "6c332877-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-416550", "value": 0.15523960837645273, "ngenes": 13, "description": "Sema4D mediated inhibition of cell attachment and migration", "id": "6c332878-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-416572", "value": 0.23118902204729833, "ngenes": 40, "description": "Sema4D induced cell migration and growth-cone collapse", "id": "6c332879-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-416700", "value": 0.20154680837673186, "ngenes": 34, "description": "Other semaphorin interactions", "id": "6c33287a-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-375165", "value": 0.05480660879995323, "ngenes": 136, "description": "NCAM signaling for neurite out-growth", "id": "6c33287b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-419037", "value": 0.28183528584023576, "ngenes": 86, "description": "NCAM1 interactions", "id": "6c33287c-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-376176", "value": 0.2067127613059018, "ngenes": 432, "description": "Signaling by ROBO receptors", "id": "6c33287d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-428540", "value": 0.3398926150402077, "ngenes": 23, "description": "Activation of RAC1", "id": "6c33287e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-428542", "value": 0.07036121269750556, "ngenes": 17, "description": "Regulation of commissural axon pathfinding by SLIT and ROBO", "id": "6c33287f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-428543", "value": 0.027442881526086187, "ngenes": 26, "description": "Inactivation of CDC42 and RAC1", "id": "6c332880-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-428890", "value": 0.003989082736615938, "ngenes": 14, "description": "Role of ABL in ROBO-SLIT signaling", "id": "6c332881-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8985586", "value": 0.23765650749627418, "ngenes": 6, "description": "SLIT2:ROBO1 increases RHOA activity", "id": "6c332882-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8985801", "value": 0.0063875042478012106, "ngenes": 8, "description": "Regulation of cortical dendrite branching", "id": "6c332883-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9010553", "value": 0.27542187088999515, "ngenes": 340, "description": "Regulation of expression of SLITs and ROBOs", "id": "6c332884-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9010642", "value": 0.07515791588204858, "ngenes": 15, "description": "ROBO receptors bind AKAP5", "id": "6c332885-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-373760", "value": 0.3498188432265399, "ngenes": 209, "description": "L1CAM interactions", "id": "6c332886-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-437239", "value": 0.07679509370564543, "ngenes": 75, "description": "Recycling pathway of L1", "id": "6c332887-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-445095", "value": 0.2194412507194543, "ngenes": 63, "description": "Interaction between L1 and Ankyrins", "id": "6c332888-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-445144", "value": 0.01859630193143732, "ngenes": 42, "description": "Signal transduction by L1", "id": "6c332889-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-447038", "value": 0.02193835559741582, "ngenes": 14, "description": "NrCAM interactions", "id": "6c33288a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-447041", "value": 0.13966130319430406, "ngenes": 19, "description": "CHL1 interactions", "id": "6c33288b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-447043", "value": 0.11718463292876465, "ngenes": 15, "description": "Neurofascin interactions", "id": "6c33288c-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8853659", "value": 1.2350900877771369e-05, "ngenes": 86, "description": "RET signaling", "id": "6c33288d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8866376", "value": 0.276661834954096, "ngenes": 13, "description": "Reelin signalling pathway", "id": "6c33288e-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9619665", "value": 0.029598370187725907, "ngenes": 40, "description": "EGR2 and SOX10-mediated initiation of Schwann cell myelination", "id": "6c33288f-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-381340", "value": 0.8451742806962416, "ngenes": 124, "description": "Transcriptional regulation of white adipocyte differentiation", "id": "6c332890-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-525793", "value": 0.963994649656727, "ngenes": 52, "description": "Myogenesis", "id": "6c332891-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5619507", "value": 0.14318802366075786, "ngenes": 163, "description": "Activation of HOX genes during differentiation", "id": "6c332892-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5617472", "value": 0.14318802366075786, "ngenes": 163, "description": "Activation of anterior HOX genes in hindbrain development during early embryogenesis", "id": "6c332893-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5682910", "value": 0.7283687232635842, "ngenes": 18, "description": "LGI-ADAM interactions", "id": "6c332894-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6805567", "value": 0.0016880581512946457, "ngenes": 263, "description": "Keratinization", "id": "6c332895-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-6809371", "value": 0.0010363597174473528, "ngenes": 173, "description": "Formation of the cornified envelope", "id": "6c332896-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9616222", "value": 0.18143252712456426, "ngenes": 121, "description": "Transcriptional regulation of granulopoiesis", "id": "6c332897-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1474244", "value": 0.9530296213324254, "ngenes": 516, "description": "Extracellular matrix organization", "id": "6c332898-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1474228", "value": 0.7950832700073012, "ngenes": 242, "description": "Degradation of the extracellular matrix", "id": "6c332899-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1442490", "value": 0.4204771812460541, "ngenes": 100, "description": "Collagen degradation", "id": "6c33289a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1592389", "value": 0.7779813594787727, "ngenes": 49, "description": "Activation of Matrix Metalloproteinases", "id": "6c33289b-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1566977", "value": 0.006051251035021077, "ngenes": 15, "description": "Fibronectin matrix formation", "id": "6c33289c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1566948", "value": 0.43852483989965196, "ngenes": 71, "description": "Elastic fibre formation", "id": "6c33289d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2129379", "value": 0.2537372625973, "ngenes": 64, "description": "Molecules associated with elastic fibres", "id": "6c33289e-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-216083", "value": 0.4328313805701905, "ngenes": 141, "description": "Integrin cell surface interactions", "id": "6c33289f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-1474290", "value": 0.14759508107715033, "ngenes": 164, "description": "Collagen formation", "id": "6c3328a0-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2022090", "value": 0.4025892610337889, "ngenes": 124, "description": "Assembly of collagen fibrils and other multimeric structures", "id": "6c3328a1-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2214320", "value": 0.6788066496581511, "ngenes": 33, "description": "Anchoring fibril formation", "id": "6c3328a2-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2243919", "value": 0.20576245390229717, "ngenes": 28, "description": "Crosslinking of collagen fibrils", "id": "6c3328a3-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1650814", "value": 0.2242552143512601, "ngenes": 109, "description": "Collagen biosynthesis and modifying enzymes", "id": "6c3328a4-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8948216", "value": 0.6247979836912028, "ngenes": 72, "description": "Collagen chain trimerization", "id": "6c3328a5-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-3000157", "value": 0.4997500712929101, "ngenes": 53, "description": "Laminin interactions", "id": "6c3328a6-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3000171", "value": 0.4841276528712197, "ngenes": 114, "description": "Non-integrin membrane-ECM interactions", "id": "6c3328a7-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3000170", "value": 0.32322614155989415, "ngenes": 47, "description": "Syndecan interactions", "id": "6c3328a8-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-3000178", "value": 0.9164706129148282, "ngenes": 129, "description": "ECM proteoglycans", "id": "6c3328a9-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8941237", "value": 0.006482188376467031, "ngenes": 11, "description": "Invadopodia formation", "id": "6c3328aa-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5653656", "value": 0.10570533612616784, "ngenes": 1076, "description": "Vesicle-mediated transport", "id": "6c3328ab-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-199991", "value": 0.08122201482622915, "ngenes": 1004, "description": "Membrane Trafficking", "id": "6c3328ac-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1445148", "value": 0.8483799675055577, "ngenes": 109, "description": "Translocation of SLC2A4 (GLUT4) to the plasma membrane", "id": "6c3328ad-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-157858", "value": 0.0006606898794046455, "ngenes": 72, "description": "Gap junction trafficking and regulation", "id": "6c3328ae-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-190828", "value": 0.0002013787688361368, "ngenes": 67, "description": "Gap junction trafficking", "id": "6c3328af-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-190861", "value": 5.699356398060231e-07, "ngenes": 46, "description": "Gap junction assembly", "id": "6c3328b0-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-190704", "value": 0.027424415704063284, "ngenes": 3, "description": "Oligomerization of connexins into connexons", "id": "6c3328b1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-190827", "value": 0.027424415704063284, "ngenes": 3, "description": "Transport of connexins along the secretory pathway", "id": "6c3328b2-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-190872", "value": 2.4644533924852043e-09, "ngenes": 24, "description": "Transport of connexons to the plasma membrane", "id": "6c3328b3-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-190840", "value": 3.3543753454414874e-10, "ngenes": 23, "description": "Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane", "id": "6c3328b4-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-190873", "value": 1.6452756758667278e-05, "ngenes": 22, "description": "Gap junction degradation", "id": "6c3328b5-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-196025", "value": 3.406159232747121e-05, "ngenes": 21, "description": "Formation of annular gap junctions", "id": "6c3328b6-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-191650", "value": 0.013037692545972672, "ngenes": 6, "description": "Regulation of gap junction activity", "id": "6c3328b7-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-199977", "value": 0.049692164064441796, "ngenes": 245, "description": "ER to Golgi Anterograde Transport", "id": "6c3328b8-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-204005", "value": 0.003553174369557855, "ngenes": 122, "description": "COPII-mediated vesicle transport", "id": "6c3328b9-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5694530", "value": 0.02909659866468163, "ngenes": 73, "description": "Cargo concentration in the ER", "id": "6c3328ba-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6807878", "value": 0.3126086995958799, "ngenes": 144, "description": "COPI-mediated anterograde transport", "id": "6c3328bb-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-199992", "value": 0.3094766159451027, "ngenes": 125, "description": "trans-Golgi Network Vesicle Budding", "id": "6c3328bc-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-432720", "value": 0.6370370446253683, "ngenes": 61, "description": "Lysosome Vesicle Biogenesis", "id": "6c3328bd-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-432722", "value": 0.47910293314870767, "ngenes": 99, "description": "Golgi Associated Vesicle Biogenesis", "id": "6c3328be-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-6811442", "value": 0.010352271673531394, "ngenes": 287, "description": "Intra-Golgi and retrograde Golgi-to-ER traffic", "id": "6c3328bf-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8856688", "value": 0.0007484008546170623, "ngenes": 185, "description": "Golgi-to-ER retrograde transport", "id": "6c3328c0-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-6811434", "value": 8.52733962568885e-20, "ngenes": 142, "description": "COPI-dependent Golgi-to-ER retrograde traffic", "id": "6c3328c1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6811436", "value": 0.13427299705103465, "ngenes": 65, "description": "COPI-independent Golgi-to-ER retrograde traffic", "id": "6c3328c2-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-6811438", "value": 0.020042413786961276, "ngenes": 70, "description": "Intra-Golgi traffic", "id": "6c3328c3-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6811440", "value": 0.05959685319265916, "ngenes": 72, "description": "Retrograde transport at the Trans-Golgi-Network", "id": "6c3328c4-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9007101", "value": 0.09245696916000011, "ngenes": 205, "description": "Rab regulation of trafficking", "id": "6c3328c5-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8854214", "value": 0.15006004322325509, "ngenes": 65, "description": "TBC/RABGAPs", "id": "6c3328c6-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8876198", "value": 0.06780870108802882, "ngenes": 157, "description": "RAB GEFs exchange GTP for GDP on RABs", "id": "6c3328c7-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8856828", "value": 0.2508224149600614, "ngenes": 232, "description": "Clathrin-mediated endocytosis", "id": "6c3328c8-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8856825", "value": 0.45667576326837633, "ngenes": 162, "description": "Cargo recognition for clathrin-mediated endocytosis", "id": "6c3328c9-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-917729", "value": 0.0045656507212278475, "ngenes": 49, "description": "Endosomal Sorting Complex Required For Transport (ESCRT)", "id": "6c3328ca-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-2173782", "value": 0.4705791747549734, "ngenes": 76, "description": "Binding and Uptake of Ligands by Scavenger Receptors", "id": "6c3328cb-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2168880", "value": 0.431814262296479, "ngenes": 27, "description": "Scavenging of heme from plasma", "id": "6c3328cc-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3000471", "value": 0.6243505240971601, "ngenes": 11, "description": "Scavenging by Class B Receptors", "id": "6c3328cd-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3000480", "value": 0.0355597499843788, "ngenes": 31, "description": "Scavenging by Class A Receptors", "id": "6c3328ce-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3000484", "value": 0.22755411611551457, "ngenes": 9, "description": "Scavenging by Class F Receptors", "id": "6c3328cf-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3000497", "value": 0.22960102558554568, "ngenes": 4, "description": "Scavenging by Class H Receptors", "id": "6c3328d0-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-392499", "value": 0.21183929705454527, "ngenes": 3271, "description": "Metabolism of proteins", "id": "6c3328d1-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-72766", "value": 0.15858141356822933, "ngenes": 505, "description": "Translation", "id": "6c3328d2-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-72613", "value": 0.10763213143626878, "ngenes": 248, "description": "Eukaryotic Translation Initiation", "id": "6c3328d3-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-156827", "value": 0.11718463292876465, "ngenes": 236, "description": "L13a-mediated translational silencing of Ceruloplasmin expression", "id": "6c3328d4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-72737", "value": 0.10763213143626878, "ngenes": 248, "description": "Cap-dependent Translation Initiation", "id": "6c3328d5-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-72662", "value": 0.07603333403030835, "ngenes": 120, "description": "Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S", "id": "6c3328d6-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-72649", "value": 0.07894671564739117, "ngenes": 119, "description": "Translation initiation complex formation", "id": "6c3328d7-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-72689", "value": 0.12380593625268725, "ngenes": 217, "description": "Formation of a pool of free 40S subunits", "id": "6c3328d8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-72695", "value": 0.08605247725321616, "ngenes": 103, "description": "Formation of the ternary complex, and subsequently, the 43S complex", "id": "6c3328d9-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-72702", "value": 0.061864192669170606, "ngenes": 121, "description": "Ribosomal scanning and start codon recognition", "id": "6c3328da-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-72706", "value": 0.10570533612616784, "ngenes": 239, "description": "GTP hydrolysis and joining of the 60S ribosomal subunit", "id": "6c3328db-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-72731", "value": 0.023619168786469438, "ngenes": 9, "description": "Recycling of eIF2:GDP", "id": "6c3328dc-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-156842", "value": 0.15698226750267408, "ngenes": 208, "description": "Eukaryotic Translation Elongation", "id": "6c3328dd-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-156902", "value": 0.14632222307541312, "ngenes": 197, "description": "Peptide chain elongation", "id": "6c3328de-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1799339", "value": 0.13514568958982004, "ngenes": 228, "description": "SRP-dependent cotranslational protein targeting to membrane", "id": "6c3328df-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-379724", "value": 0.00014929500925455597, "ngenes": 55, "description": "tRNA Aminoacylation", "id": "6c3328e0-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-379716", "value": 8.178156314767601e-15, "ngenes": 32, "description": "Cytosolic tRNA aminoacylation", "id": "6c3328e1-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-379726", "value": 0.1713663191105792, "ngenes": 26, "description": "Mitochondrial tRNA aminoacylation", "id": "6c3328e2-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5368287", "value": 0.6163154739903766, "ngenes": 145, "description": "Mitochondrial translation", "id": "6c3328e3-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5368286", "value": 0.4474211901535635, "ngenes": 133, "description": "Mitochondrial translation initiation", "id": "6c3328e4-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5389840", "value": 0.4567125600063888, "ngenes": 132, "description": "Mitochondrial translation elongation", "id": "6c3328e5-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5419276", "value": 0.5581297247219166, "ngenes": 136, "description": "Mitochondrial translation termination", "id": "6c3328e6-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-72764", "value": 0.1569895752700173, "ngenes": 200, "description": "Eukaryotic Translation Termination", "id": "6c3328e7-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-597592", "value": 0.294591317554744, "ngenes": 2279, "description": "Post-translational protein modification", "id": "6c3328e8-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-163841", "value": 0.31464243394264546, "ngenes": 68, "description": "Gamma carboxylation, hypusine formation and arylsulfatase activation", "id": "6c3328e9-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-159854", "value": 0.0019100924209210003, "ngenes": 15, "description": "Gamma-carboxylation, transport, and amino-terminal cleavage of proteins", "id": "6c3328ea-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-159740", "value": 0.0021322417670884553, "ngenes": 14, "description": "Gamma-carboxylation of protein precursors", "id": "6c3328eb-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-159763", "value": 0.0039456866848666975, "ngenes": 13, "description": "Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus", "id": "6c3328ec-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-159782", "value": 0.003398197050741607, "ngenes": 14, "description": "Removal of aminoterminal propeptides from gamma-carboxylated proteins", "id": "6c3328ed-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-1663150", "value": 5.531027031359787e-12, "ngenes": 20, "description": "The activation of arylsulfatases", "id": "6c3328ee-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-204626", "value": 0.19033171998059326, "ngenes": 7, "description": "Hypusine synthesis from eIF5A-lysine", "id": "6c3328ef-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5358493", "value": 0.07490636955544028, "ngenes": 14, "description": "Synthesis of diphthamide-EEF2", "id": "6c3328f0-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-163125", "value": 2.4126874297190546e-05, "ngenes": 140, "description": "Post-translational modification: synthesis of GPI-anchored proteins", "id": "6c3328f1-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-162699", "value": 0.06639095317036248, "ngenes": 6, "description": "Synthesis of dolichyl-phosphate mannose", "id": "6c3328f2-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-162710", "value": 0.0014411540651865322, "ngenes": 29, "description": "Synthesis of glycosylphosphatidylinositol (GPI)", "id": "6c3328f3-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-162791", "value": 0.0001970814291284269, "ngenes": 9, "description": "Attachment of GPI anchor to uPAR", "id": "6c3328f4-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-446203", "value": 0.0992012447783749, "ngenes": 485, "description": "Asparagine N-linked glycosylation", "id": "6c3328f5-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-446193", "value": 0.8293103224453596, "ngenes": 126, "description": "Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein", "id": "6c3328f6-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-446219", "value": 0.017114779597088424, "ngenes": 102, "description": "Synthesis of substrates in N-glycan biosythesis", "id": "6c3328f7-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-162699", "value": 0.06639095317036248, "ngenes": 6, "description": "Synthesis of dolichyl-phosphate mannose", "id": "6c3328f8-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-4085001", "value": 0.02460084122631806, "ngenes": 54, "description": "Sialic acid metabolism", "id": "6c3328f9-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-446199", "value": 0.5748927681168847, "ngenes": 10, "description": "Synthesis of Dolichyl-phosphate", "id": "6c3328fa-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-446205", "value": 0.007993286172980537, "ngenes": 11, "description": "Synthesis of GDP-mannose", "id": "6c3328fb-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-446210", "value": 0.1512297361776561, "ngenes": 13, "description": "Synthesis of UDP-N-acetyl-glucosamine", "id": "6c3328fc-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6787639", "value": 3.173367211339042e-10, "ngenes": 6, "description": "GDP-fucose biosynthesis", "id": "6c3328fd-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-948021", "value": 0.06900787287214245, "ngenes": 297, "description": "Transport to the Golgi and subsequent modification", "id": "6c3328fe-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-199977", "value": 0.049692164064441796, "ngenes": 245, "description": "ER to Golgi Anterograde Transport", "id": "6c3328ff-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-204005", "value": 0.003553174369557855, "ngenes": 122, "description": "COPII-mediated vesicle transport", "id": "6c332900-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5694530", "value": 0.02909659866468163, "ngenes": 73, "description": "Cargo concentration in the ER", "id": "6c332901-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6807878", "value": 0.3126086995958799, "ngenes": 144, "description": "COPI-mediated anterograde transport", "id": "6c332902-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-964739", "value": 0.12790238017138023, "ngenes": 10, "description": "N-glycan trimming and elongation in the cis-Golgi", "id": "6c332903-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-964827", "value": 0.4657903614548386, "ngenes": 4, "description": "Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2", "id": "6c332904-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-975576", "value": 0.10535363917636822, "ngenes": 42, "description": "N-glycan antennae elongation in the medial/trans-Golgi", "id": "6c332905-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-975577", "value": 0.0020670353945839463, "ngenes": 25, "description": "N-Glycan antennae elongation", "id": "6c332906-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-975578", "value": 0.0900485783230847, "ngenes": 15, "description": "Reactions specific to the complex N-glycan synthesis pathway", "id": "6c332907-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-532668", "value": 0.013695001787852578, "ngenes": 56, "description": "N-glycan trimming in the ER and Calnexin/Calreticulin cycle", "id": "6c332908-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-901042", "value": 0.006428018997266781, "ngenes": 45, "description": "Calnexin/calreticulin cycle", "id": "6c332909-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-901032", "value": 0.016863118777828243, "ngenes": 39, "description": "ER Quality Control Compartment (ERQC)", "id": "6c33290a-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-2990846", "value": 0.44758565136676015, "ngenes": 325, "description": "SUMOylation", "id": "6c33290b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3215018", "value": 0.14518948415085434, "ngenes": 15, "description": "Processing and activation of SUMO", "id": "6c33290c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3065676", "value": 0.911195249508345, "ngenes": 7, "description": "SUMO is conjugated to E1 (UBA2:SAE1)", "id": "6c33290d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3065678", "value": 0.13795356767983102, "ngenes": 12, "description": "SUMO is transferred from E1 to E2 (UBE2I, UBC9)", "id": "6c33290e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3065679", "value": 0.02921757704401139, "ngenes": 8, "description": "SUMO is proteolytically processed", "id": "6c33290f-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-3108232", "value": 0.3280621768486478, "ngenes": 319, "description": "SUMO E3 ligases SUMOylate target proteins", "id": "6c332910-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3108214", "value": 0.17465784109252389, "ngenes": 134, "description": "SUMOylation of DNA damage response and repair proteins", "id": "6c332911-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3232118", "value": 0.9785128202993659, "ngenes": 46, "description": "SUMOylation of transcription factors", "id": "6c332912-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3232142", "value": 0.08325462565312794, "ngenes": 75, "description": "SUMOylation of ubiquitinylation proteins", "id": "6c332913-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3899300", "value": 0.976271670261368, "ngenes": 81, "description": "SUMOylation of transcription cofactors", "id": "6c332914-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-4085377", "value": 0.07405450558080441, "ngenes": 58, "description": "SUMOylation of SUMOylation proteins", "id": "6c332915-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-4090294", "value": 0.9835282197825542, "ngenes": 68, "description": "SUMOylation of intracellular receptors", "id": "6c332916-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-4551638", "value": 0.009931149699526574, "ngenes": 108, "description": "SUMOylation of chromatin organization proteins", "id": "6c332917-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-4570464", "value": 0.07679509370564543, "ngenes": 79, "description": "SUMOylation of RNA binding proteins", "id": "6c332918-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-4615885", "value": 1.4428993689138354e-12, "ngenes": 73, "description": "SUMOylation of DNA replication proteins", "id": "6c332919-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-4655427", "value": 1.184234006118431e-13, "ngenes": 34, "description": "SUMOylation of DNA methylation proteins", "id": "6c33291a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-4755510", "value": 0.005306207323269956, "ngenes": 18, "description": "SUMOylation of immune response proteins", "id": "6c33291b-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-5173105", "value": 0.07946731344098612, "ngenes": 165, "description": "O-linked glycosylation", "id": "6c33291c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5173214", "value": 0.2622808783522277, "ngenes": 59, "description": "O-glycosylation of TSR domain-containing proteins", "id": "6c33291d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-913709", "value": 0.11777630059142877, "ngenes": 92, "description": "O-linked glycosylation of mucins", "id": "6c33291e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-977068", "value": 0.008330489781654432, "ngenes": 45, "description": "Termination of O-glycan biosynthesis", "id": "6c33291f-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-5688426", "value": 0.6806363127271342, "ngenes": 444, "description": "Deubiquitination", "id": "6c332920-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5689603", "value": 0.47514038043848866, "ngenes": 165, "description": "UCH proteinases", "id": "6c332921-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5689877", "value": 0.16890482254738393, "ngenes": 20, "description": "Josephin domain DUBs", "id": "6c332922-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5689880", "value": 0.8453275888788241, "ngenes": 322, "description": "Ub-specific processing proteases", "id": "6c332923-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5689896", "value": 0.022634885265574615, "ngenes": 61, "description": "Ovarian tumor domain proteases", "id": "6c332924-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5689901", "value": 0.49548112457381205, "ngenes": 53, "description": "Metalloprotease DUBs", "id": "6c332925-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8852135", "value": 0.745341395347533, "ngenes": 131, "description": "Protein ubiquitination", "id": "6c332926-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8866652", "value": 0.0068231832431217875, "ngenes": 55, "description": "Synthesis of active ubiquitin: roles of E1 and E2 enzymes", "id": "6c332927-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8866654", "value": 0.9687632284208971, "ngenes": 94, "description": "E3 ubiquitin ligases ubiquitinate target proteins", "id": "6c332928-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8873719", "value": 0.9849259800134336, "ngenes": 99, "description": "RAB geranylgeranylation", "id": "6c332929-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8876725", "value": 0.447022874441219, "ngenes": 34, "description": "Protein methylation", "id": "6c33292a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8951664", "value": 0.6522142160471123, "ngenes": 414, "description": "Neddylation", "id": "6c33292b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8955332", "value": 7.833023774473981e-08, "ngenes": 62, "description": "Carboxyterminal post-translational modifications of tubulin", "id": "6c33292c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8957275", "value": 0.401724673834549, "ngenes": 165, "description": "Post-translational protein phosphorylation", "id": "6c33292d-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-2980736", "value": 0.05214008741113826, "ngenes": 136, "description": "Peptide hormone metabolism", "id": "6c33292e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2022377", "value": 0.001291263562382984, "ngenes": 25, "description": "Metabolism of Angiotensinogen to Angiotensins", "id": "6c33292f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-209952", "value": 0.12210296979847508, "ngenes": 16, "description": "Peptide hormone biosynthesis", "id": "6c332930-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-209822", "value": 0.5677347598569016, "ngenes": 12, "description": "Glycoprotein hormones", "id": "6c332931-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-264876", "value": 0.18458504058237474, "ngenes": 47, "description": "Insulin processing", "id": "6c332932-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-400508", "value": 0.1824959853506288, "ngenes": 37, "description": "Incretin synthesis, secretion, and inactivation", "id": "6c332933-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-381771", "value": 0.18625986386836935, "ngenes": 34, "description": "Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)", "id": "6c332934-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-400511", "value": 0.20534411075108655, "ngenes": 18, "description": "Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)", "id": "6c332935-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-422085", "value": 0.34766469334661665, "ngenes": 29, "description": "Synthesis, secretion, and deacylation of Ghrelin", "id": "6c332936-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-381119", "value": 0.7886293320800668, "ngenes": 150, "description": "Unfolded Protein Response (UPR)", "id": "6c332937-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-381042", "value": 0.07894671564739117, "ngenes": 46, "description": "PERK regulates gene expression", "id": "6c332938-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-380994", "value": 0.6965614231904725, "ngenes": 41, "description": "ATF4 activates genes in response to endoplasmic reticulum  stress", "id": "6c332939-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-381070", "value": 0.8691645053784193, "ngenes": 90, "description": "IRE1alpha activates chaperones", "id": "6c33293a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-381038", "value": 0.7903034189657243, "ngenes": 87, "description": "XBP1(S) activates chaperone genes", "id": "6c33293b-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-381033", "value": 0.0025921201064921726, "ngenes": 19, "description": "ATF6 (ATF6-alpha) activates chaperones", "id": "6c33293c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-381183", "value": 1.064998183206434e-05, "ngenes": 14, "description": "ATF6 (ATF6-alpha) activates chaperone genes", "id": "6c33293d-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8874211", "value": 0.05718519809362029, "ngenes": 13, "description": "CREB3 factors activate genes", "id": "6c33293e-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-381426", "value": 0.11785839993980847, "ngenes": 191, "description": "Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)", "id": "6c33293f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-391251", "value": 0.7594402132883133, "ngenes": 159, "description": "Protein folding", "id": "6c332940-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-390466", "value": 0.9738346164928023, "ngenes": 151, "description": "Chaperonin-mediated protein folding", "id": "6c332941-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-389958", "value": 5.0107266710638485e-05, "ngenes": 47, "description": "Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding", "id": "6c332942-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-389957", "value": 0.0007260127802908744, "ngenes": 42, "description": "Prefoldin mediated transfer of substrate  to CCT/TriC", "id": "6c332943-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-389960", "value": 2.289094024853927e-07, "ngenes": 36, "description": "Formation of tubulin folding intermediates by CCT/TriC", "id": "6c332944-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-390450", "value": 3.953369769385709e-05, "ngenes": 18, "description": "Folding of actin by CCT/TriC", "id": "6c332945-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-390471", "value": 5.720143229806291e-09, "ngenes": 72, "description": "Association of TriC/CCT with target proteins during biosynthesis", "id": "6c332946-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-6814122", "value": 0.05209455363729061, "ngenes": 62, "description": "Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding", "id": "6c332947-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-389977", "value": 4.154034098616977e-09, "ngenes": 29, "description": "Post-chaperonin tubulin folding pathway", "id": "6c332948-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5676934", "value": 0.010081270997589657, "ngenes": 9, "description": "Protein repair", "id": "6c332949-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5683826", "value": 0.5507318108531101, "ngenes": 52, "description": "Surfactant metabolism", "id": "6c33294a-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-977225", "value": 0.2675922675321366, "ngenes": 155, "description": "Amyloid fiber formation", "id": "6c33294b-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-69306", "value": 2.3550047627559715e-12, "ngenes": 215, "description": "DNA Replication", "id": "6c33294c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-69239", "value": 2.3575674703788227e-10, "ngenes": 206, "description": "Synthesis of DNA", "id": "6c33294d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-69190", "value": 1.3789620622265962e-12, "ngenes": 54, "description": "DNA strand elongation", "id": "6c33294e-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-176974", "value": 1.6515975144447306e-13, "ngenes": 18, "description": "Unwinding of DNA", "id": "6c33294f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-69109", "value": 0.0004439150088424428, "ngenes": 28, "description": "Leading Strand Synthesis", "id": "6c332950-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-69091", "value": 0.0004439150088424428, "ngenes": 28, "description": "Polymerase switching", "id": "6c332951-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-69186", "value": 1.6307240466831002e-06, "ngenes": 36, "description": "Lagging Strand Synthesis", "id": "6c332952-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-69091", "value": 0.0004439150088424428, "ngenes": 28, "description": "Polymerase switching", "id": "6c332953-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-69183", "value": 3.929526243965144e-09, "ngenes": 24, "description": "Processive synthesis on the lagging strand", "id": "6c332954-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-69166", "value": 2.6892531473764623e-06, "ngenes": 23, "description": "Removal of the Flap Intermediate", "id": "6c332955-88c5-11eb-abfe-4d49f1a5f950"}]}]}]}, {"source": "R-HSA-69052", "value": 2.482692656523164e-08, "ngenes": 161, "description": "Switching of origins to a post-replicative state", "id": "6c332956-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-68949", "value": 0.0001106439826535499, "ngenes": 121, "description": "Orc1 removal from chromatin", "id": "6c332957-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-69017", "value": 0.008326222944761206, "ngenes": 131, "description": "CDK-mediated phosphorylation and removal of Cdc6", "id": "6c332958-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-68952", "value": 0.0004260760590762161, "ngenes": 11, "description": "DNA replication initiation", "id": "6c332959-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-69002", "value": 1.4043361545757021e-05, "ngenes": 136, "description": "DNA Replication Pre-Initiation", "id": "6c33295a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-68867", "value": 0.002092132579716394, "ngenes": 114, "description": "Assembly of the pre-replicative complex", "id": "6c33295b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-68616", "value": 6.867171574092847e-08, "ngenes": 9, "description": "Assembly of the ORC complex at the origin of replication", "id": "6c33295c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-68689", "value": 1.7961488927847918e-16, "ngenes": 16, "description": "CDC6 association with the ORC:origin complex", "id": "6c33295d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-68827", "value": 0.1433703837975839, "ngenes": 101, "description": "CDT1 association with the CDC6:ORC:origin complex", "id": "6c33295e-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-68962", "value": 3.5096712062002506e-13, "ngenes": 47, "description": "Activation of the pre-replicative complex", "id": "6c33295f-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-8963743", "value": 0.7373554461622137, "ngenes": 40, "description": "Digestion and absorption", "id": "6c332960-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8935690", "value": 0.7790381966040238, "ngenes": 35, "description": "Digestion", "id": "6c332961-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-189085", "value": 0.6329639275663769, "ngenes": 22, "description": "Digestion of dietary carbohydrate", "id": "6c332962-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-192456", "value": 0.00016420056500946714, "ngenes": 7, "description": "Digestion of dietary lipid", "id": "6c332963-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-8963676", "value": 0.1187122997589825, "ngenes": 5, "description": "Intestinal absorption", "id": "6c332964-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-8981373", "value": 0.0700688297079225, "ngenes": 4, "description": "Intestinal hexose absorption", "id": "6c332965-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-1852241", "value": 0.4270541421617548, "ngenes": 471, "description": "Organelle biogenesis and maintenance", "id": "6c332966-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1592230", "value": 0.6813472276670933, "ngenes": 151, "description": "Mitochondrial biogenesis", "id": "6c332967-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-2151201", "value": 0.773184284378466, "ngenes": 83, "description": "Transcriptional activation of mitochondrial biogenesis", "id": "6c332968-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-2151209", "value": 0.03062705998531739, "ngenes": 19, "description": "Activation of PPARGC1A (PGC-1alpha) by phosphorylation", "id": "6c332969-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8949613", "value": 0.6590737225712482, "ngenes": 52, "description": "Cristae formation", "id": "6c33296a-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5617833", "value": 0.3076067092004024, "ngenes": 320, "description": "Cilium Assembly", "id": "6c33296b-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5620912", "value": 0.0011698965708096891, "ngenes": 153, "description": "Anchoring of the basal body to the plasma membrane", "id": "6c33296c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5620920", "value": 0.29721582864904045, "ngenes": 82, "description": "Cargo trafficking to the periciliary membrane", "id": "6c33296d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5620916", "value": 0.5576365543887813, "ngenes": 31, "description": "VxPx cargo-targeting to cilium", "id": "6c33296e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5620922", "value": 1.919244561386922e-07, "ngenes": 41, "description": "BBSome-mediated cargo-targeting to cilium", "id": "6c33296f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5624138", "value": 8.448508955297425e-06, "ngenes": 6, "description": "Trafficking of myristoylated proteins to the cilium", "id": "6c332970-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5624958", "value": 0.27140893919963927, "ngenes": 5, "description": "ARL13B-mediated ciliary trafficking of INPP5E", "id": "6c332971-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-5620924", "value": 2.61066548397675e-10, "ngenes": 85, "description": "Intraflagellar transport", "id": "6c332972-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-4839726", "value": 0.32322614155989415, "ngenes": 438, "description": "Chromatin organization", "id": "6c332973-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3247509", "value": 0.32322614155989415, "ngenes": 438, "description": "Chromatin modifying enzymes", "id": "6c332974-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-3214815", "value": 0.49548112457381205, "ngenes": 109, "description": "HDACs deacetylate histones", "id": "6c332975-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3214841", "value": 0.5888135677888017, "ngenes": 115, "description": "PKMTs methylate histone lysines", "id": "6c332976-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3214842", "value": 0.057744061899746395, "ngenes": 55, "description": "HDMs demethylate histones", "id": "6c332977-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3214847", "value": 0.9613675648148727, "ngenes": 209, "description": "HATs acetylate histones", "id": "6c332978-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-3214858", "value": 0.16561890807811652, "ngenes": 109, "description": "RMTs methylate histone arginines", "id": "6c332979-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-1500931", "value": 0.03188286383493482, "ngenes": 264, "description": "Cell-Cell communication", "id": "6c33297a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-373753", "value": 0.006753257432110538, "ngenes": 37, "description": "Nephrin family interactions", "id": "6c33297b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-446728", "value": 0.751106746014806, "ngenes": 194, "description": "Cell junction organization", "id": "6c33297c-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-421270", "value": 6.534607014517915e-08, "ngenes": 123, "description": "Cell-cell junction organization", "id": "6c33297d-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-373756", "value": 0.8224168614764014, "ngenes": 3, "description": "SDK interactions", "id": "6c33297e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-420029", "value": 0.4204771812460541, "ngenes": 50, "description": "Tight junction interactions", "id": "6c33297f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-418990", "value": 1.0729426565622716e-06, "ngenes": 70, "description": "Adherens junctions interactions", "id": "6c332980-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-420597", "value": 0.025156133429495638, "ngenes": 13, "description": "Nectin/Necl  trans heterodimerization", "id": "6c332981-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-446107", "value": 0.03618878346525569, "ngenes": 39, "description": "Type I hemidesmosome assembly", "id": "6c332982-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-446353", "value": 0.00350880258230142, "ngenes": 37, "description": "Cell-extracellular matrix interactions", "id": "6c332983-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-446343", "value": 0.24916944737656072, "ngenes": 8, "description": "Localization of the PINCH-ILK-PARVIN complex to focal adhesions", "id": "6c332984-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-446388", "value": 0.04594427842390494, "ngenes": 15, "description": "Regulation of cytoskeletal remodeling and cell spreading by IPP complex components", "id": "6c332985-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-391160", "value": 0.4929315492085499, "ngenes": 34, "description": "Signal regulatory protein family interactions", "id": "6c332986-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-397014", "value": 0.7790381966040238, "ngenes": 365, "description": "Muscle contraction", "id": "6c332987-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-390522", "value": 0.43673540604784883, "ngenes": 61, "description": "Striated Muscle Contraction", "id": "6c332988-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-445355", "value": 0.6370370446253683, "ngenes": 71, "description": "Smooth Muscle Contraction", "id": "6c332989-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5576891", "value": 0.0011478421390272945, "ngenes": 245, "description": "Cardiac conduction", "id": "6c33298a-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5576886", "value": 5.88136291218158e-07, "ngenes": 34, "description": "Phase 4 - resting membrane potential", "id": "6c33298b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5576890", "value": 0.20532790414024638, "ngenes": 15, "description": "Phase 3 - rapid repolarisation", "id": "6c33298c-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5576892", "value": 0.010435898354045776, "ngenes": 68, "description": "Phase 0 - rapid depolarisation", "id": "6c33298d-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5576893", "value": 0.0019555313465172345, "ngenes": 32, "description": "Phase 2 - plateau phase", "id": "6c33298e-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5576894", "value": 0.03558331188782417, "ngenes": 19, "description": "Phase 1 - inactivation of fast Na+ channels", "id": "6c33298f-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5578768", "value": 0.12917283153865403, "ngenes": 20, "description": "Physiological factors", "id": "6c332990-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-5578775", "value": 0.5293812045158534, "ngenes": 102, "description": "Ion homeostasis", "id": "6c332991-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-9612973", "value": 0.26961021049519585, "ngenes": 249, "description": "Autophagy", "id": "6c332992-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-1632852", "value": 0.3494089624330179, "ngenes": 222, "description": "Macroautophagy", "id": "6c332993-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-9663891", "value": 0.26607147795621, "ngenes": 135, "description": "Selective autophagy", "id": "6c332994-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5205647", "value": 0.8931196307933348, "ngenes": 51, "description": "Mitophagy", "id": "6c332995-88c5-11eb-abfe-4d49f1a5f950", "children": [{"source": "R-HSA-5205685", "value": 0.8608410052756269, "ngenes": 33, "description": "PINK1-PRKN Mediated Mitophagy", "id": "6c332996-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-8934903", "value": 0.3959633767095228, "ngenes": 25, "description": "Receptor Mediated Mitophagy", "id": "6c332997-88c5-11eb-abfe-4d49f1a5f950"}]}, {"source": "R-HSA-9613354", "value": 0.019892441589417765, "ngenes": 17, "description": "Lipophagy", "id": "6c332998-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9646399", "value": 0.03113661977489383, "ngenes": 67, "description": "Aggrephagy", "id": "6c332999-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9664873", "value": 0.13017966196302347, "ngenes": 22, "description": "Pexophagy", "id": "6c33299a-88c5-11eb-abfe-4d49f1a5f950"}]}]}, {"source": "R-HSA-9613829", "value": 0.6521879174703202, "ngenes": 44, "description": "Chaperone Mediated Autophagy", "id": "6c33299b-88c5-11eb-abfe-4d49f1a5f950"}, {"source": "R-HSA-9615710", "value": 0.5075589092321199, "ngenes": 60, "description": "Late endosomal microautophagy", "id": "6c33299c-88c5-11eb-abfe-4d49f1a5f950"}]}]}